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Summary
Dual energy imaging (DE) is a potential alternative breast imaging modality for patients with dense
breasts. It utilises intravenous injection of contrast agent (CA) to highlight structures of interest,
such as tumours. Following CA administration, images are acquired at two different energies, such
that the change in attenuation of the CA across the energy range differs significantly from that of the
background material, such as across its K-edge. Implementation of DE on a conventional detector
requires two separate exposures, leading to a higher dose and possible patient movement between
exposures, which can lead to incomplete background removal.
The novelty of this work is the implementation of the DE algorithms using a hyperspectral energy-
sensitive detector, HEXITEC, which gives a whole spectrum per pixel. This allows multiple energy
images to be obtained simultaneously by integrating appropriate bands of the spectra acquired by
each individual pixel, thereby providing a single-shot approach to DE. The ability to access a whole
array of possible image combinations from a single exposure provides a powerful tool in determining
the optimum beam parameters and energy ranges to produce the DE images.
Two different contrast agents were compared: a clinical iodinated contrast agent and gold nanopar-
ticles (AnNPs), which have the potential to be preferentially absorbed by tumours through targeting
and functionalisation.
Imaging performance was assessed for both contrast agents via reconstructed concentration cal-
culations and CNR. The cell toxicity of each CA was also investigated using clonogenic assays to
generate a cell survival curve following exposure to CA and radiation between 0-5 Gy. Both iodine
and AuNPs showed good agreement with nominal values in terms of reconstructed concentration for
a range of nominal concentrations (the reconstructed concentration of 200 mg/ml CA was 189 ± 10
and 216 ± 8 mg/ml for AuNPs and iodine respectively). Iodine outperformed AuNPs in terms of
CNR. Toxicity results indicated a statistically significant decrease at the 68% confidence level in the
α parameter of the linear quadratic dose curve with the addition of AuNPs but not with the addi-
tion of iodine, suggesting an increased toxicity with AuNPs (alpha values were found to be 0.46±1,
0.40 ±1 and 0.19±1 Gy−1 for no CA, iodine and AuNPs respectively). Iodine outperformed AuNPs
overall, but further work is required (including optimisation of the energy spectra) to allow the full
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potential of AuNPs to be determined.
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Chapter 1
Introduction and Thesis Structure
1.1 Introduction and Motivation
Breast cancer is the most common form of cancer in the UK, with one in eight women and one in
870 men diagnosed during their lifetime. According to Cancer Research UK (CRUK, 2018), a total
of 54,800 new invasive cases were diagnosed in 2015 alone, 370 of which were in males. These figures
are increasing every year, as shown in graph (a) of fig.1.1. Breast cancer is also the third largest
cause of death from cancer, after lung and bowel cancer, with 11,563 deaths in 2016, 80 of which
were in males. It is therefore important that breast cancer is detected and treated as quickly and as
effectively as possible. The trend of breast cancer deaths per 100,000 of the population over time is
shown in graph (b) of fig.1.1. It shows that, for most age categories, the mortality rate was on the
rise or constant before the introduction of breast cancer screening in 1988 (marked on graph (b) by a
purple vertical line). Since then, there has been a steady fall for all age categories up to the present
time.
Since 1988, the NHS Breast Screening Programme has been in operation, in which all asymp-
tomatic women in the UK between the ages of 50 and 70 are invited for routine screening every three
years. Women over 70 can request screenings every three years. This is currently being extended in
some areas to include women aged 47-73 on a trial basis.
X-ray mammography is the method of choice for the NHS Breast Screening Program and has
been confirmed to perform well in terms of both sensitivity and specificity (Pisano et al., 2005;
Kolb et al., 2002; Barlow et al., 2002; Kim et al., 2017). However, as these and other studies have
concluded (Buist et al., 2004), its performance is significantly reduced when imaging dense breasts,
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Figure 1.1: Graph (a) shows invasive breast cancer incidence over time in the UK from 1993 to 2015. Graph
(b) shows breast mortality rates in the UK from 1971 to 2016 adapted from Cancer Research UK (CRUK,
2018). The vertical purple line shows the year that breast screening was introduced in the UK.
i.e. those whith a significant glandular component, due to the radiographically similar appearance of
fibroglandular tissue and carcinoma. This can cause cancerous lesions to be masked from view (Mousa
et al., 2014; Holland et al., 2017). Studies have also shown that higher breast density is linked to a
higher likelihood of developing breast cancer (Turashvili et al., 2009a; Boyd et al., 2011a; Wanders
et al., 2017). It is therefore important that they can be imaged both effectively and efficiently.
Intravenous injection of contrast agent can be used to highlight cancerous lesions, which will
have a higher uptake than healthy tissue due to increased vascularisation. This technique is called
contrast-enhanced digital mammography (CEDM). Currently, iodinated contrast agents are the most
widely used for mammography, due to iodine’s high atomic number and low toxicity. Gold nanopar-
ticles (AuNPs), which have the ability to be preferentially taken up in specific types of cells via
functionalisation, are of particular interest as a potential X-ray contrast agent and have also been
investigated extensively as radiosensitisers and drug delivery vehicles (Zhang et al., 2008; Butter-
worth et al., 2010, 2012; Dreaden et al., 2012). As gold has a high attenuation coefficient and higher
atomic number (Z=79), it would make an ideal contrast agent and could overcome the limitations
associated with iodine, such as short times between injection and imaging, as it stays in the blood
for longer (Nanoprobes, 2011a). However, the small size and large surface area to volume ratio of
nanoparticles mean that they have considerably different properties to the bulk material. Although
gold is well established as non-toxic, its properties at the nano-scale are yet to be fully understood.
Other potential uses of contrast-enhanced imaging include enhancement pharmacokinetics, where
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the uptake and wash-out patterns of the contrast agent may be used to classify malignant breast
lesions (Yang et al., 2016).
Addition of contrast agent alone may not be sufficient for breast imaging due to the complex, non-
uniform background of structures within the breast that can be visualised on a mammogram. This
has led to the development of techniques to remove the background post-acquisition by combining
multiple images to enable clearer visualisation of contrast-enhanced lesions. Typically this involves
acquiring two images of different energies and combining them in such a way so as to remove the
background. There are currently some clinical detectors on which CEDM can be implemented, such
as the GE SenoBright system (Carton et al., 2012). However, this requires two separate exposures.
The use of position-sensitive spectroscopic detectors could also aid contrast-enhanced mammog-
raphy. Unlike conventional mammography detectors, which give only positional information, spec-
troscopic detectors are able to record individual photon energies. Some spectroscopic detectors work
based on thresholds, where only photons above a set energy are recorded. By implementing multi-
ple thresholds simultaneously, and subtracting one resulting image from a consecutive one, a band
containing only photons with energies between the two thresholds can be obtained. The Medipix
family is an example of this type of detector (Ballabriga et al., 2011). Others, such as the HEXITEC
detector (Jones et al., 2009), give a whole spectrum of energies for each pixel, allowing the selec-
tion of energy bands by appropriate integration of specific portions of the spectrum. Both of these
detectors allow multiple images to be obtained from a single exposure. This could reduce patient
dose and overcome problems with patient movement between exposures, which can cause incomplete
background removal.
The aim of this project is to improve current contrast-enhanced mammography techniques by
using a spectroscopic detector (HEXITEC) and by comparing both clinical iodinated and AuNP
contrast agents to improve background removal. The removal will be achieved by decomposing
images into a contrast image and a water-equivalent image. Another important aim is to investigate
the radiobiological effects on cells of irradiation in the presence of contrast agent, which will be
achieved by toxicity tests in the form of clonogenic assays.
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1.2 Thesis Structure
This thesis is divided into two distinct parts: Spectroscopic Imaging (part 1) and Radiobiology (part
2). Part 1, as well as investigating the implementation of CEDM using the HEXITEC detector,
assesses the contrast agents in terms of image quality. Part 2, on the other hand, assesses the
contrast agents in terms of their biological effects on cells.
Part 1
Chapter 2: Background/ Theory
Background and theory of X-ray interactions, breast anatomy and breast imaging techniques. The
theory behind different CEDM techniques is outlined and an overview of clinical mammography
detectors is given. The operation of spectroscopic detectors is explained, with particular emphasis
on the HEXITEC detector and its associated components, along with its charge-sharing and dead
time characteristics.
Chapter 3: System Characterisation
This chapter outlines the main components of image quality as well as characterisation of the HEX-
ITEC detector. The calibration procedure on both a global and individual pixel level is presented as
well as Modulation Transfer Function (MTF) measurements.
Chapter 4: Main Imaging Investigations
This chapter introduces the experimental set-up and presents the imaging experiments with a custom
test object. Imaging using both a clinical iodinated contrast agent and AuNPs are outlined and
compared. Analysis by dual energy decomposition is investigated, the results of which are quantified
by the reconstructed contrast agent concentration and contrast-to-noise ratio.
Chapter 5: Dead Time Studies
An investigation into the maximum operating count rate of HEXITEC when charge sharing correc-
tions are implemented is presented. True vs measured count rates are used to generate a dead time
model, which is used to correct reconstructed contrast agent concentration in images acquired above
the maximum count rate.
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Part 2
Chapter 6: Radiobiology Background/Theory
Background and theory into the use of AuNPs in both radiotherapy and in imaging. Methods of cell
culture and of quantifying biological effects of radiation are described.
Chapter 7: Radiobiology Main Investigations
The main biology experiments are outlined here. Clonogenic assay results obtained both with and
without exposure to contrast agents and radiation are presented. Cell survival is quantified by both
number of colonies present and percentage area of flask covered. The results lead to the generation
of cell survival curves for AuNPs, iodine and no added contrast agents. Beam half-value layer is also
quantified.
Conclusions
Chapter 8: Conclusions and Further Work
This chapter brings together the conclusions from both parts of the investigation and outlines possible
further investigations that would strengthen and expand the results obtained from the project.
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Part I
Spectroscopic Imaging
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Chapter 2
Background and Theory
2.1 X-rays
X-rays were discovered in 1985 by German scientist Wilhelm Röntgen whilst he was investigating
the effects of passing high electrical current through discharge tubes containing very low-pressure
gasses. After wrapping the tube with black card to prevent the glow caused by electrons, he noticed
a glow from a nearby phosphor screen. Knowing it could not be caused by cathode rays (electrons),
he subsequently concluded that some other ray that could traverse matter must be responsible.
Today, we know that X-rays are a form of electromagnetic radiation, with a much smaller wave-
length than visible light (typically 0.01 nm to 10 nm). X-rays are widely used in the medical field to
visualise internal structures such as bones and organs within the body, thus avoiding invasive surgery.
Prolonged and frequent exposure to X-rays was later found to be potentially harmful because the
ionising nature of the radiation can cause damage to cell DNA via the breaking of chemical bonds,
which can lead to cancer. However, this also makes X-rays suitable for use in radiotherapy treatment
to kill or control cancer cells.
2.1.1 X-ray Interactions with Matter
There are three main methods by which X-radiation may interact with matter in the imaging energy
range, namely via photoelectric absorption, Compton (incoherent) scattering and Rayleigh (coherent)
scattering. Pair production may also occur, but only at energies in the radiotherapy energy range
(above 1.02 MeV). A projection of the objects in the X-ray beam can be built up based on the amount
of energy deposited from these interactions within the detector material. However, as explained in
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Figure 2.1: Atomic diagram to show the process of the photoelectric interaction (a) and the Compton inter-
action (b) (HyperPhysics, 2018)
sections 2.1.3 to 2.1.5, not all detected events are useful in determining the in-beam object and some
may even be detrimental to the quality of the image.
2.1.2 The Photoelectric Effect
The photoelectric effect describes the emission of electrons, termed photo-electrons, from a material
due to exposure to photons. During the interaction, a single photon transfers all of its energy to a
bound electron within an atom, typically situated in a K- or L-shell. Part of the energy absorbed
by the electron is used to overcome its binding energy i.e. to allow the electron to escape the atom.
The electron is then ejected with kinetic energy equal to the difference between the incident photon
energy and the binding energy. This means that photoelectric emission can only occur for incident
photons with energy at least equal to that of the electron’s binding energy. It is most probable
that the emitted electron is that with the closest binding energy below the incident photon energy.
Following the emission, the atom is left ionised, with an inner-shell vacancy. The vacancy will be
quickly filled with an electron from an outer shell. This vacancy is then filled with an electron from a
shell further out. This cascading process continues until the vacancy is in the outer shell, causing the
emission of characteristic X-rays and/or Auger electrons. At mammographic energies (15-30keV),
the photoelectric effect is the dominant interaction of X-rays with soft tissue. The probability is
approximately proportional to the cube of the atomic number of the material (Z3). The interaction
is explained in fig. 2.1.
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2.1.3 Compton Scattering
The Compton effect (shown in fig. 2.1) is the increase in wavelength (and loss of energy) of a photon
following an inelastic scattering interaction with a charged particle. This is typically a loosely-bound
valence electron with binding energy much less than the photon’s energy (Bushberg et al., 2002).
The electron can therefore be thought of as a stationary free particle. The increase in wavelength
is caused by the transfer of a portion of energy from the photon to the electron. Following the
interaction, the electron (termed the recoil electron) is ejected and may interact further. The photon
continues to travel with its new energy and at a scattered angle, θ. As there is a transfer of energy,
this interaction contributes to patient dose. However, Compton scattering is almost independent of
atomic number (Z) and, because the photon is scattered from its incident trajectory, information on
the site of interaction is lost and therefore no useful imaging information is obtained. By using the
conservation of momentum and energy (relativistic as the photon travels at the speed of light), the
change in wavelength can be described by eq. (2.1), where Ep is the incident photon energy.
λf − λi = ∆λ = h
mec
(1− cosθ) (2.1)
in which λi and λf are the initial and final wavelengths respectively, c is the speed of light, me is
the rest mass of an electron and h is Planck’s Constant. Alternatively, the energy of the scattered
photon can be calculated using eq. (2.2).
Escat =
Ep
1 +
Ep
mec2
(1− cosθ)
(2.2)
2.1.4 Rayleigh Scattering
Rayleigh scattering (also called coherent or elastic scattering) occurs when the incident photon energy
is much lower than the binding energy of electrons within a target atom. The photon therefore does
not have enough energy to liberate any individual electrons and instead interacts with and excites
the atom as a whole. The atom becomes excited upon absorbing the photon’s energy, causing the
electrons to vibrate, before undergoing de-excitation via the release of a photon with the same energy
as the incident photon but in a different direction. Therefore, no energy transfer takes place but
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Figure 2.2: A diagram to show the interaction of pair production (wikidot.com, 2018).
Figure 2.3: Dominance of different X-ray interactions as a function of photon energy (log scale) and Z. The
red box shows the region used in this project and in mammography in general. Adapted from (Evans, 1955).
as the photon is emitted at a scattered angle, its detection is detrimental to image quality. As
the energies of photons undergoing Rayleigh scattering are low, they are usually quickly absorbed
following the interaction.
2.1.5 Pair Production
Pair production is an interaction in which an X-ray photon becomes an electron-positron pair. This
only occurs at photon energies at or above 1.02 MeV, twice the electron rest-mass energy. Any energy
above this is converted into kinetic energy of the electron-positron pair, each of which move away
with equal but opposite angles from the incident photon trajectory. Therefore, this effect is not likely
to occur in the diagnostic energy range, but is increasingly more likely in radiotherapy energy ranges.
The interaction is shown in fig. 2.2. Figure 2.3 shows the regions of dominance for pair production,
Compton scattering and the photoelectric effect as a function of X-ray energy and Z. The region
used in this project (E = 40-80 keV and Z=53(I) - Z=79(Au)), shown in red, is Photoelectric effect
dominant.
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Figure 2.4: A diagram to show the basic anatomy of the female breast (Canadian Cancer Society, 2018).
2.2 The Female Breast and Associated Cancer Types
2.2.1 The Female Breast
The human breasts (Hamdi et al., 2005; Going, 2010) are paired cone-shaped protrusions, overlying
the pectoralis major muscle on the chest wall, to which they are attached via fibrous tissue known as
Cooper’s Ligaments (Cooper, 1840). The breasts themselves contain no muscle tissue. Breast tissue
typically extends vertically from the collar bone to approximately the sixth rib and horizontally to
the axilla (armpits). They have a composition consisting of fatty (adipose), fibrous and glandular
tissue, although the latter two are often described collectively as fibroglandular tissue, which develops
during female puberty (breasts are present in males but contain considerably less breast tissue and
are incapable of lactation).
Figure 2.4 shows the basic anatomic layout of a breast, focusing on major structures. The nipple
and the dark skin surrounding it (the areola) are visible at the apex of the cone. The areola contains
sebaceous glands which provide secretions to lubricate the nipple during breastfeeding. Inside the
breast, thin tubular structures known as ducts radiate away from the nipple before branching off into
smaller milk ducts, where they are connected to the lobules. Both ducts are lactiferous and carry
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the milk to the nipple during breastfeeding. There are typically around 12-20 lobes in each breast,
consisting of smaller lobules which contain hollow sacs, or alveoli, where milk is produced. The milk
travels through the ducts to the nipple (Zucca-Matthes et al., 2016).
As show in fig. 2.4, the lobes and ducts are surrounded by fatty adipose tissue as well as with
ligaments, lymphatic tissue and connective tissues (plus nerves and blood vessels). Generally, the
size of the lobes does not vary significantly across the population and therefore it is the amount of
adipose surrounding them that determines the overall size of the breasts. Breast density also changes
with age, becoming more fatty over time, after the menopause.
In most cases, breast cancer begins in the mammary glands i.e. in the ducts, lobes or lobules.
The breasts also contain lymph nodes, part of the lymphatic system which is present throughout
the body. These nodes allow the removal of waste products from the breasts via lymphatic drainage
into the veins. The lymphatic system is of great clinical significance as it is a common route by
which breast cancer spreads from the breasts to other parts of the body. It is therefore often key in
determining to what degree breast cancer has metastasised.
Breast Cancer Types
Cancer begins in cells. Cell division is a normal and necessary bodily function, for example to replace
damaged or lost cells and its frequency is controlled by particular genes. Before a cell can divide,
it must first replicate its DNA. Sometimes, the DNA is not copied correctly (parts may be copied
incorrectly, missed out or incorrectly inserted). In most cases, this does not lead to cancer. However,
occasionally, these mutations occur on a gene controlling cell-division, which can lead the cell to
divide uncontrollably. After many divisions a tumour may form. Not all tumours are cancerous.
Those that will not spread to other parts of the body are termed benign and often do not require
medical intervention.
Most cancers originate from one of three types of cells: epithelial cells (carcinoma), cells within
the blood or lymphatic system (leukaemia and lymphoma respectively) or cells in connective tissues
(sarcoma). There are two main types of breast cancer: invasive and in-situ (or non-invasive). Non-
invasive breast cancers refer to those in which the cancerous cells have not spread from the ducts or
lobes where they originated (CRUK, 2017; Macmillan, 2014). Invasive cases are those which have
started to spread to other areas. The most common type of in-situ breast cancer is ductal carcinoma
in-situ (DCIS) in which the cancerous cells are confined to the duct lining. There are often no
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lumps associated with DCIS and it is usually only discovered during a mammogram, after which a
grade will be assigned that describes the rate at which the cells are growing and the likelihood that
the cancer will become invasive. Lobular carcinoma in-situ (LCIS) may also be diagnosed from a
mammogram. It presents as changes to the lining of the lobes (often in several places simultaneously
and occasionally present in both breasts). It is not truly breast cancer but rather an indication
that the patient is at greater risk of developing breast cancer at a later time, although many LCIS
diagnoses do not lead to cancer (Sharma et al., 2010).
Approximately 80% of invasive breast cancers are ductal. They begin in the ducts before spreading
outside of the ductal wall lining. As the cells continue to grow a lump will begin to form and tissue
thickening occurs. Once outside the lining, the cancer can spread via the blood or lymphatic systems
to other parts of the body. A further 10% of invasive breast cancers begin in the lobes. The manner
in which lobular cancer grows makes it more difficult to diagnose.
Signs of Breast Cancer
Some features on a mammogram are indicative of breast cancer. These include masses, which can be
picked up on a mammogram long before they can be felt with a physical examination. Asymmetries
and/or distortions are also a sign that cancer is present, especially if there are architectural changes
between mammograms. Calcium deposits known as calcifications are also a typical feature that is
observed on mammograms. Although larger calcifications are normal, clusters of small, microcalcifi-
cations (∼100 µm) may be an indication of breast cancer, usually in-situ. Therefore, in order to be
diagnostically suitable, breast imaging techniques must be able to resolve these features.
2.3 Contrast-enhanced Mammography (CEDM)
2.3.1 The Need for CEDM
If the true pathological results are known, the effectiveness of a mammogram can be quantified using
two parameters, sensitivity and specificity. Sensitivity is the number of true positives (positive cases
that were correctly identified) as a fraction of the total number of positive cases. Specificity is the
number of true negatives as a fraction of the total number of negatives. In an early study (Carney
et al., 2003) it was found that, compared to women with fatty breasts, mammographic sensitivity
was 19.3% lower for women with heterogeneously dense breasts (based on 167,003 mammograms
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containing 945 cases of cancer) and 26% lower for women with extremely dense breasts (based on
36,303 mammograms containing 193 cases of cancer). Specificity also fell from 96.5 to 89.9 for the
densest breasts. These results highlight the need for an alternative to mammography for patients
with dense breasts, for whom the procedure results in unnecessary dose. The limitation to the study
was that all cases were based on images taken on screen-film systems. Today almost all screening
units are digital and these systems have been shown (Pisano et al., 2005; Bluekens et al., 2012)
to produce significantly higher quality images in the large majority of cases. One study (Pisano
et al., 2008), concluded that for post-menopausal (aged 65+) patients with fatty breasts, the two
methods were almost equal, with screen-film performing slightly, although not significantly, better.
For younger women, however, digital mammography significantly outperformed film imaging.
K-edge subtraction (or dual-energy subtraction imaging) was first documented over sixty years
ago (Jacobson, 1953), but technology limitations meant that it was not implemented fully until the
1980s. In order to perform this technique, both a high and a low energy image are acquired after
injection of a contrast agent and the two are subtracted logarithmically. The energies are chosen so
as to exploit the large change in attenuation occurring over the K-edge of the contrast agent. The
development of digital mammography has made way for improved image analysis and processing
capabilities, allowing KES to be applied with ease after acquisition. An early clinical study (Asaga
et al., 1995) investigated dual energy subtraction in 42 patients with pathologically-proven breast
cancer where conventional mammography (screen-film) had not been sufficient in achieving a correct
diagnosis. They found that, using subtraction mammography, better diagnostic information was
obtained in 21 (50%) of the patients. The authors named patient movement as a limiting factor, as
well as the use of a screen-film system.
An alternative method is to use temporal subtraction (TS), where images are acquired both
before and after CA injection at the same energy. One phantom study used both TS and KES and
compared the minimum amount of contrast agent necessary for the methods to be effective with both
monochromatic X-ray beams and with conventional beams using a clinical mammography system
(Baldelli et al., 2006). Another (Hill et al., 2013b) investigated anatomical noise reduction using TS,
modelled by a power law based on the Wiener Spectrum. Anatomical noise in the resulting images
was found to decrease by approximately a factor of two with TS. This study also highlighted that
patient movement is more of a problem in TS than KES as the time between exposures is longer
and the CA has to be administered in between. The second part to this report (Hill et al., 2013c)
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compared TS to dual energy subtraction using a clinical image dataset and found the latter to have
less anatomical noise after subtraction. Other, clinical studies (Jong et al., 2003; Dromain et al.,
2009; Lewis et al., 2017) have also concluded that CEDM is a useful diagnostic tool and should be
further researched.
The concept of dual energy decomposition imaging (DE) was first proposed for CT in 1976
(Alvarez and Macovski, 1976), and later for single projection imaging (Lehmann et al., 1981). As
in KES, images are acquired at two different energies. In the most general case, for example the
bone/soft tissue case, a K-edge is not necessary due to the large difference in attenuation coefficient
between the two materials. Each pixel is seen as a vector and is projected onto a two material basis,
e.g. {water, contrast agent}, allowing a water-equivalent and a CA-equivalent image to be created.
In a more recent study (Dromain et al., 2012) CEDM was clinically tested on 110 women, by
creating iodine-enhanced images, and was found to be a good technique to aid with cases where
conventional mammography is insufficient. The paper also studied breast ultrasound and found
that, in terms of lesion visibility, CEDM was comparable to or better than ultrasound ∼ 80% of
the time and was a more cost effective approach. Some of the work has focused on the detection
of micro-calcification clusters (Kappadath and Shaw, 2004; Bliznakova et al., 2006; Kappadath and
Shaw, 2008). These are small specks of calcium deposit, which can be an early indicator of breast
cancer. These can be as small as a few tens of microns and so, even though calcium has relatively
high attenuation, they can be particularly hard to identify in dense breasts where other structures
obscure them.
The major limitation in all of the above CEDM techniques is the need to doubly expose the patient
in order to obtain the two images. This implies a dose increase and leads to possible problems with
patient movement between exposures. Several of the papers discussed so far have suggested that
patient movement is a limiting factor, which arises from the need for multiple acquisitions.
2.3.2 Current Dual-energy CEDM Imaging Techniques
Implementation of CEDM using clinical, integrating detectors is limited. Although a polychromatic
beam is used in mammography, the spectrum is not optimised for spectral imaging and so filtration
must be used in order to achieve different energy bands (Dromain et al., 2011; Lobbes et al., 2013).
This requires two separate exposures to obtain both the high energy and low energy images needed
for DE, which may be subject to overlapping energy ranges. These difficulties have been highlighted
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in the literature (Lobbes et al., 2013; Ducote and Molloi, 2010) and photon counting detectors have
been suggested as possible alternatives.
Although most of the literature has focused on KES, some studies have looked into decomposition
DE imaging and investigated it as a means to distinguish between glandular and adipose tissue
(Ducote and Molloi, 2010). This study used a Hologic Selenia system, which is a clinical integrating
system routinely used in screening. The low energy was acquired at 28 kVp using 50 µm rhodium
filtration at 60 mAs and the high energy image was acquired at 49 kVp using 300µm copper filtration
at 30mAs. They found that with dual energy decomposition they could replicate breast density in a
breast phantom within 5%. They highlighted three improvements needed for use of the technique
clinically and in conjunction with screening: maximisation of energy separation between the two
beams, minimisation of the lag between the high and low energy images and minimisation of the
time between exposures (for both patient comfort and to minimise motion artifacts).
There are currently some clinical mammography detectors that allow contrast enhanced tech-
niques to be implemented. The most notable example is the GE SenoBright system (Carton et al.,
2012). This is specifically designed for iodinated contrast agent (administered prior to image acqui-
sition) and works by the acquisition of two separate images at different energies, above and below
the K-edge of iodine (33.2 keV). As in conventional mammography examinations, two breast views
are acquired, namely craniocaudal (CC) and mediolateral oblique (MLO). The procedure is consid-
erably longer than a conventional mammogram due to both the extra pair of images required and the
administration of contrast agent. Typically, the lower energy image is approximately equivalent to a
standard mammography image. A clinical study (Dromain et al., 2011) noted that, although there
is an approximate 20% increase in dose with this CEDM technique, these are still within European
Reference Frame (EUREF) limits (Perry et al., 2006).
In the clinic, the procedure duration with the Senobright system is seven minutes, as outlined
in the detector white paper (Carton et al., 2012). The first step is IV injection of iopamidol. The
contrast agent is allowed to accumulate for two minutes. The right breast is then compressed and
the CC views are acquired at low energy followed by high energy, before the breast is uncompressed.
The same acquisitions then follow for left CC, right MLO and finally left MLO. A further advantage
of this system is that upgrade software can be installed into existing clinical models (Senographe DS
and Senograph Essential) to allow the CEDM to be implemented. This makes the technology more
affordable as new machines are not required. A proposed protocol for the system has been written to
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test the high energy and contrast agent characteristics (Oduko et al., 2014). The system was found
to have good reproducibility and a response which was proportional to the amount of contrast agent.
This was verified for different breast glandularities and thicknesses.
The feasibility of single-shot subtraction mammography has been described (Bornefalk et al.,
2006). Later, the first and currently only clinical photon counting detector for mammography, the
Philips Microdose, was introduced (Philips, 2011). In this system, a counter is incremented each
time an incoming photon above a selected threshold is detected, determined by a charge-sensitive
amplifier, pulse shaper and comparator in the read-out electronics. Scan time is quoted as 10-15 s
and a 50µm pixel size is used. Unlike the SenoBright system, this makes use of a novel detector,
which uses edge-on silicon strips. This orientation allows a sufficient thickness for absorption within
the Si material, which has a low attenuation coefficient meaning that the photons can travel up to
several cm before absorption (in contrast to CdTe which can be less than 1 mm thick and still achieve
the necessary absorption efficiency).
2.3.3 Theory
The diminished intensity of a monochromatic beam, after passing through an object of thickness, x,
with attenuation coefficient, µ, is related to the initial intensity, I0, by equation (2.3).
I = I0e
−µx (2.3)
In mammography, the object is a breast, which usually has a cluttered, non-uniform background on
an x-ray image due to overlapping structures with similar attenuation properties. Breast tissue can
be thought of as being composed of one material of interest (in this case the contrast agent) and
some background material (the rest of the breast tissue). Figure 2.5 explains this.
In a situation where more than one material is traversed, the contributions from each material
are summed exponentially. In dual energy imaging (this also applies to KES), images are acquired
at two energies, typically one above and one below the K-edge of the contrast agent. Therefore, the
equations needed to calculate the final beam intensities are given in equations (2.4)
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Figure 2.5: Simplified objects to show beam attenuation. Left: Single material object. Right: Object
composed of two materials, where µi is the material of interest and µbgd is the background material.
Ilow = I
low
0 exp(−µlowA xA − µlowB xB)
Ihigh = I
high
0 exp(−µhighA xA − µhighB xB)
(2.4)
where the superscripts low and high refer to the low and high energies respectively and the sub-
scripts A and B refer to the two different materials (e.g. contrast agent and background materials
respectively). If both sides of equations (2.4) are divided by initial intensity and the natural log is
taken, they can be re-written as equations (2.5).
Mlow = ln(
I low0
I low
) = µlowA xA + µ
low
B xB
Mhigh = ln(
Ihigh0
Ihigh
) = µhighA xA + µ
high
B xB
(2.5)
where M is the logarithmic attenuation of the breast tissue, broken into its two constituent parts
(contrast agent and background). In this work, a spectroscopic detector was used, using a poly-
chromatic beam, from which specific energy bands were integrated. In this case, the attenuation
coefficient for the average energy of the band will be used. Depending on the two materials, A and
B, two different approaches may be used, subtraction imaging or decomposition imaging.
In this work, the materials A and B are the contrast agent and background tissue respectively.
Initially iodine was used as the contrast agent and subsequently gold nanoparticles were compared.
The background material for KES is the rest of the breast tissue. For DE water was used which has a
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Figure 2.6: Zoomed-in region of mass attenuation coefficient against energy for iodine, water and breast tissue
from 10-70keV. Generated with XMudat(Nowotny, 1998)
similar attenuation to soft tissue. This can be seen in fig. 2.6, which compares the mass attenuation
coefficients of iodine, water and generic breast tissue in the range 10-100 keV.
K-edge Subtraction
At the K-edge energy of a material, there is a sharp increase in photoelectric absorption as the
incoming photons have just sufficient energy to overcome the binding energy of K-shell electrons.
They are therefore much more likely to be absorbed than photons with energy just below it. This
causes a large jump in the attenuation coefficient, which can be visualised for iodine in fig. 2.6.
In KES, two images of different energies are acquired after CA-administration. The low and high
images must be acquired at energies just below and just above the K-edge of the CA (33.2 keV for
iodine) in order to fully exploit the attenuation change across it. Logarithmically subtracting the
high image from the low (from eq. 2.5) leads to equation 2.6.
Sub = Mhigh −Mlow = xCA(µhighCA − µlowCA) + xbg(µhighbg − µlowbg ) (2.6)
where the subscripts CA and bg represent the contrast agent and the background respectively. KES
works on the assumption that the attenuation coefficient of the background does not change signifi-
cantly between the two energies. Figure 2.6, on which the K-edge of iodine can be clearly visualised,
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demonstrates that, provided the high and low energies used are close enough together (and on either
side of the K-edge), the attenuation of the background material does not change significantly and the
assumption is valid. In this case, equation (2.6) reduces to (2.7). Therefore, after subtraction, there
will be very little signal remaining for the background; it is effectively cancelled out. The iodine,
however, should give a high signal due to the large attenuation difference across the K-edge.
Sub≈(µhighI − µlowI )xI (2.7)
where I refers to iodine and Sub is the subtracted value for each pixel, i.e. the pixel value in the
high/low images are replaced with the corresponding Sub value for that pixel. Equation (2.7) can be
re-written as (2.8), where ρx is the surface concentration and µ/ρ is the mass attenuation coefficient.
This is a more convenient form when the concentration of the contrast agent is unknown.
Sub =
(
(
µhighI
ρ
)− (µ
low
I
ρ
)
)
ρxI (2.8)
The closer the two energies are, the better background removal and therefore the closeness of the
bands places a limitation on this method, although wider bands do allow higher statistics. The effect
of energy separation has been investigated previously (Sarnelli et al., 2007) where it was concluded
that the energy separation has only a small effect on image quality up to 4keV and would not be the
limiting factor to the technique. However, the source used was a synchrotron source, allowing energy
separation to be very small and energy bands to be very narrow. In clinical situations, separations
higher than this may need to be used. Another limitation to this study was that the phantom used
lacked a cluttered background.
Temporal Subtraction
In temporal subtraction (TS), images are acquired before and after the administration of a contrast
agent, at the same energy. For a monochromatic beam, the equation for the pre-contrast agent image
is simply given by equation (2.3). The post-CA acquisition can be quantified using equation (2.9)
I = I0exp(−µ(x− xI)− µIxI) (2.9)
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where x is the total traversed thickness as in equation (2.3), xI is the thickness containing the
contrast agent, µ is the attenuation coefficient of the material and µI is the attenuation coefficient
of the contrast agent. The pre-contrast agent image is subtracted from the post-contrast image,
usually logarithmically so as to reduce dependencies on breast properties and initial count rate. The
resulting pixel values, which can be obtained from equation (2.8), will be proportional to the amount
of contrast agent (Baldelli et al., 2006).
The equations become more complex with a polychromatic beam, which are used in this work
with spectroscopic detectors. However, previous work has shown that these equations hold well as
long as a narrow spectrum band is used (Skarpathiotakis et al., 2002), which is the case in this work.
Dual Energy Decomposition
The attenuation of any material can be expressed as a linear combination of those of any other two
materials (Lehmann et al., 1981), as shown in equation (2.10).
µx
ρx
= α
µa
ρa
+ β
µb
ρb
(2.10)
where α and β are weighting coefficients. Equations (2.5) are essentially a set of two simultaneous
equations, provided that the attenuation coefficients for both materials are known. Therefore, ac-
quiring images at two different energies allows the equation to be solved for xI and xW (instead of A
and B as in eq. (2.5); water replace the xbgd terms), the equivalent thicknesses of iodine and water
respectively for each pixel. This can be written as equations (2.11).
(ρx)I =
(
µ
ρ
)high
w
Mlow −
(
µ
ρ
)low
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Mhigh(
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ρ
)high
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(
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(2.11)
In other words, each pixel can be seen as a vector, which can be projected onto a two-material basis.
Here, the base materials are iodine and water and therefore, the images can be decomposed into an
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iodine-equivalent and a water-equivalent image. This is equivalent to calculating α and β in equation
(2.10). There is less restriction on the background attenuation coefficient remaining the same than
in the KES method and therefore it is less dependent on the closeness of the high and low energy
bands. There is also no need necessarily to have a K-edge between the two energies as long as the
attenuation differs significantly between the two materials.
Current Contrast Media
A contrast agent works by increasing the natural attenuation of tissue in areas where it is taken up.
When injected intravenously, contrast agent is preferentially taken up in regions with high blood
supply. In a cancerous lesion, angiogenesis will occur, the process by which new blood vessels form
from existing ones, to allow the tumour sufficient oxygen and nutrients for continued growth. As
they develop quickly, new blood vessels may be poorly formed and leaky (Hashizume et al., 2000;
McDonald and Baluk, 2002). The leakiness of tumour vessels can be exploited by the contrast agent
as it may flow through gaps in the endothelium wall, helping them to be distinguished from benign
findings (Hill et al., 2013a). Therefore, a contrast agent can act to highlight the cancer by increasing
the contrast between the cancerous tissue and the background.
In mammography, the most typical contrast agents are iodine based. This is because iodine has a
K-edge within the typical mammographic energy range and is not highly toxic (and is less toxic than
gadolinium, which is used as a contrast agent in MRI (Rogosnitzky and Branch, 2016)), although it
can sometimes cause renal toxicity, particularly in patients whose kidney function is already reduced
(Briguori et al., 2003). In severe cases it can lead to renal failure but this is not usually a concern
for patients with normal kidney function. Low toxicity is an important quality for a contrast agent
as it is directly injected into a patient. A major imaging limitation is its fast clearing time, which
imposes imaging time restrictions. As well as type, the concentration of the contrast agent must
be considered. Giving a patient too high a dose of contrast agent can have adverse effects. Studies
have been performed to outline the minimum dose required to achieve an image of sufficient quality
(Baldelli et al., 2006).
Some of the limitations associated with iodinated contrast agents could be overcome by using
alternative contrast agents, such as gold nanoparticles. Contrast agents with higher atomic number
give greater photoelectric absorption at kV energies and therefore allow a greater contrast for a
given CA dose. Equivalently, a smaller amount of contrast agent could be used to achieve the same
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contrast. AuNPs are of particular interest (Au Z = 79) as they can be functionalised (by altering
the surface chemistry of their outer coating) to be more easily assimilated to specific types of cells
e.g. cancer cells (Rosa et al., 2017). As well as the increase in contrast due to the higher atomic
number (and therefore larger attenuation coefficient), AuNPs can also increase the contrast due to
the increase in the concentrations of gold that are able to accumulate in the tumour site (Cole et al.,
2015).
2.4 Clinical Requirements for CEDM
In order for a system to be suitable for use in clinical imaging, there are several requirements that must
be satisfied. Of particular importance are patient dose, acquisition time and spatial resolution. Due
to the need to detect small and/or low contrast objects in mammography, a high spatial resolution
is required. Breast microcalcifications (small calcium deposits that can be a sign of breast cancer)
for example, can be smaller than 100 µm. Their detection would require a spatial resolution of at
least5-10 lp/mm (Philips, 2011). Resolution this fine requires a small pixel size; in typical clinical
mammography systems pixel size may be 70-100 µm (Strudley et al., 2014, 2015; Oduko and Young,
2016). Spatial resolution is also affected by the size of the focal spot and the geometry of the system
and is measured using the Modulation Tranfer Function (MTF), which will be described in detail in
Chapter 3, along with other image quality parameters.
Breast dose is an important consideration, especially as CEDM is aimed as a secondary exam for
those for whom mammography is less effective. Maxmimum doses for mammography are outlined
by the European Reference Frame (EUREF) limits (Perry et al., 2006). They give a limiting mean
glandular dose (the mean absorbed dose in the glandular tissue of a compressed breast) of 2.5 mGy
for a standard breast (5.3 cm compressed thickness, which can be represented with 4.5 cm PMMA).
This document also suggests that a single exposure should take between 0.2-3 seconds in order to
avoid any unsharpness/blurring caused by patient motion.
Conventional digital mammography detectors (Diffey, 2015) give only positional photon informa-
tion; they are unable to distinguish between photons of different energies. Each pixel is displayed
as a greyscale value, proportional to the total integrated energy deposited during an acquisition.
Implementation of dual energy techniques on this type of system requires two separate exposures,
acquired at different energies (see section 2.3). Clinically, this implies a higher patient dose, and
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results will be subject to artifacts caused by patient movement between exposures.
Although conventional CEDM procedures may still fall within acceptable limits for a procedure,
the ALARA principle must always be followed, which states that dose must be kept As Low As
Reasonably Achievable. This is particularly important for mammography applications as the breast
is highly radiosensitive and the intended patients may have an increased risk of developing radiation-
induced cancer. Studies have compared the dose of a single breast view between two-exposure CEDM
and conventional digital mammography. One (Jeukens et al., 2014) reported an average MGD (mean
glandular dose) of 2.8 mGy (from 47 patients) and 1.55 mGy (from 715 patients) for CEDM and
conventional mammography respectively. Another (James et al., 2017) found a mean MGD of 3.0±1.1
mGy (from 173 patients) for CEDM compared to 2.1 mGy (based on 6214 patients) for the same
breast thickness of 63 mm with conventional mammography.
2.5 Current Clinical Detectors
There are two main types of digital detectors: those which generate electron-hole pairs directly
(direct detectors) and those that generate visible light which is then detected by a photodiode and
converted into electron-hole pairs (indirect detectors).
2.5.1 Phosphor flat panel Detectors
A phosphor flat panel detector consists of a glass plate upon which is a pixellated array of light-
sensitive photodiodes. A phosphor layer, typically of thallium-doped caesium iodide, CsI(Tl), is
deposited on top. As CsI is a crystalline structure, the electron orbital energies take the form
of continuous energy bands, with forbidden regions between (band gaps). The Tl doping creates
extra allowed energies within the CsI band-gaps (Yaffe, 2010a). When X-rays interact with the
phosphor, electrons are excited from the valence to the conduction band. During de-excitation, the
extra energies provided by the dopant materials create trapping sites, specifically chosen so that
transitions between them cause the emission of visible light.
The photodiodes detect this light and convert it into a charge via the creation of electron-hole
pairs, which is stored for that pixel until it is read out. Each pixel is connected to a control line,
data line and thin-film transistor (TFT) switch. Control lines are energised on a row-by-row basis,
activating all switches for that row. The signal from all pixels in a row are transferred to an amplifier
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and digitiser along a readout row simultaneously. Clinical systems of this type include the GE
Senographe range (Ghetti et al., 2008).
2.5.2 Photostimulable Phosphor (CR System)
Commonly referred to as CR (computed radiography), photostimulable phosphor systems are widely
used in a range of imaging procedures and operate using photostimulable luminescence. The detectors
consist of a phosphor screen with an interaction process similar to that of a phosphor flat panel
detector except that there are many more trapping sites present during de-excitation (Yaffe, 2010b).
This is due to large amounts of doping, chosen so as to control the wavelength of the light emitted
during the transitions. The number of filled traps is proportional to the number of X-rays interacting
with the surface at a particular position. These are not pixellated but rather have a continuous
surface, producing an analogue image onto the phosphor plate. The plate is physically removed and
read by a red laser, which frees the electrons from their traps as it passes through them (allowing the
plate to be re-used). This causes light to be emitted at wavelengths determined by the energies of
the traps from the dopant materials. Usually blue light is chosen which can be read using an optical
filter and a photomultiplier tube. As the plate is not pixellated, coordinates are instead defined by
scanning the laser for a certain time between each reading in each direction.
2.5.3 Amorphous Selenium Flat Panel Detectors
In amorphous selenium flat panel detectors, X-rays interact with a layer of crystalline amorphous
selenium (typically 0.1-0.2 mm thick), directly creating electron-hole pairs via excitation of electrons
from the valence to conduction band. An electric field is applied above and below the a-Se layer,
attracting the electrons and holes in opposite directions before they can recombine. The electrons
are attracted to the cathode, a pixellated array of capacitors in this case, which store the charge
until it is read out. In most cases charge collection happens via a TFT array in a similar manner
to that in phosphor flat panel detectors. Clinical examples that have been evaluated for the NHS
Breast Screening Programme include the Hologic Selenia Dimensions (Mungutroy et al., 2014), the
Siemens Inspiration (Oduko et al., 2016) and the IMS Giotto (Strudley et al., 2013).
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2.6 Spectroscopic Detectors
Spectroscopic X-ray detectors are photon counting detectors (PCDs) that are able to distinguish
between photons of different energies using pulse height analysis. This means that, for a single
acquisition, it is possible to obtain either a spectrum of the detected photon energies or at least
several different energy bands per pixel using different energy thresholds. In the latter case, typically
2-8 energy windows (or bins) per pixel are used, each with its own threshold. Only pulses higher
than this threshold will be recorded as a count in each case. The difference in counts between two
thresholds gives the number of photons detected in the energy range between them. If at least two
image bands can be created, then only one exposure is required to obtain both the high and low
energy images necessary for DE and KES. As well as potentially reducing the dose, this eliminates
the possibility of patient movement. The spectroscopic detector that will be used in this work is the
HEXITEC detector (Seller et al., 2011).
2.6.1 HEXITEC
The HEXITEC (High Energy X-ray Imaging Technology) consortium is a collaboration between
several universities and other groups, formed in 2006, which specialises in the development of photon
counting spectroscopic detectors for use in high energy X-ray imaging.
The HEXITEC system used in this work consists of a 20 x 20 x 1 mm CdTe Schottky diode de-
tector, manufactured by Acrorad Ltd. (Japan), bump-bonded to a HEXITEC spectroscopic readout
ASIC (application-specific integrated circuit). The detector readout is pixellated, consisting of an
80 x 80 array of pixels, with a pitch of 250 µm, a 200 µm pad size and an inter-pixel spacing of 50
µm. The detector was bump-bonded to the ASIC using gold stud and silver epoxy flip-chip bonding,
where every pixel is associated with its own identical set of electronics, as shown in figure 2.7 (Jones
et al., 2009). Every pixel has a charge sensitive pre-amplifier, a 2 µs shaping amplifier and a peak
track-and-hold circuit, which stores the largest pulse until the pixel is read out. This combination
allows the full energy spectrum to be acquired for each pixel from 2-200 keV (Veale et al., 2014).
Data is read out using a rolling shutter technique, in which rows are selected in turn and the data in
each pixel is multiplexed from the ASIC after being digitised. The digitised data is then transferred
to a PC by a Camera Link framegrabber (Veale et al., 2012). The detector has a resolution of ∼1
keV (FWHM) at 60 keV (Seller et al., 2011; Veale et al., 2011).
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Figure 2.7: Block diagram (Jones et al., 2009) showing the electronics associated with a single pixel in the
HEXITEC ASIC.
The charge induced in the pixel is directly proportional to the pulse height, so long as the charge
falls onto a single pixel. However, as the pixel size is relatively small, it is comparable to the typical
electron charge cloud size. This means that there is a high likelihood that the cloud may be shared
between neighbouring pixels. This effect is known as charge sharing and will be explained in greater
detail in section 2.6.3.
The results are given in terms of counts per ADU or channel numbers, which are proportional to
their energy. These are grouped into bins. The corresponding energy of each channel number can
be determined via a calibration using sources with known energy peaks. The detector is controlled
through a software package, 2Easy, which can be used to set initial parameters such as detector
temperature and acquisition length and also to process the resulting data sets using appropriate
data corrections.
As well as medical imaging, other applications of HEXITEC include material identification for
security (O’Flynn et al., 2016) and the study of elemental distribution and dynamics of alloys (Liotti
et al., 2015). A system consisting of 4 HEXITEC detectors tiled into a 2x2 grid and, more recently,
a 10 cm x 10 cm module have been developed (Wilson et al., 2013, 2015). These have effective areas
of 16 cm2 and 100 cm2 respectively, making them more feasible systems for clinical applications.
2.6.2 Other Spectroscopic Detectors: Medipix
The Medipix3 is part of the Medipix family of detector readout chip, developed at CERN. The
sensor layer consists of a pixellated semiconductor bump-bonded to an electronics layer. Each pixel
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is attached to its own electronics read-out. The detector has 256x256 pixels, with a pixel pitch of 55
µm. The electronic components and operation of the chip and its original prototype are explained
in greater detail in the literature (Ballabriga et al., 2011).
Rather than giving an energy spectrum for each pixel, Medipix works by setting user-defined
thresholds, where only photons of energy at or above the threshold register a count (Mir et al.,
2017). Each pixel has two counters, which can either be operated in simultaneous read/write mode
where one is read as the other is counting (allowing only one threshold to be set) or in sequential
read/write mode which enables two different thresholds. However, if only one in four pixels are
bump-bonded to the electronics chip, eight thresholds can be used in sequential mode (making the
effective pixel pitch 110 µm) because each 110 µm pixel is associated with eight counters. This
allows selection different energy bands from one acquisition, which are obtained from the difference
in counts between two energy thresholds. This is important for K-edge subtraction as it allows the
selection of energy bands above and below the a K-edge if suitable thresholds are chosen.
Medipix can be operated in either single pixel mode (SPM) or in charge summing mode (CSM).
In the latter the charges from four neighbouring pixels are summed at their common node and the
charge is attributed to the pixel with the largest initial charge. Although the charge counting is spread
over four pixels, the spatial resolution of a single pixel remains. CSM was implemented to eliminate
the charge sharing (explained in 2.6.3) limitation of its predecessor, Medipix2, but problems have
been noted with mis-allocation of counts (Gimenez et al., 2011). These issues have been addressed
in the literature (Maj et al., 2012).
2.6.3 Charge Sharing
Ideally, when a photon reaches the detector, it will deposit all of its energy within a single pixel. In
this case, the charge induced by the photon will be directly proportional to its energy. However, the
electron charge cloud is sometimes distributed between two or more neighbouring pixels, resulting in
multiple, lower-energy signals. This is known as charge sharing and is detrimental to image quality
as it gives incorrect energy values for the detected x-rays. The smaller the pixel size, the more likely
charge sharing is to occur because the charge cloud size becomes larger relative to the pixel size and
therefore the probability of it covering only one pixel decreases.
Previous work has suggested that with normal operation of the HEXITEC detector, which has a
pixel pitch of 0.25mm, 36.4% of events may experience charge sharing (Veale et al., 2014). A smaller
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Figure 2.8: Diagram to explain the effects of applying the charge sharing addition and charge sharing dis-
crimination correction algorithms with HEXITEC.
pixel size is, however, advantageous in terms of spatial resolution and of the Small Pixel Effect
(Wilson et al., 2007): based on the Shockley-Ramo theorem (He, 2001), if the size of the anode (a
pixel in this case) is small compared to the thickness of the detector, then only electrons arriving
in the close vicinity of that pixel will cause a significant charge. Several studies have investigated
the effect in HEXITEC and similar detectors (Veale et al., 2011, 2012; Allwork et al., 2012). For
HEXITEC, corrections are in place and different algorithms can be implemented in the processing
stage using the 2Easy software.
Charge Sharing Corrections in HEXITEC
In order to overcome the effects of charge-sharing in HEXITEC, two correction algorithms may be
used: addition (CSA) or discrimination (CSD). If any neighbouring pixels (including diagonally)
have a signal above a given threshold (which is set prior to image acquisition) in any one data frame,
they are considered to be one shared signal. In CSA, the energies from each of the sharing pixels are
summed and assigned to the pixel that received the largest share of the signal. The other neighbours
are set to zero for that frame. In CSD, all pixels sharing the charge are assigned a value of zero.
Both methods are shown in fig 2.8. In both cases the corrected spectrum has less statistics as counts
are removed. This happens to a greater extent in discrimination as no counts are registered where
charges are shared.
Both methods have their advantages and limitations. In CSD, the resulting spectrum has a high
energy resolution but suffers from a reduced number of counts relative to the number of incident
photons. CSA has greater sensitivity but suffers a loss of energy resolution, caused by both noise
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and errors within the CSA algorithms (Veale et al., 2014). Careful calibration of pixels takes place
for CSA so that the contributions from each pixel can be summed accurately. In previous work this
has been carried out using the characteristic X-ray lines of 241Am, and calculating the corresponding
FWHM of the 59.5 keV peak, averaged all 6400 pixels (Veale et al., 2012, 2014; Wilson et al., 2013).
However, slight errors in this calibration can lead to incorrect total energies. Electronic noise is also
summed when several pixels are added, giving rise to a broader peak.
When applying charge sharing corrections, however, the detector should only be used at up to 10-
20% occupancy (Wilson et al., 2013). This is because a charge-shared event cannot be distinguished
from two events that just happen to arrive at two adjacent pixels in the same frame and at higher
rates this becomes increasingly likely; more charges will be considered as shared than actually are.
This causes detrimental effects to the output spectra. This effect and its consequences on the output
spectra and on DE reconstruction will be investigated in chapter 5.
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System Characterisation
3.1 Introduction to Chapter
As outlined in chapter 2, multi-energy imaging has the potential to overcome some of the problems
associated with conventional mammography by combining images acquired at different energies in
order to effectively remove the background and highlight areas of high blood supply such as tumours.
In particular, the use of spectroscopic detectors such as the HEXITEC detector, which gives a full
energy spectrum per pixel, allows images at different energies to be obtained simultaneously by
integration of specific bands of the resulting energy spectrum.
In order to fully assess and compare images, it is important to understand how the detector
operates and to know what parameters are needed to quantify the image quality, especially when
comparing images acquired with different contrast agents. This chapter outlines some important
image quality parameters and describes the initial characterisation of the detector.
3.2 Image Quality Metrics
In order to characterise and test the images produced by the HEXITEC detector, it is important
to first define what is meant by image quality. In medical imaging, the quality of an image can be
thought of as a measure of the useful clinical information that can be obtained from that image.
The aim of medical imaging is to acquire images of sufficient quality whilst keeping dose as low as is
achievable. The overall quality of an image is determined by a combination of factors.
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3.2.1 Contrast
Contrast is a measure of how well objects of different intensities in an image can be differentiated.
It is defined by equation (3.1). However, there is no dependence on the background and noise is
not taken into account. This means that the contrast does not necessarily correlate to the visibility
of a detail. A more complete measure is given by the signal to noise ratio (SNR), which uses the
integrated signal both inside and outside a detail.
C =
|Iout − Iin|
max(Iout − Iin) (3.1)
where Iin and Iout are the average intensities of a region of interest (ROI) inside and outside the
object of interest respectively. If Tin and Tout represent the total integrated signal inside and outside
a detail respectively and σout represents the standard deviation outside of the detail, then the SNR
is defined as:
SNR =
|Tin − Tout|
σout
(3.2)
In other words, the SNR is the difference between the total signal of some object of interest within
the image and the total signal of an area of comparable size in the immediate background of that
object, normalised to the standard deviation of the pixel intensities in that background area. It
is particularly useful for objects where the signal varies across the object surface as it factors in
contributions of noise and detail size (Bushberg et al., 2011). For homogeneous objects where the
average signal in an ROI is representative of the entire object, the contrast to noise ratio (CNR)
is a useful alternative (Bushberg et al., 2011). This is similar to SNR but instead uses the average
signal in an ROI inside an object, Avgin and in an ROI in its immediate background, Avgout. CNR
is defined as follows:
CNR =
|Avgin −Avgout|
σout
(3.3)
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3.2.2 Noise
Noise can manifest as either an addition or subtraction of counts and may be of a random nature
(Bushberg et al., 2002; Alsleem and Davidson, 2012). Noise can be caused by various sources and
can be divided into three categories: quantum noise, structured noise and electronic noise (Monnin
et al., 2014; Mackenzie and Honey, 2007).
Quantum noise (or Poisson noise) is a major source of noise in X-ray imaging. It is unavoidable
as it is a consequence of the random nature of X-ray interactions, which follow a Poisson distribution
where the standard deviation is proportional to the square root of the mean number of X-rays.
Therefore, quantum noise can be reduced by increasing the incident count rate.
Most other sources of noise in digital mammography can be attributed to the detector. So-called
structured noise can be caused by non-uniform gain across the pixel array of the detector (Ravaglia
et al., 2009). This can be reduced by performing flat field exposures, where images are acquired
without the objects in the beam, giving a uniform illumination across the detector surface, which can
be used to calibrate the images. In energy-sensitive detectors, systematic noise can cause differences
in energy across the detector surface, where a photon will be assigned to a different energy depending
upon the pixel it arrives at. This can be greatly reduced by an energy calibration, using known energy
peaks (Veale et al., 2012). Electronic noise is also present in digital mammography, caused by noise in
electronic components, such as preamplifiers, amplifiers and readout electronics (Lioliou and Barnett,
2015). Post-processing corrections can also introduce noise. In photon-counting or energy-sensitive
detectors for example, charge-sharing corrections can introduce noise, particularly when they involve
the summation of energy contributions from neighbouring pixels (Veale et al., 2014).
Image noise can be measured using variance and standard deviation or CNR (described in section
3.2.1). A more complete description of noise in mammography images may be given by the Noise
Power Spectrum (NPS), which measures noise as a function of spatial frequency by calculating the
absolute value of the 2D Fourier transform of flatfield images (Aufrichtig et al., 2001; Dobbins III
et al., 2006). Explanation of its various computation methods are described extensively in the
literature (Dobbins III, 2000; Dobbins III et al., 2006).
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3.2.3 Spatial Resolution
Spatial resolution is a measure of how well objects that are close together in space can be discrim-
inated as two separate objects. Both contrast and spatial resolution are important parameters in
mammography because structures within mammograms that could suggest breast cancer are often
small (calcifications, typically 100 µm ) or inconspicuous (masses). Calcifications in particular may
be both very small and close together. There are two main contributing factors to spatial resolution:
The set-up geometry of the system and the limiting resolution of the detector. The finite size of
the focal spot introduces blurring (unsharpness) into the system in the form of penumbra caused by
magnification (DiDomenico et al., 2016). This can be reduced by placing the object to be imaged as
close to the detector as possible as well as by using a smaller focal spot size. Patient motion can also
cause blurring to the image which would reduce the spatial resolution (Huda and Abrahams, 2015).
This effect can be reduced by shortening the acquisition time. Each detector has an intrinsic spatial
resolution, largely determined by the pixel pitch (but also affected by other factors such as the size
of the spread of the charge cloud). Current digital mammography systems typically have pixel sizes
of ≤50-100 µm (Ghetti et al., 2008; Strudley et al., 2014), leading to a limiting detector resolution of
10-5 lp/mm (DiDomenico et al., 2016). Spatial resolution is typically measured by the modulation
transfer function (MTF). Resolution test objects may also be used.
3.2.4 MTF
The MTF is an important and widely accepted measure of the image quality in medical imaging
detectors. It quantifies a system’s ability to transfer the contrast of an object to the resulting image
as a function of the object’s spatial frequency. The MTF is the output (image) contrast normalised to
the input (object) contrast. It always has a value between zero and one and is plotted against spatial
frequency to produce the MTF curve which displays the MTF as a function of spatial frequency.
There are several methods of measuring the MTF (Samei et al., 2006; Maidment and Albert, 2003).
It may be determined by finding the line spread function (LSF). This is the response of the imaging
system to an infinitesimally thin line source (which itself can be thought of as a linear integral of
individual point sources, the response to which is given by the Point Spread Function, PSF). In
practice, the LSF can be measured using a narrow finite slit. However, very fine manufacture and
beam alignment is required, as well as corrections to account for slit width. Alternatively, the LSF
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may be obtained via differentiation of the Edge Spread Function (ESF), which is the response of the
system to a sharp straight edge (Neitzel et al., 2004; Samei et al., 1998). A metal edge is usually
positioned so as to cover half of the imaging area (with the remaining half left empty) and placed at a
shallow angle (3-5 ◦) from the pixel axes in one direction. This eliminates the effects of the sampling
phase, i.e. the position of the edge relative to the pixel alignment, as each row will be at a slightly
different distance from the pixel axis. A disadvantage of the edge method is the amplification of noise
during the differentiation step (Kuhls-Gilcrist et al., 2010). The MTF (as a function of frequency)
from the edge method can be calculated from eq. (3.4), in which FFT is the Fast Fourier Transform:
MTF (f) = FFT (LSF (x)) =
[
d
dx
(ESF (x))
]
where FFT (x) = Y (k) =
N∑
j=1
X(j)W (j−1)(k−1)n
and where Wn = e−(2pii)/n
(3.4)
In eq. (3.4), j represents the input sample number (associated with x ) and k represents the
output sample number (associated with f ). n is the total number of samples i.e. the length of the
input vector.
3.3 Experimental Set-up
All imaging work was carried out using a HEXITEC spectroscopic detector, which consists of a 20
x 20 x 1 mm CdTe Schottky diode detector bonded to the HEXITEC ASIC and is described in
section 2.6.1. It has an active imaging area of 2 cm x 2 cm. A Hamamatsu L6731-01 Tungsten (W)
X-ray source (Hamamatsu, Japan), with maximum operating parameters of 80 kVp and 100 µA, was
used throughout this work. Aluminium filtering was also used to give a maximum intensity of the
spectrum around the iodine K-edge (33.2 keV). In all cases, the centre of the source was aligned to
the centre of the HEXITEC imaging area. Typically, images were acquired at 2-3 µA to avoid pulse
pile-up. This set-up is shown in fig. 3.1.
Imaging with HEXITEC was controlled through 2Easy, a dedicated software which allows both
acquisition and processing through a user-interface. This includes the setting of detector temperature
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Figure 3.1: Diagram to show the general imaging set-up used in this work. For some work a test object was
placed in the beam. The red dashed line shows the centre of both the source and the active area of HEXITEC,
which were always aligned. The Al, in the form of 5 x 5 cm sheets, was held using a clamp and stand.
and performing a bias refresh, which prevents detector polarisation due to negative charge build-up
at the detector anode. During an acquisition, the energy and positional information of every event
is stored in binary data files. These can be processed either automatically or at a later date. The
processing procedure compiles all data into a 3D-array (pixel column, pixel row, energy). The user
also has the option to apply charge sharing corrections to the data.
3.4 Calibration of the HEXITEC detector
When an image is acquired with HEXITEC, a 3D position-energy array is created (after some basic
pre-processing), providing a whole spectrum per pixel in the range 5-200 keV. However, the energy is
given in terms of channel number, arranged into bins. A calibration procedure is therefore required
in order to convert these bins into keV to allow appropriate selection of energy ranges for KES and
DE. To correct for variations in pixel gain across the detector, the calibration is performed on an
individual pixel basis. In this work, a linear relationship between channel number and keV was
determined using known energy peaks from a variable X-ray (VEX) source. The primary source was
241Am, which emits 59.54 keV γ photons. The source housing contains six different metal foil targets
(silver (Ag), molybdenum (Mo), copper (Cu), rubidium (Rb), barium (Ba) and terbium (Tb)), each
of which can be placed in front of the source using a dial. The γ-rays interact with the target foil,
causing excitation in the target material atoms and leading to the emission of characteristic X-rays.
The K-α characteristic energies of Tb, Ag, Ba and Mo were used as the known energies (K-α emission
occurs after a transition from a 2P (L-shell) to 1S (K-shell)), as it was the most intense peak. The
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Z Kα1 (keV) Kα2 (keV) Kβ (keV)
Cu 29 8.05 8.03 8.91
Rb 37 13.40 13.34 14.96
Mo 42 17.48 17.37 19.61
Ag 47 22.16 21.99 24.94
Ba 56 32.19 31.82 36.38
Tb 65 44.48 43.74 50.38
Table 3.1: Energies, in keV, for the Kα1, Kα2 and Kβ each
of the six available target materials from the VEX source.
Values from (Bearden, 1967)
Figure 3.2: Example of K-α and K-β transitions
for Copper (Kuiper, 2018)
K-α and K-β values for each target material are given in table 3.1 and the corresponding energy
transitions are shown in fig. 3.2.
3.4.1 Calibration Measurements
Images were acquired with the VEX source for 30 minutes for Mo and 20 minutes for Ba, Tb
and Ag to allow sufficient statistics to resolve the peaks. The detector operating temperature was
approximately 22-23◦C. The bias voltage was set to -500 V and was refreshed, to prevent polarisation
of the detector, every minute for 2 s, during which time no data is acquired. Figure 3.3 shows the
recorded spectra for each of the four calibration points using addition charge sharing corrections.
The K-α and K-β peaks are labelled.
Spectrum analysis was performed using in-house software in IDL (Pani, 2014), which was operated
as follows: For each calibration material the spectra from all pixels were summed and averaged to
display an average set of peaks. Due to the different pixel gains, the average peak is typically
relatively broad. A region around this peak was user-selected and the maximum (peak) value over
this range was located for each pixel. The final output was an 80x80 array, containing the position of
the maximum (location of the peak) for each individual pixel. This process was repeated for each of
the calibration materials. The array for each material was compiled into one 80x80xn array, where
n is the number of materials used. Using the true energies of the peaks in the calibration materials,
80x80 arrays of for the gradient (M0) and intercept (M1) were calculated, allowing bin numbers to
be converted into energies. Equation 3.5 shows this relationship.
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Figure 3.3: Average spectrum per pixel for each of the four calibration target materials used. All data was
processed with addition charge sharing corrections. In each case, the K-α peak was used for the calibration.
E = M1 ∗Bin+M0 (3.5)
where M0 is the average intercept over the calibration materials, M1 is the average gradient over
the calibration materials and Bin is the energy bin number. This result was averaged over all
pixels to give the final relationship between bin number and energy. This was used to determine
the appropriate range of bins to give energy windows just above and just below the K-edge of both
iodine (33.2 keV) and gold (80.7 keV). Using a threshold minimum of 0.5 and 0.25 for M0 and M1
respectively, to remove any dead or less responsive pixels, the average for M0 and M1 was calculated
and put into equation (3.5) to obtain the appropriate bins. The average values were 1.634±0.008
keV and 0.2992±0.001 keV/bin for M0 and M1 respectively.
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Figure 3.4: Variation of individual pixels from the mean for both M0 and M1 for both addition and discrim-
ination charge sharing corrections. In both images, the mean value has been subtracted from each pixel to
show areas that differ the most from the average.
Variation in M0 and M1
Figure 3.4 shows the output matrices of M0 and M1 across the whole detector array. In each case
the global average (also given on 3.4) has been subtracted from each matrix element. For M0, the
majority of pixels fell within around ±0.5 of the mean value of 1.634±0.008 keV/bin (∼ 30%). The
standard deviation was 0.7 keV/bin. For M1, the vast majority of points fell within 10% of the
mean of 0.2992±0.001 keV, most of which were above it, with a few pixels significantly below. The
standard deviation was 0.8 keV. Interestingly, for M0 there was a distinct divide between the left
and right half of the images, cut off at column 40. This could be caused by the readout process.
Figure 3.5 shows the variation of both the intercept (M1) and gradient (M0) between each row
and column of the pixel array and the global average. The left-right divide can be visualised more
clearly here; while the distribution of the rows (i.e. top to bottom) does appear to have a weak
positive correlation, there is a distinct shift for the columns at row 40 where columns swap from
being generally below the average (columns 1-40) to generally above it (columns 41:80).
3.4.2 Linear Interpolation of the Energy Array
Using the average values of M0 and M1 is useful to determine which channels correspond to which
energy range but different pixel gains leads to a slightly different channel-energy relationship for
each pixel, causing a spread of energies in the bands. Using the M0 and M1 coefficients, linear
interpolation was performed on each pixel in turn so that each energy channel corresponded to the
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Figure 3.5: Variation of the mean intercept, M0 for each row and column of the final image. Error bars were
calculated using the standard error in the mean for each row or column.
same energy in every pixel. To achieve this, a MATLAB routine was used to generate an average
pixel energy array based on the average M0 and M1 values. The total counts in each energy bin
in all pixels were adjusted, via linear interpolation, to correspond to those expected for the average
pixel energies. This procedure is important for this work as both DE and KES require the selection
of specific energy bands.
Figure 3.6 shows the average spectrum obtained per pixel across an iodine detail and for a
background ROI with and without interpolation. The interpolation process led to narrower, higher
spectrum peaks (as there is no longer a dependence on pixel gain) and a sharper K-edge behind
the iodine detail. There was also a significant shift in the position of the K-edge before and after
interpolation. Before correction, the spectrum is a convolution of the corrected spectrum by the
Gaussian representing the spread in the gain of the pixels. Therefore, when applying the DE al-
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Figure 3.6: Average spectrum per pixel before and after interpolation for an ROI behind an iodine-containing
detail (left) and for a breast tissue-like background region (right).
Figure 3.7: Original (a) vs interpolated (b) images for a 3 µA, 30 minute acquisition at 50 kVp. (c) and
(d) show the interpolated results subject to the restrictions: 0.25<M0<2.0 and 0.0<M1<2.0. In (c), pixels
outside of these restrictions have kept their original energy array and in (d) they have been set to zero for all
bands. The grainy appearance arises from the shifting of the energy scale.
gorithms, variations on high and low bin ranges were tested to ensure that the K-edge was always
between the two.
Figure 3.7 shows the whole spectrum images for a 3 µA acquisition. (a) and (b) are the original
and interpolated images respectively. Although interpolation adjusts and shifts counts over the
energy range, one would expect the total number of counts to stay the same. However, pixels that
were very far away from the average pixel gain had counts at energies deemed to be outside of the
energy bin range which are lost after interpolation. Image (c) shows the interpolated results with
some conditions (0.25<M0<2.0 and 0.0<M1<2.0) applied. Pixels that didn’t meet this condition
had their counts in each bin unchanged. (d) shows interpolated results with the same conditions but
in this case, pixels outside of this range had all values set to zero (for visualisation purposes only).
It can be seen that the majority of these pixels are along the edges of the detector.
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3.5 Acquiring MTF Images with HEXITEC
Images were acquired on the HEXITEC detector (described in section 2.6.1). In each case, a razor
blade, held in position using a clamp stand at a shallow angle (3-5 ◦) to the pixel edges, was placed
in the beam, as close to the detector as possible, so as to cover half the image area. The rest of
the beam area is left empty, resulting in an image of two distinct regions. Before MTF images were
acquired, a flat field image was taken in order to account for different pixel efficiencies across the
detector and variations in the intensity of the radiation field.
An MTF image was acquired at 20kVp, 10µA for 180s, taking into account a 2s bias refresh time
every 60s. The source-detector distance was 58±1 cm. Flat field and MTF images were acquired
sequentially, under the same conditions. The resulting ESF, LSF and MTF are shown in fig. 3.9.
The MTF image was divided by the flat field image on a pixel-by-pixel basis to create the final
MTF image. As the blade used is very thin (0.5 mm) steel and has a sloping edge, the energy used
is limited to no more than 20 keV (Green, 2016). Above this energy, a significant proportion of the
X-rays can pass through the blade, more so at the very edge due to the slope and this distorts the
ESF. The images were analysed post-acquisition using a modified version of a pre-existing MATLAB
code (Green, 2016), in which a sigmoid function, of the form shown in eq. (3.6) was fitted to each
row of the data.
f(x) =
1
1 + exp(−x) (3.6)
The maximum of the differentiation of the fit data corresponds to the edge pixel. The edge pixel
is shifted so that the maximum is in the same column for each row. All rows are then summed
to generate the ESF, from which the MTF is calculated as per eq.(3.4). Figure 3.8 shows the flow
diagram showing the process from the original image to the MTF.
The results obtained from the MTF analysis are shown in figure 3.9 Graph (a) shows the ESF,
obtained as outlined in section 3.2.4. This result was differentiated to give the LSF, shown in graph
(b). The LSF was analysed by fitting a Gaussian curve to the data and the full width at half
maximum (FWHM) and the full width at tenth maximum (FWTM) were obtained. These were
found to be 0.3±0.001 mm and 0.6 ±0.002 mm respectively, where the uncertainties arise from the
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Figure 3.8: Flow diagram to show how the MTF is calculated using image analysis
95% confidence intervals of the fit. A Fast Fourier Transform (FFT) was performed on the LSF in
order to generate the MTF values. The literature shows a varied opinion on the resolution limit based
on MTF results; in many cases there is comparison between multiple systems (Samei et al., 2006).
Another study used both the 0.5 and 0.1 MTF levels for comparison points (Samei et al., 1998). For
this study, the 0.5 MTF level was used as a measure of the spatial resolution of the system. This
limit has been used in several other studies (Astromskas, 2016; Samei et al., 1998). The 0.5 MTF
level was found to be 3.7 ±1 lp/mm. The uncertainty arises from the low number of pixels in the
image and takes into account that the razor blade used in the images has a sloping edge (this was
studied in previous work (Green, 2016)).
Work comparing the MTF of HEXITEC and Medipix (Astromskas, 2016) found the 50% MTF to
be 2.2 lp/mm and 3.5 lp/mm for HEXITEC and Medipix 3 respectively. The results for HEXITEC
were found to be lower than in this work, however the study notes that no charge sharing corrections
were applied to the data and an ROI containing several times more pixels was used.
The literature has suggested that a spatial resolution of 5-10 lp/mm is required for mammography
in order to resolve features on the order of 50-100 µm such as microcalcifications (Philips, 2011).
Therefore, HEXITEC does not currently meet the requirements for a clinical system. However,
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Figure 3.9: ESF (a), LSF (b), LSF fitted with Gaussian (c) and MTF curve (d) for HEXITEC, acquired at
10 µA and 20 kVp. In graph (c), the dashed lines show the 10% and 50% LSF lines and in graph (d), the
dashed line shows the 0.5 MTF level.
the aim of this work is to determine whether the technique of single-shot dual energy imaging
could be used in principle rather than deciding whether one particular detector could be used. The
results obtained in the literature for Medipix suggest that this system too falls short of the clinical
requirement in terms of spatial resolution in its current form .
3.6 Summary of Characterisation
This chapter has outlined the main components of image quality as well as the characterisation
of the HEXITEC detector in order to generate meaningful reconstructed images in dual energy
decomposition analysis.
A calibration was performed which allowed the linear conversion from energy bins to keV. Inspec-
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tion of the calibration coefficients across the detector array showed that there is some variation. In
particular, a distinct difference between the left and right side of the image in terms of the calibration
offset was seen. Pixels at the edges of the detector showed the largest variation from the average
calibration gradient. This calibration allowed appropriate choice of energy bins over the necessary
energy bands for DE imaging across the iodine K-edge. However, it did not account for inter-pixel
gain differences. The effect of pixel gain was removed by means of a linear interpolation in which the
energy scale of all pixels was adjusted to that of the average pixel. Counts were adjusted accordingly.
Comparison of the spectra both behind an iodine detail and a generic background region showed a
significant spectral shift after interpolation and gave rise to a higher and sharper K-edge. The MTF
was also assessed by imaging a steel edge, from which the ESF was calculated via differentiation and
Fast-Fourier transform.
The 50% MTF was found to be 3.7 ±1 lp/mm; the literature suggests that a spatial resolution
of 5-10 lp/mm is required for mammography in order to resolve small and/or conspicuous features
(Philips, 2011). Therefore, HEXITEC does not fully meet the requirements for a clinical system in its
current form. However, the aim of this work is to determine whether the technique of single-shot dual
energy imaging could be used in principle rather than deciding whether one particular detector could
be used. Techniques such as the implementation of sub-pixel resolution algorithms could improve
this to be more in line with the clinical requirements (Milanfar, 2010).
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Chapter 4
Main Investigations: Imaging
4.1 Introduction to Chapter
The aim of this project is to improve upon the current clinical techniques of CEDM as a potential
secondary procedure for patients for whom conventional mammography is less successful, such as
those with dense breast. Dense, firbroglandular tissue presents similarly to tumour tissue on a mam-
mogram and also acts to mask any suspicious findings. The ability to effectively remove background
material from a breast image to leave only structures of interest, i.e. tumours, could therefore greatly
improve the ability to detect cancers in dense breasts. As described in chapter 2, current clinical
implementations of CEDM (largely KES) require two separate acquisitions which can lead to both
an increased dose and potential problems with background removal due to patient movement.
In this chapter, single-shot dual energy decomposition was investigated using the HEXITEC
spectroscopic detector (section 2.6.1), which gives an entire energy spectrum per pixel allowing a
choice of energy bands to a high precision. This was implemented using a custom-made test object
4.2 with known properties to replicate the properties of breast tissue with added CA. Test object
imaging has the advantage that repeatable acquisitions can be made and directly compared.
The aim of this chapter, as well as to determine the effectiveness of spectral imaging for CEDM,
was to compare current clinically used contrast agents (iodine) to potential alternatives, in this case
AuNPs. A reason for this is that AuNPs can be functionalised to be more easily assimilated to
specific types of cells e.g. cancer cells (Rosa et al., 2017). A quantitative analysis of contrast agent
concentration was carried out for both a clinical iodinated contrast agent and for 15 nm AuNPs. The
two were compared in terms of both CNR measurements and of the accuracy of the reconstructed CA
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Figure 4.1: Experimental set-up. The test object was placed in the beam 5 cm from the detector and aligned
both horizontally and vertically, shown by the dashed line, both with the source and with the active area of
the detector (which is 2 x 2 cm).
concentration. These were compared to the clinical requirements outlined in section 2.4 Spectrum
analysis was also carried out.
4.2 Experimental Set-up
The X-ray setup used in this work is shown in fig. 4.1. It is the same general set up as described
in section 3.3, with the addition of the test object. The detector was connected to a computer from
which acquisition was controlled. Before each acquisition, the centre of the source and detector were
aligned. The test object was placed onto a platform with adjustable height. It was positioned before
each acquisition and then a short image was acquired to check both vertical and horizontal alignment
with the detector.
4.3 The Test Object
The test object used throughout this project is shown in fig 4.2. It was composed of a small PMMA
(also known as acrylic or Perspex) box, 5 cm in each dimension, so as to be approximately equivalent
in thickness to a compressed breast. According to a dose review for the NHS Breast Screening
Porgramme (Young and Oduko, 2016), a standard compressed breast used for dose calculations is 53
mm thick. The MGD quoted for a breast of a given thickness, as outlined by the Institute for Physics
and Engineering in Medicine (IPEM) Report 89 (Moore, 2005), may be estimated using appropriate
thicknesses of PMMA. For the standard 53 mm breast, this is equivalent to approximately 45 mm
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Figure 4.2: The test phantom used throughout this work, consisting of a plastic box containing Perspex
spheres and cooking oil. CA is injected into drilled cavities in a Perspex slab attached to the surface facing
the detector. The diameters of the tubes were 3 mm, 2 mm and 1 mm.
PMMA.
Within the PMMA box were PMMA spheres of various diameters up to 15 mm (representing
glandular tissue). The remaining space was filled with olive oil (representing the fatty adipose tissue).
A custom-made PMMA slab was attached to the surface facing the detector using Parafilm. This
had three tubes drilled in (as shown in fig. 4.2) with diameters of 3 mm, 2 mm and 1 mm. The tubes
were filled with contrast agent using a needle and syringe. A 0.4 mm diameter needle was used so
that the smaller tubes could be filled effectively. The aim was to incorporate a complex, cluttered
background and to use materials that mimic the attenuation of breast tissues to obtain results that
were comparable to a clinical situation. A complex background is an important feature to achieve in
order to assess the effectiveness of the background removal.
4.4 Choice of Materials
The main component of the test object consisted of PMMA. This is also known as Perspex or
acrylic and is a widely used soft-tissue equivalent material in medical X-ray phantoms, particularly
in mammography (Vedantham and Karellas, 2013; Sharma et al., 2012; Moore, 2005), due to its
similar attenuation properties to soft tissue in the keV range and because it is relatively cheap and
easily machined. The latter study found that, in the mammography energy range (20-40 keV), 40
mm PMMA was equivalent to 45 mm compressed breast thickness and 50 mm PMMA was equivalent
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Figure 4.3: Graph to show the linear attenuation coefficients for olive oil, PMMA, adipose and average breast
tissue between 15 and 50 keV.
to 60 mm compressed breast thickness.
PMMA is also used as a breast tissue substitute during the routine testing of mammography
detectors, for example when using the CDMAM contrast-detail phantom, which consists of a grid
of gold discs of varying diameter and thickness to test the system resolution (Elizalde-Cabrera and
Brandan, 2015; Moore, 2005). Fatty adipose tissue was replicated using olive oil. A comparison of
the linear attenuation coefficients of adipose tissue, glandular tissue, PMMA and olive oil is given
in fig. 4.3. The data were generated using both XmuDat (Nowotny, 1998) and XCOM software
(Berger, 1999).
Similar choices of phantom have been used previously in the literature. One study (Kahani et al.,
2016), which looked into dual energy material decomposition to identify constituent thicknesses of
calcification, iodinated CA and bismuth CA simultaneously, chose olive oil as a tissue-equivalent for
adipose breast tissue based on the similarity of their attenuation characteristics. They also used
acrylic (PMMA) to represent glandular tissue. Another study (Bornefalk et al., 2006), used a similar
phantom design to that used here, consisting of a 50x50x27 mm PMMA box filled with PMMA
cylinders (to be filled with contrast agent) and olive oil. They also used a box filled with shattered
PMMA pieces of various sizes up to 15 nm in order to create anatomical clutter. The study investi-
gated the use of single-shot dual energy subtraction mammography using a photon counting detector
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that implemented a threshold energy to split the counts into a high and low energy bin to form
two images simultaneously. The authors quoted the approximate chemical formula of olive oil to be
C18H36O6.
As with the previous study, they noted and quantified the similarity of the linear attenuation coeffi-
cients between the phantom materials and breast tissue (across the 20-50 keV range).
4.5 The Contrast Agents
4.5.1 Iodinated CA
Experiments were first carried out using a clinical, iodinated contrast agent (see section 2.3.3). This
was to form the basis against which other contrast agents, i.e. AuNPs, could be compared. The main
contrast agent used in this work was Omnipaque300® (GE Healthcare, UK), an aqueous solution
containing 647 mg/ml of iohexol, equating to an iodine concentration of 300 mg/ml (GE-Healthcare,
2009). The solution has a viscosity of 11.6 mPas at 20◦C, approximately 11 times that of water.
Niopam300® (Bracco, Milan) was also used for some initial experiments. It is an aqueous solution
containing 61.2% weight by volume iopamidol, giving an iodine concentration of 300 mg/ml. Other,
lower concentrations of contrast agent were achieved by mixing the CA with deionised water before
injection into the tubes.
4.5.2 Gold Nanoparticle CA
The gold nanoparticle contrast agent used in this work was Aurovist® 15 nm gold nanoparticles
(Nanoprobes, NY, USA), consisting of a 15-nm gold core, coated with a water-soluble organic shell
(Nanoprobes, 2011b). These were supplied, in solution, in 0.2ml vials, which had been diluted in
PBS (20nM sodium phosphate, 150mM NaCl, pH of 7.4). Each vial contained 40 mg of gold metal
(the weight of the shell was not included), which gave a concentration of 200 mg/ml Au. The AuNPs
were kept refrigerated when not in use. As explained in chapter 6.1, as well as gold having a higher
atomic number than iodine (Z(Au)=79 compared to Z(I)=53), AuNps have the advantage that they
can be made to target specific cells through targeting and functionalisation. The results using this
contrast agent were compared against those from the iodinated CA. Deionised water was used to
dilute the AuNPs. These particular nanoparticles have a blood half life of approximately 15 hours
(Nanoprobes, 2011a) and, due to their size, do not significantly leak from normal blood vessels,
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Figure 4.4: The generated spectrum used in this work with and without the test object (equivalent to 5 cm
breast tissue) in the beam with 3.5 mm Al filtering. The dashed lines show the peak energies in each case.
Data were generated using a spectrum generator (Cranley et al.).
allowing them to accumulate into tumours for up to 24 hours via ’leaky’ vessels.
4.6 Acquiring Iodine Images with HEXITEC
HEXITEC was used to obtain quantitative data for DE analysis. The detector was calibrated for
energy on an individual pixel basis as described in section 3.4. This is an important step as it ensured
that all pixels had the same energy scale and allowed for sharper peaks because the spread caused
by different pixel gains had been corrected. A full set of images was acquired with the HEXITEC
detector with Omnipaque300. Images were acquired at 50 kVp, 2µA, at a source-detector distance
of (76 ±1) cm, for 30 minutes. Current was kept this low to avoid pulse pile-up. The beam was
filtered with 3.5 mm aluminium, which gave a maximum count rate around the iodine K-edge (33.2
keV). This ensured that a significant proportion of the spectrum could be used for imaging, therefore
minimising the dose delivery from spectral components that did not contribute to the image. A
simulated spectrum, obtained from a spectrum generator (Cranley et al.), is shown in figure 4.4.
Other currents were investigated in order to model the effects of pulse pile-up; this is discussed in
chapter 5.
The contrast agent was injected into the tubes of the test object using a needle and syringe.
Dilutions with lower iodine concentrations were obtained by mixing the 300 mg/ml solution with
deionised water. This was achieved by drawing up the appropriate volume of each liquid into the
syringe and mixing inside the syringe before injection into the test object. The syringe had a 0.1
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Volume 300 mg/ml
Omnipaque (ml)
Volume DI water
(ml) Total Volume (ml)
Iodine Concentra-
tion (mg/ml)
3.0 0.0 3.0 300±15
2.0 1.0 3.0 200±50
1.5 1.5 3.0 150±40
1.0 2.0 3.0 100±30
Table 4.1: Table to show the quantities of 300 mg/ml Omnipaque and DI water used to make iodine solutions
of different concentrations for injection into the test object. Errors were calculated based on the uncertainty
in volume of liquid and in the mixing process.
mm graduated scale and typically 3-4 ml of solution was made at a time. Table 4.1 shows how each
concentration was made up. The quoted uncertainty was a combination of both the uncertainty in
the volumes of each component and in the effectiveness of the mixing process. After each acquisition,
the test object tubes were cleaned by flushing with a water-filled syringe several times. It was also
routinely cleaned in an ultrasonic bath to remove any crystallised CA.
4.6.1 DE Image Analysis
The imaging data was processed in 2easy to give 3D arrays of counts (x-pixel, y-pixel, energy bin).
After calibration, images were analysed using the DE equations outlined in section 2.3.3. To obtain
the low and high energy images, appropriate energy bins were summed for all pixels. For iodine,
energy bands of 30:32 keV (bins 95:102) and 34:36 keV (bins 108:115) were summed to give the low
and high energy images respectively. The attenuation coefficient for the average band energy was
used in each case. The dual energy equations (eq. 2.11) were applied to each pixel of the images,
where the unattenuated beam intensity was acquired using an ROI from a background region in the
image, to give the CA-equivalent surface concentration. The result was then divided by the tube
diameter to give the reconstructed CA concentration.
Figure 4.5 shows some examples of the images acquired before and after DE analysis. (a) and
(b) show the full spectrum image before and after individual pixel calibration respectively. The
appearance of noise in (b) arises from the individual pixel calibration, which is described in section
3.4.2. Because the gain of each pixel is normalised to that of the average pixel, this can cause a
significant shift in the spectral channels of some pixels. For a downward shift, the highest energy
bins are left empty as the counts have been reassigned to lower energy bins. (c) and (d) show the
low and high energy images (using bins 95:102 and 108:115 respectively). As can be seen some
pixels appear to be less efficient, particularly around the right-hand edge of the high energy band.
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Figure 4.5: Images obtained with undiluted Omnipaque (300 mg/ml I) with CSA charge sharing corrections
applied (a) Full spectrum image (b) Full spectrum image after individual pixel energy calibration (c) Low
energy image using bins 95:102 (d) High energy image using bins 108:115 (e) Iodine equivalent image after
DE analysis.
As explained above, this noise is exacerbated when the pixel counts in each bin are shifted during
calibration. Finally, (e) shows the iodine-equivalent image after DE analysis. From the colour
bar scale, which shows surface concentration, it can be seen that the surface concentrations are in
agreement with the nominal values of 0.09, 0.06 and 0.03 g/cm2 for the 3 mm, 2 mm and 1 mm
tubes respectively. It can also be seen that the background has largely been removed. The images
shown in fig 4.5 have had CSA charge sharing corrections applied.
4.6.2 Comparison of Spectra
In order to compare the results from different charge sharing corrections, the average spectra across
ROIs both behind the 3 mm tube and in a background region were compared. These are shown
in fig 4.6, where (a)-(c) show the spectra behind the 3 mm tube and (d)-(f) show the spectra in
a background ROI for nominal iodine concentrations of 300, 200 and 100 mg/ml respectively. The
K-edge of iodine (33.2 keV) is shown as a dashed line in each case. The expected K-edge coincides
with the sharp drop of counts in the spectrum, which shows that the calibration is accurate. Both
CSA and CSD corrections removed the majority of the low energy counts that were observed in the
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uncorrected spectra. For CSD, there is a large drop in overall counts but the overall shape of the
spectrum is similar to CSA.
Figure 4.6: Graphs to show the average spectrum per pixel for images acquired at 50 kVp, 2µA for different
concentrations of iodinated contrast agent. (a)-(c) show the spectra for a ROI behind the 3 mm CA-filled tube,
for concentrations of 300, 200 and 100 mg/ml iodine respectively. (d)-(f) show the spectra for a background
region without CA for concentrations of 300, 200 and 100 mg/ml iodine respectively. In each case, CSA, CSD
and no charge sharing corrections are compared. The dashed lines show the iodine K-edge.
4.6.3 Reconstructed Concentration for Undiluted CA (300 mg/ml I)
Figure 4.7 shows the average profile plots for undiluted Omnipaque with CSA charge sharing. To
ensure that there was no pulse pile-up and that there were sufficient statistics, images were acquired
at 2 µA for 30 minutes. Based on the peak profile value of each tube, the reconstructed iodine
concentration for the 3, 2 and 1 mm diameter tubes were (304±6) mg/ml, (332±9) mg/ml and
(342±17) mg/ml respectively. Graph (b) compares the reconstructed profile for CSA, CSD and no
charge sharing corrections. Based on this and on the spectra in fig. 4.6, it was decided to use CSA
corrections for all the imaging work.
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Figure 4.7: Average profile plots of the iodine-equivalent image to show the surface concentration obtained
from DE analysis.The image was acquired for 30 minutes at 2µA and 50 kVp with undiluted Omnipaque
(300 mg/ml I). (a) shows results with CSA corrections. The blue horizontal lines show the nominal surface
concentrations for each tube. (b) compares CSA, CSD and no corrections.
4.6.4 Different Iodine Concentrations
Figure 4.8 shows the iodine-equivalent images obtained from different concentrations of iodine be-
tween 300-100 mg/ml. The colour bars show the reconstructed surface concentration of iodine in
each case. Average profile plots were made from these images by plotting the average profile between
rows 20:60 (41 rows), so as to avoid the noisy pixels around the top and bottom edges. As fig. 4.8
shows, there were also a relatively large number of noisy pixels along the edge columns. So that
these pixels did not affect the reconstructed profiles, a threshold system was put into place whereby
any pixels above a given value (taken to be 1.5-2 times the average value of an ROI within the 3
mm tube) were set to NaN and not included in dual-energy analysis. The threshold was manually
checked for each concentration to ensure that the threshold was at an appropriate level. Without
this step profiles became noisy, with multiple spikes.
The resulting profiles for different iodine concentrations are shown in graphs (a)-(d) of fig 4.9.
Graph (e) compares the different concentrations on the same axes. The results have been converted
into reconstructed iodine concentration for each tube diameter and each nominal concentration in
fig. 4.10. The undiluted Omnipaque (300 mg/ml), shown in graph (a) of fig. 4.9, gives promising
results; the reconstructed thicknesses of the 3 mm, 2 mm and 1 mm tubes were (304±6) mg/ml,
(332±7) mg/ml and (342±17) mg/ml I respectively. The standard error in the mean across image
rows forming the average profile was used to determine the uncertainty.
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Figure 4.8: Iodine-equivalent images obtained after DE analysis using different concentrations of iodine be-
tween 300-100 mg/ml. The colour bars in each case show the reconstructed surface concentration which, when
divided by tube thickness, gives the reconstructed iodine concentration. The white horizontal lines show the
central rows used to generate the average profile.
Diluted concentrations tended to give an over-estimated reconstructed concentration but this
was likely largely due to the uncertainty associated with the dilution process. As the solution was
viscous and colourless, it was difficult to determine how well the solution was mixed. As the contrast
agent was added to the syringe after the water, and was therefore at the needle end of the syringe,
incomplete mixing would have lead to a higher concentration. There is also some uncertainty in the
volumes drawn into the syringe, which had graduations of 0.1 mm. The uncertainties associated
with the nominal concentrations are given in table 4.1. For the 3 mm tube, which was the most
reliable as it covered the most columns of pixels in the image, all concentrations except the lowest
100 mg/ml were well within the error bars given in table 4.1. For the 2 mm tube, all concentrations
were within 5 mg/ml of the error bars. The 1 mm tube only covers approximately 2-3 columns.
The reconstructed concentration was determined by the peak value of the average profile (due to the
circular shape of the tubes) and therefore the angle of the tubes in relation to the pixel axes also
makes a difference.
4.6.5 CNR Measurements
As an assessment of the image quality, the CNR of the iodine-equivalent images as a function of
nominal iodine concentration was calculated. The values were calculated as outlined in section 3.2.1.
In each case, two background regions covering at least 250 pixels were combined to give an overall
mean and standard deviation for the background. This was to offset any differences caused by shifts
in the position of the tubes between concentrations (these difference can be seen in fig. 4.8) and
different noise levels over the detector regions.
Figure 4.11 shows the calculated CNR values for each iodine concentration for both the 3 mm
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Figure 4.9: Average profile plots of the iodine images, showing reconstructed I surface concentration for differ-
ent dilutions of Omnipaque. All images were acquired for 30 minutes at 2µA and 50 kVp with I concentrations
of (a) 300 mg/ml, (b) 200 mg/ml, (c) 150 mg/ml and (d) 100 mg/ml. The dashed grey lines show the nominal
surface concentrations for each tube. (e) shows a comparison of the 100, 200 and 300 mg/ml profiles on the
same axes. The dashed lines show the nominal surface concentrations for the 3mm tube. In each case CSA
corrections have been applied to the data.
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Figure 4.10: Bar chart to show the reconstructed iodine concentrations for each CA-filled tube for nominal
concentrations between 300 mg/ml and 100 mg/ml for each tube thickness. Error bars were calculated from
the standard deviation between the image rows used to create the profiles. CSA correction had been applied
in each case.
and 2 mm tubes. The 1 mm tubes were omitted as they cover so few pixels in the image. Looking at
fig. 4.8 it can be seen that the tube positions varied by several pixels between concentrations which
could affect the background standard deviation.The differences in CNR between the 2 and 3 mm
tubes are consistent and are approximately in the 3:2 ratio that would be expected when error bars
are considered. There is a general positive correlation between nominal concentration and CNR and
both tubes display a linear correlation with concentration as expected.
There is a positive, linear correlation between CNR and iodine concentration, as expected from
the literature (Hwang et al., 2018; Baldelli et al., 2006; Razak et al., 2013; Leithner et al., 2013). The
latter study used a phantom composed of a PMMA slab containing solid iodine platelets (iopamidol
embedded into a polystyrene/graphite matrix) of varying equivalent iodine concentrations in order
to quantify the form of the CNR vs iodine concentration curve. The relationship was found to be
linear with R2 > 0.99. The images were acquired using a Siemens Mammomat Inspiration prototype
(Strudley et al., 2015) which had been modified for CEDM.
Based on the reasoning provided in the above literature, a linear fit of reconstructed vs nominal
concentration was performed for each tube. The equations obtained for the 3 mm and 2 mm tubes
were (y = 0.032x±2.27 ) and (y = 0.027x±1.11) respectively . In all cases except for the 2 mm tube
at the lowest concentration of 100 µg/ml, the CNR was higher than 5. This value has been suggested
76
CHAPTER 4. MAIN INVESTIGATIONS: IMAGING
Figure 4.11: CNR as calculated from the iodine images generated from DE analysis. Results are shown for
CSA-corrected data for both the 3mm and 2 mm tubes. Errors were based on differences in background
standard deviations in different ROIs. In each case a linear fit has was applied with equations of (y =
0.032x+ 2.27) and (y = 0.027x+ 1.11) for the 3 mm and 2 mm tubes respectively.
as the CNR required for an object to be visible (Baldelli et al., 2006).
Concentration vs Dose
The contrast agent concentrations used in this work are higher than those that would be typically
seen clinically, which can be as low as 1-2 mg/cm2 (Jong et al., 2003) for iodinated CA. This was
due to the difficulties found in obtaining accurate dilutions to such low concentrations .
CNR is directly proportional to iodine concentration (Baldelli et al., 2006) and to the square root
of the dose. This relationship was used in the literature (Ballabriga et al., 2011) and incorporated
into a figure of merit proportional to the dose (CNR2/MGD), by which to compare techniques. In
their work, a graph of this figure of merit against iodine concentration gave a linear relationship.
Their requirements for the mimumum iodine concentration were based on a CNR of 5 (minimum)
and a MGD of 2 mGy (maximum).
The CNR graphs shown in fig. 4.11 give CNR as a function of iodine concentration for both the 3
mm and the 2 mm tubes. Using the undiluted (300 mg/ml) CA, the CNR values obtained were 12±1
and 9±1 for the 3 mm and 2 mm tubes respectively, both of which are above the limit of 5. The 1
mm tube, shown in fig. 4.8, was still visible (which is what is needed in a clinical situation), even
at a concentration of 100 mg/ml. This equates to 10 mg/cm2 and required a dose of approximately
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50 µGy. Therefore, as CNR is proportional to the square root of dose, in order to visualise a surface
concentration of 2 mg/cm2, a dose of 1.25 mGy would be required, which is within the acceptable
limits for mammography (Boyd et al., 2011b).
Partial Volume Effects
When imaging small objects, artifacts can be introduced if the size of the object is below the limiting
spatial resolution of the system. In particular, in the case of CA imaging it can cause an underesti-
mation in the activity of the pixel (particularly when imaging with radioactive isotopes) or, in this
case, in the contrast agent concentration in the pixels. It also causes an overestimation in the activity
or concentration in neighbouring pixels, termed spillover. For object sizes approximately equal to the
spatial resolution, the observed activity or concentration is the sum of this partial volume effect and
of the spillover. The literature, which is largely focused on PET and SPECT imaging, has suggested
that this limit can be determined from the FWHM of the LSF (Hoffman et al., 1979; Nyathi et al.,
2016) The spatial resolution of the HEXITEC system was determined in section 3.5 using the LSF
and the 50% MTF, which were found to be be 0.3±0.001 mm and 3.7 ±1 lp/mm respectively. These
results suggest that the partial volume effect becomes significant between 0.3-0.5 mm (or 1-2 pixels).
When imaging the tubes containing CA in the phantom, the central columns are used to calculate
the reconstructed CA concentration. This is because it is the thickest part of the cylinder (i.e. the
diameter). For both the 3 mm and 2 mm tubes, this region constitutes at least 3 pixels. For the 1
mm tube, however, only 1-2 pixels are covered and therefore it is at the limit of being affected by
the partial volume effect. Therefore, it is the results from the 3 mm and 2 mm tubes that are the
most reliable and therefore only they were used for the quantitative analysis.
4.7 AuNP Imaging with HEXITEC
The imaging results with iodine (section 4.6) showed that the DE algorithms allow for accurate
reconstruction of iodinated contrast agent and gave sensible results for diluted concentrations, taking
into account the uncertainty associated with the dilution process. Iodine was used because its K-
edge (33.2 keV) lies within a typical mammographic energy range and therefore distinct spectral
differences between the high and low images, compared to that of the background, could be achieved
by integrating above and below the K-edge respectively. The filtering chosen (3.5 mm Al) also
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allowed the maximum number of counts to be in the K-edge region. As explained in chapter 1,
there are some potential advantages of AuNP contrast agents over iodinated CA, such as larger
photoelectric absorption (due to higher Z) and the potential of preferential absorption by specific
types of cells through targeting and functionalisation, where specific molecules are attached to the
nanoparticles. One of the aims of this project was to compare the images acquired using AuNPs
to those acquired with iodinated CA in order to investigate their potential as an alternative CA.
For dual-energy imaging to work, unlike for K-edge subtraction, there does not necessarily need to
be an absorption edge present but there do need to be clear differences in the attenuation of the
background material and the CA for meaningful results to be obtained. In the case of iodine it was
possible to fully exploit the change in counts the K-edge. However, the K-edge of gold is at 80.7
keV, which lies just above the maximum operating voltage (80 kVp) of the X-ray source used in this
project and therefore bands on either side of the Au K-edge could not be achieved.
4.7.1 Spectrum Analysis
Graphs (a)-(c) in fig. 4.12 show the average spectrum per pixel obtained both behind the 3 mm
AuNP-filled tube (at a concentration of 200 mg/ml Au) and in a background region with CSA,
CSD and no corrections respectively. It can be seen that, unlike iodine, there is no absorption edge
present for gold in the energy range covered and therefore both spectra have the same general shape.
However, there is some variation in the relative differences between the two across the spectrum. It
is important to exploit these differences in order to correctly reconstruct the gold concentration. As
with the iodine images, the average energy has increased after correction. Graphs (d) and (e) compare
all charge sharing corrections on the same axis for the background ROI and behind the 3 mm tube
respectively. Behind the 3 mm tube, the count rate drops by approximately 50% and the intensity of
the Bremsstrahlung continuum is considerably higher for CSA compared to the uncorrected spectra,
but otherwise the two graphs are very similar.
Figure 4.13 shows the mass attenuation coefficients for gold, iodine and liquid water (the back-
ground material) in the range 10-100 keV (Nowotny, 1998). The energy range used for imaging iodine
is shown highlighted in red and the energy range of the imaging source is highlighted in yellow. The
graph shows that the attenuation coefficient for gold decreases logarithmically across the whole en-
ergy range of the source. Water decreases logarithmically between 10-20 keV but changes very little
between 40-80 keV. The largest difference would be between 10 and 80 keV, but the number of counts
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Figure 4.12: A comparison of the spectra obtained behind the 3mm AuNP-filled tube and a background
region. (a), (b) and (c) show the spectra for CSA, CSD and no corrections respectively. (d) and (e) compare
the different charge sharing corrections in each case.
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Figure 4.13: A comparison of the mass attenuation coefficients of gold, iodine and water from 1-100 keV. The
pink region shows the energy range used for iodine imaging. The yellow band shows the achievable energy
regions for the X-ray source used. Data was generated with XMudat (Nowotny, 1998).
present for each energy band also has to be considered. Images were acquired at both 50 kVp and 80
kVp to give a larger range of energy bands. In each case, the DE algorithms were implemented using
different energy bands and the results, in terms of image quality, number of counts and reconstructed
thickness, were compared.
4.7.2 Image Acquisition with HEXITEC
Images were acquired both at 50 kVp, 2 µA for 30 minutes and at 80 kVp, 3 µA for 30 minutes. 3
µA was used for 80 kVp as this was the lowest current that was stable for this voltage. The source-
detector distance was 77 ±1 cm. The AuNPs were injected into the test object tubes using a needle
and syringe. However, due the small volumes involved (the AuNPs were supplied in 0.2 ml vials),
dilutions were made by drawing up an exact volume of AuNPs using a calibrated pipette (accurate
to 0.6-1.8% with a range of 20-200 µl) and dispensing into a test vial. The corresponding volume
of deionised water was then added in the same way. Thorough mixing was achieved by drawing the
entire solution in and out of the pipette tip several times. Once mixed, the diluted solution was
injected into the test object using a needle and syringe. Although this dilution process was much
more precise than that used for Omnipaque, the small volumes used gave an increased uncertainty
in the exact concentration. Table 4.2 shows how the different concentrations were made.
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Volume 200 mg/ml
AuNPs (ml)
Volume DI water
(ml) Total Volume (ml)
Gold Concentra-
tion (mg/ml)
0.25±0.005 0 0.25 200±10
0.15±0.003 0.05±0.001 0.2 150±8
0.2±0.004 0.2±0.004 0.4 100±5
0.1±0.002 0.3±0.006 0.4 50±3
Table 4.2: Table to show the quantities of 200 mg/ml AuNPs and DI water used to make AuNP solutions of
different concentrations for injection into the test object. Errors were based on the accuracy of the pipette.
Figure 4.14: (a) shows the relative difference in mass attenuation coefficient between water and gold from
20-80 keV (Nowotny, 1998). (b) shows the full-energy spectrum obtained with 200 mg/ml Au at 50 kVp split
into 5 keV bands, where the two yellow regions mark the lowest and highest bands that could be used for DE.
4.7.3 Results: 50 kVp spectrum
Figure 4.14 (b) shows the average spectrum per pixel for both a background region and a region
behind the 3 mm AuNP-filled tube for the undiluted AuNPs (200 mg/ml Au, after individual pixel
calibration and with CSA correction). The spectrum has been divided into 5 keV bands. The two
highlighted bands show the highest and lowest energies with potentially sufficient counts to be used in
the DE algorithms. Graph (a) in fig. 4.14 shows the relative difference between the mass attenuation
coefficients of gold and water using the data from fig. 4.13. This relationship is important for
determining suitable energy bands and shows that the larges differences occur at the lower energies.
Figure 4.15 shows the full spectrum image for this acquisition (50kVp, 2µA, 30 mins) before (a)
and after (b) individual pixel calibration. The colour bars give number of counts and have been
adjusted to the same scale. There is a distinct gap in the image behind the smallest tube which was
caused by an air bubble in the tube. Overall, the number of counts inside the tubes remains the
same after calibration. There are some differences in the background; the calibrated image has fewer
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Figure 4.15: Full spectrum image of the test object with 200 mg/ml Au. (a) and (b) show the images before
and after individual pixel calibration respectively, with CSA corrections applied.
counts due to some counts at either end of the spectrum being lost when the counts are shifted during
the individual pixel calibration to correct for different pixel gains. Although this gave the images a
noisier appearance across the full spectrum, it allowed specific energy bands to be integrated more
accurately across the pixel array. Some bands between 23 and 45 keV are shown in fig. 4.16.
In each case, a 2 keV band width, consisting of 8 energy bins, was used by summing the counts
from the corresponding energy bins. The colour scale shows counts per band. As expected from fig.
4.14, the number of counts changes with energy, with the highest number in the 30-37 keV range.
At lower energies, the counts become lower and images appear noisier. However, at higher energies
(38-45 keV) more and more pixels with very low counts appeared. This begins at the edges and
by 43-45 keV the entire image is speckled with very low count pixels. This largely comes from the
individual calibration procedure. Over the lifetime of the detector, more pixels were being shifted
down in energy by larger amounts in order for pixel gains to be uniform across the array, suggesting
that the detector was degrading. It was still possible to obtain good reconstruction results but only
by removing affected pixels from the analysis. This was achieved, as before, by applying a threshold
to the high and low energy bands and setting any outlying pixels to NaN.
Figure 4.17 shows the gold-equivalent images obtained from DE analysis with different combi-
nations of high and low energy bands (from fig. 4.16). The reconstructed thicknesses of each band
combination, as well as the average energy separation between them, is given in table 4.3. This was
based on the average reconstructed surface concentrations behind an 88 pixel ROI in the middle of
the 3 mm tube. These results indicate that the further away the two bands are (for this spectrum),
the closer to the nominal concentration the results become. This makes sense because over a larger
energy range, the difference in absorption properties between gold at water is greater and it is there-
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Figure 4.16: Images constructed using different energy bands from 23-45 keV, acquired at 50 kVp. The colour
bars show number of counts.
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Figure 4.17: Gold-equivalent images from DE analysis obtained from a range of low and high energy bands
from a 50 kVp spectrum. The colour scale shows the reconstructed surface concentration of gold in each case.
Low Energy
(keV)
High Energy
(keV)
Average Energy
Separation (keV)
Reconstructed
Surface conc.
(g/cm2)
Reconstructed
Conc. (mg/ml)
25:27 35:37 10 0.197 656±20
25:27 40:42 15 0.125 416±18
23:25 40:42 17 0.105 349±17
20:22 40:42 20 0.0782 261±8
Table 4.3: Table to show the reconstructed Au concentration when imaging 200 mg/ml AuNPs at 50 kVp
(with CSA corrections applied)
fore easier to distinguish between the two components. The results in table 4.3 show that in general,
the further apart the energies of the two bands, the lower the reconstructed thickness. However, even
at the largest separation of 20 keV, the reconstructed gold concentration in the 3 mm tube is still
approximately 30% larger than the nominal concentration. As fig. 4.14 shows, this is the maximum
separation that can be achieved with the 50 kVp spectrum. Therefore, a higher energy spectrum was
needed.
4.7.4 80 kVp
In order to visualise a larger range of energies, and to fully assess the energy dependence of the
reconstruction, images were also acquired using an 80 kVp spectrum. Graphs (a)-(c) in 4.18 show the
average spectrum per pixel for both a background region and a region behind the 3 mm AuNP-filled
tube, with CSA, CSD and no corrections applied respectively. Figure 4.19 shows the CSA-corrected
spectrum only, where the potential lowest and highest energy regions with sufficient counts to form
an image are highlighted in yellow (25-30 keV and 55-60 keV respectively) and the maximum 80
keV energy is shown as a dashed black line. As with the 50 keV spectrum, different high and low
energy bands were created and analysed with the DE algorithms to determine the optimal energy
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Figure 4.18: Full spectrum from imaging of the test phantom with 200 mg/ml Au at 80 kVp both behind the
3 mm tube and in a background ROI. (a)-(c) have CSA, CSD and no corrections applied respectively.
Figure 4.19: Full spectrum from imaging of the test phantom with 200 mg/ml Au at 80 kVp (CSA) to show
the energies that could be used in DE analysis. The minimum and maximum energy ranges with sufficient
counts are highlighted in yellow. The black dashed line shows the maximum photon energy, 80 keV. Any
counts above this are caused by pulse pileup.
separation. It can also be seen that there were some counts registered above 80 keV, which can be
attributed to pulse pile-up from the CSA algorithm (this will be investigated in chapter 5).
The full spectrum images, which were acquired at 3 µA, 80 kVp for 30 minutes, are shown in
fig. 4.20. (a) and (b) show the images with CSA corrections applied before and after individual
pixel calibration respectively; (c) and (d) show the images with no charge sharing corrections applied
before and after individual calibration respectively. Overall the images appear to have more noise
around the edges compared to those acquired at 50 kVp, particularly after calibration. The gold-
equivalent images obtained for concentrations of 200, 150 and 100 mg/ml Au are shown in fig. 4.21.
The 80 kVp spectrum generates a higher count rate than the 50 kVp, as can be seen by comparing
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Figure 4.20: Full spectrum phantom images at 200 mg/ml Au. (a) and (c) show the images with CSA and
(b) and (d) show the images with no CS corrections before and after individual pixel calibration respectively.
Figure 4.21: Gold-equivalent images obtained from DE analysis with the 80 kVp spectrum for concentrations
of 200, 150 and 100 mg/ml Au. The colour bar shows the reconstructed surface concentration of gold.
figures 4.14 and 4.19. It is expected that the number of counts increases approximately by the square
of the kVp (Nickoloff and Berman, 1993). This causes some mis-corrections of charge sharing due to
pulse pile-up. This is the cause of the small percentage of counts observed at energies above 80 keV
in fig 4.18 (a). This effect is investigated in chapter 5.
4.7.5 Comparison of Energy Bands
To get a more complete picture of the relationship between the chosen energy bands and the recon-
structed Au concentration obtained with DE, images were analysed with the DE algorithms using a
range of high and low bands between 30-57 keV and 23-35 keV respectively. The results are shown
in fig 4.22. In each case, 2 keV wide bands were used. For each combination, the quoted value is
the reconstructed Au concentration as measured from the 3 mm tube, where the target value is 200
mg/ml. As in section 4.6, this was measured as the peak value from the average profile across the
CA-image to account for the circular shape of the tube. As before, measures were taken to exclude
non-responsive pixels from the analysis, such as those shown in the bottom row of fig 4.16. The
results show that when the bands are close together, the Au concentration is greatly overestimated.
87
CHAPTER 4. MAIN INVESTIGATIONS: IMAGING
Figure 4.22: Tables to show the reconstructed Au concentrations obtained after DE analysis using 200 mg/ml
AuNPs at 80 kVp, 3 µA for different combinations of high and low energy bands. (a) and (b) show the results
with no corrections and with CSA respectively. The squares outlined in yellow show the two reconstructions
that were closest to the nominal concentration in each case.
However, at the other end of the scale, when the energies become too far apart (from 27+ keV dif-
ference), the concentration is underestimated. This may be due to low counts, as well as incorrect
summation of charge-shared events.
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Figure 4.23: (a), (b) and (c) show the resulting Au profiles for nominal concentrations of 200, 150 and
100 mg/ml Au. The red and black dashed lines show the nominal results for the 3 mm and 2 mm tubes
respectively. (d) shows all concentrations superimposed, where the dashed lines show the nominal results for
the 3 mm tubes. (e) displays the reconstructed Au concentrations for each concentration and tube thickness.
The dashed lines show the nominal results. In each case CSA corrections were applied and error bars were
calculated from the standard error in the mean across the rows averaged to form the profiles.
Taking these results into account, it was decided to use energy bands of 23:25 keV (average 24
keV) and 43:45 keV (average 44 keV) as the low and high bands respectively as they gave the best
reconstruction for CSA (and were also the third most accurate when no corrections were applied).
These bands were used to generate the reconstructed gold profiles for each concentration acquired.
The reconstructed iodine profiles generated for nominal Au concentrations of 200 mg/ml, 150
mg/ml and 100 mg/ml are shown in charts (a), (b) and (c) of fig. 4.23 respectively. In each case the
images were acquired at 80 kVp and had CSA corrections applied. The red and black dashed lines on
each graph show the nominal surface concentrations for the 3mm and 2 mm tubes respectively. The
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Figure 4.24: Graph to show the CNR values measures for each nominal gold concentration for both the 3
mm and 2 mm tubes. CNR was measures from the gold-equivalent images obtained from DE analysis. Errors
were calculated using the standard deviation between different background regions within each image.
1 mm tubes were not included in the analysis due to the difficulty in injecting the AuNPs without
air gaps and the small number of pixels behind the tube. The profiles show accurate reconstructed
surface concentrations for these specific energy bands.
Chart (d) shows all concentrations superimposed onto the same axes. The results were converted
into Au concentration (mg/ml) and are displayed in chart (e) of fig. 4.23. The quoted uncertainties
were calculated using the standard deviation of the averaged rows over which the profile was taken.
4.7.6 CNR Measurements
CNR measurements were calculated from the gold-equivalent images obtained from DE analysis (as
shown in fig. 4.21). In all cases the images were relatively noisy and therefore several background
ROIs were used in each case. The 200 mg/ml image was much noisier than the others and therefore
had a high background standard deviation, which reduced the CNR. These results are shown in fig.
4.24.
As explained in section 4.5.5, the relationship between concentration and CNR is expected to
be linear (Baldelli et al., 2006; Leithner et al., 2013; Hwang et al., 2018). Although there was a
proportional increase (relative to the concentration) seen between concentrations of 100 mg/ml and
150 mg/ml Au, this was not seen for the highest 200 mg/ml Au. From figures 4.20 and 4.21 it can
be seen that there are a large number of noisy pixels in these images that have made quantitative
calculations difficult and prone to large uncertainty. Almost all results had a CNR below 5, even
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with error bars taken into account. The limit of visibility for CNR is 3-5 according to the literature
(Baldelli et al., 2006; Dickerscheid et al., 2013). As can be seen in fig. 4.21, the 1mm tube cannot be
clearly seen at any of the concentrations and the 2 mm tube becomes difficult to visualise, particularly
in some areas, at 100 mg/ml Au.
The same extrapolation technique can be used here (fig. 4.24) for AuNPs as was used for iodine
in section 4.6.5. In vitro studies have calculated the maximum intracellular gold concentration by
counting the number of AuNPs in cells over time and relating it back to the number of Au atoms
(Coulter et al., 2012; Rosa et al., 2017; Chithrani et al., 2010). These studies used different cell lines
(HeLa, MDA MB-231, DU145 and L132) and different size nanoparticles (1.9-74 nm), however, all
results were between 60 µg/ml and 10 mg/ml Au.
Some problems were seen with the 200 mg/ml images, which showed inconsistencies with the
other concentrations. Therefore, the 150 mg/ml results were used, which gave CNR values of 5.8
±0.5 and 3.6 ±0.2 for the 3 mm and 2 mm tubes respectively were used. In both cases, a dose to
the phantom of approximately 165 µGy (based on a 80 kVp beam). To visualise the 2 mm tube with
10 mg/ml would require an increase in dose to bring the CNR above 5, which would be above the
acceptable limits for mammography by an order of magnitude (Boyd et al., 2011b). Further work
would be required to optimise the spectra for AuNP imaging, by increasing the kVp to include the
Au k-edge (80.7 keV) and by appropriate added filtration to remove any unnecessary dose.
4.8 Conclusions and Comparison of AuNPs to Omnipaque
This work investigated the implementation of DE analysis with clinical iodinated contrast agent
(Omnipaque300) using a HEXITEC spectroscopic detector, which allowed a full spectrum of energies
per pixel. Results using AuNPs were then compared to those of iodine to test their suitability as a
potential new contrast agent to overcome some of the limitations associated with iodinated CA.
The full spectrum images were successful for both contrast agents and the tubes could be clearly
differentiated from the background. For iodine, DE was performed using 2 keV-wide energy bands
at 30:32 keV and 34:36 keV. This gave one band either side of the iodine K-edge (33.2 keV), enabling
the change across the K-edge to be fully exploited whilst keeping the energies close enough together
to be in the maximum count region of the image (see fig. 4.6 (d)-(e)). Iodine gave an accurate
reconstructed thickness for the undiluted concentration (nominal concentration of 300±15 mg/ml)
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of 304±6 mg/ml. Good agreement with expected data was also achieved for dilutions between 100-200
mg/ml I when the uncertainty in nominal concentration was taken into account. This uncertainty
comes from both the uncertainty in the volumes of CA and water used and that associated with
the mixing and injection process. Improvements could be made to decrease this uncertainty by
performing serial dilutions and, in particular, using calibrated fine volume pipettes to achieve more
accurate concentrations. This could also allow investigations into the minimum visible iodine or Au
concentration by focusing on particular concentrations. Mixing could be improved by pipetting up
and down repeatedly.
Some detector limitations were observed, in particular a large number of pixels which had a
lower gain and required large shifts in their energy bin counts during individual pixel calibration.
This caused less counts to be registered at the higher energies, creating noise in the high energy
band and resulting in disproportionately high values in the iodine-equivalent images. These pixels
were not included in the profile analysis and were excluded on a threshold basis. These effects were
particularly noticeable at higher energies (i.e. when using the 80 kVp spectra for AuNPs), which
contributed to the difficulties in visualisation of the CA-filled tubes as well as to the low CNR values.
Ideally, the K-edge would have also been exploited for gold (80.7 keV). However, the available
source had a maximum operating voltage of 80 kVp and therefore this was not achievable. Unlike
KES, DE does not necessarily require that there be a K-edge, only that the attenuation properties of
the two materials are significantly different across the energy range used. This was investigated with
both 50 kVp and 80 kVp spectra; the reconstructed concentration in the 3 mm tube was calculated for
different combinations of high and low bands and compared to the nominal concentration. For the
final images, bands of energies at 23:25 keV and 43:45 keV were chosen. This combination was found
to give accurate reconstructions for each concentration: 189±10 mg/ml, 159±9 mg/ml, and 102±7
mg/ml for nominal concentrations of 200±10 mg/ml, 150±8 mg/ml and 100±5 mg/ml respectively.
Another limitation associated with the 80 kVp spectrum is the higher count rate generated. As
explained in section 2.6.3 the charge sharing corrections over-correct the spectrum when implemented
above ∼10% detector occupancy. This over-correction can be visualised in fig. 4.19 where counts
are present above 80 keV. This can cause distortions to the spectra which could in turn affect the
reconstructed concentrations. Therefore, lower count rates are necessary, leading to long acquisition
times of around 30 minutes. For the imaging procedure to become closer to the clinical requirements
of a few seconds (Perry et al., 2006), correction mechanisms will need to be investigated that can
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overcome any adverse effects of charge sharing whilst simultaneously correcting for any increased
dead time caused. This will be investigated in chapter 5.
As a comparison, a simulation study in the literature (Alivov et al., 2013) investigated how
different parameters, including beam energy, affected image quality in CT (by simulation of an ideal
CZT detector). Comparing Au and iodine, they found minimum detectable concentrations of 0.21
mg/ml and 0.63 mg/ml respectively for an ideal detector, suggesting a better performance for Au
based on the attenuation properties. They also investigated the effect of kVp on CNR. CNR of a
simulated test object containing Au at a concentration of 4 mg/ml was measured at beam energies
of 85-150 kVp, using a constant dose of 15 mGy. They found an exponential relationship between
CNR and kVp between 80-120 kVp, followed by a plateau at higher energies. It was found that the
optimum CNR was achieved with a beam energy was 125 kVp, which allowed sufficient flux at the
Au K-edge. These results suggest that a much higher beam energy than 8 kVp is required and that
Au may out-perform iodine given the right parameters.
In conclusion, both materials performed well and generated accurate reconstructed CA concentra-
tions, when optimal bands were chosen. However, in a clinical situation, the most important thing is
to be able to see the tumour; the CNR graphs in figures 4.24 and 4.11 show that iodine outperformed
AuNPs and therefore appears to be the more successful contrast agent in the mammographic energy
range. In particular, iodine enabled lower doses to achieve the same CNR as AuNPs. However, it
is difficult to directly compare the two due to the limitations of the source and detector and the
different spectra used. A more thorough comparison would be given using a higher energy spectrum
that incorporates the gold K-edge (at 80.7 keV). The long imaging times required (up to 30 minutes)
and large pixel size (250 µm) compared to clinical systems mean that improvements are required
before the clinical requirements outlined in section 2.4 are achieved. However, the almost-unlimited
number of energy bands that can be used provide a very useful tool in optimising the bands used for
DE. Applying algorithms to account for dead time and/or charge sharing could reduce the imaging
times without the need to physically change the detector. This will be investigated in chapter 5.
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Dead Time Investigations
5.1 Introduction to Chapter
In this chapter, an investigation into the dead time of the HEXITEC detector, caused largely by the
correction of charge-sharing events, and its effect on dual-energy reconstruction is presented. The
aim of this chapter is to determine and implement correction algorithms for images acquired at high
count rates (above the dead time) in order to allow acquisition times closer to those required clinically
whilst retaining high statistics and the ability to correct for charge sharing events. Without dead
time corrections, acquisition times of the order of 30 minutes are required to achieve sufficient image
quality, which is much longer than the 1-3 seconds (Perry et al., 2006) required clinically, particularly
if the possibility of patient movement (and discomfort) during the acquisition is considered.
In order to assess the effect of this dead-time like behaviour on reconstructed CA images, the
relationships between incident and measured count rates were quantified using a series of images at
different currents (count rates). The resulting recorded counts were used to generate fit equations
in the form of a non-paralysable dead-time curve. The equations were subsequently used to correct
images for dead time losses.
5.2 Detector Dead Time: Models
During an acquisition, the expected, or true, counts will differ from the measured counts, in part as
a result of detector dead time. Other factors include the efficiency of the detector. By definition,
the dead time of a detector is the amount of time after a detected event during which the detector
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Figure 5.1: The two models of dead time. The red spikes show incident events, the boxes show detected
events and the overlapping boxes show counts that are detected together as a single event (adapted from
Knoll, 2010).
is insensitive to any further events (Knoll, 2010). That is to say, it is the minimum separation time
between two events required for them to be recorded separately.
Figure 5.1 shows models of the two dead time behaviours: paralyzable and non-paralyzable. In
both models, if a count is detected, the detector will become insensitive to further counts for the
duration of the dead time, τ . In the paralyzable model, an event reaching the detector during the
dead time will not be detected and causes the dead time to be extended by length τ . In the non-
paralyzable model, pulses occurring within τ will not be detected but will not cause a dead time
extension. In the example in fig. 5.1, three and four of the six incident pulses (shown in red) are
detected with the paralyzable and non-paralyzable systems respectively, given τ is the same for both
models. At low count rates, the two regimes are almost identical as nearly all events will be detected.
However, as the incident count rate increases, differences emerge, as shown in fig. 5.2. Increasing
the count rate beyond a certain threshold in a paralyzable system will result in a reduction in the
number of detected counts because the detector becomes insensitive for longer and longer periods of
time. As can be seen in fig. 5.2, this means that at high rates there are two possible values of true
count rate for a given measured count rate. The true rate, n, corresponding to a measured rate, m,
for the non-paralyzable system is given by equation (5.1).
m =
n
1 + nτ
(5.1)
where τ is the dead time (Knoll, 2010). This relation can be simply derived by observing that the
total amount of time that the detector spends insensitive per unit time is mτ , giving a rate of event
losses of nmτ . Rate of loss can equally be given as n −m, leading to eq. (5.2), which is a simple
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Figure 5.2: True vs measured count rates for the two different dead time models (adapted from Knoll, 2010).
re-arrangement of eq. (5.1).
nmτ = n−m (5.2)
The paralyzable regime is more complex as the dead time intervals are not of constant length.
Therefore, the expected measured counts are based on the probability of a time interval between
events greater than τ for Poisson-distributed events with an average rate of n. The paralyzable
equation is given by eq. (5.3).
m = n exp(−nτ). (5.3)
Because both models represent idealised an detector response, real detectors often show interme-
diate behaviour between the two (Knoll, 2010; Bécares and Blázquez, 2012), where the overall dead
time response is the result of contributions from different components of the detector system.
5.3 Dead Time and Pulse Pile-up in HEXITEC
Because of the way HEXITEC works, it is difficult to associate it with a dead time by the definition
given in section 5.2. The detected counts are read out in frames, where the maximum readout speed
is 10 kHz (104 frames per second) for the 80 x 80 pixel array. In a given frame, each pixel can
only record one count (giving a maximum of 104 counts per pixel or 6.4x106 counts over the whole
detector per second). However, each pixel contains a peak-track-and hold circuit. This has the ability
to overwrite lower signals with larger ones during a frame, i.e. it can detect multiple events but only
the largest pulse is transferred to the readout (Seller et al., 2011). Therefore, although the detector
is not insensitive to further counts as it can detect and overwrite them, only one can be stored in any
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given frame. After being read out, a pixel can be reset and reactivated in less than 100 ns but the
limiting factor on the recorded count rate is the rate at which frames can be read out. Therefore, for
DE imaging purposes, the effective dead time is the maximum count rate that can be recorded per
second because, above this, the relationship between true and measured counts deviates from linear.
5.3.1 Limitations of Charge Sharing Corrections
As discussed in section 2.6.3, charge sharing occurs when the charge cloud generated by an X-ray
interaction is shared between neighbouring pixels, causing multiple lower-energy counts to be recorded
for a single event. The small pixel size of the HEXITEC detector (250 µm) is such that charge sharing
can cause significant degradation to the output spectrum. One study (Veale et al., 2014) found
that approximately 34.6% of events were affected by charge sharing when using HEXITEC under
standard conditions. This value was obtained by comparison of spectra before and after CSA and
CSD corrections at low flux, using an Am-241 sealed source with an activity of 180 MBq, equating
to a flux of ∼22 photons/s/pixel at the detector.
Corrections are made on a frame-by-frame basis by removing (CSD) or summing together (CSA)
any counts present in two or more neighbouring pixels in a given frame. This can only be implemented
at low count rates, when only one count is detected per 3x3 neighbouring pixel group per frame,
because the algorithms cannot distinguish between shared events and two independent events arriving
in neighbouring pixels. It has been suggested in previous work that the corrections can be accurately
implemented at 10% detector occupancy (Wilson et al., 2013; Scuffham et al., 2012). As the maximum
frame read-out is 10 kHz, this is equivalent to 103 counts per pixel per second. Above this maximum
(which will be referred to as EMR, effective maximum rate, in this work), over-correction starts to
occur because the probability of two independent counts arriving at neighbouring pixels becomes
significant, causing the linear relationship between incident and corrected counts to tail. In the case
of CSA, this can lead to multiple full-energy charges to be summed together.
Rather than conventional dead time, the EMR describes the maximum rate that can be accurately
corrected for charge sharing; the rate capability of a pixel remains at 104s−1. Deviations from a linear
relationship could affect image reconstructions when using dual energy decomposition, particularly
when there is significantly different attenuation across an imaging object. The need to keep below
the EMR demands long acquisition times in order to achieve sufficient statistics within the relevant
energy bands for DE.
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5.4 Measured vs Expected Counts with HEXITEC
In order to determine the form of the effective dead time effects in HEXITEC with and without
charge sharing corrections, images were acquired at different currents, using the set-up described in
section 3.3. The source-detector distance was 70±1 cm with the centre of the detector vertically and
laterally aligned to the source. The beam was filtered with the usual 3.5 cm aluminium; the test
object was not present. The data was processed with CSA, CSD and no corrections in turn. The
total number of counts across the entire energy spectrum for the whole detector was measured and
converted to the measured count rate per pixel. This was compared to the expected true count rate,
which was determined from a generated W-spectrum (Cranley et al.). Subsequent fits to the data
were made in MATLAB.
Images were acquired for 120 seconds (accounting time for bias refresh) at 50 kVp and at currents
of 2, 3, 5, 10, 15, 20, 30, 50, 70, 80 and 100 µA, representing expected count rates per pixel of
∼90-4600 s−1 respectively. Paralysable fits were made to the data, where true rate was multiplied
by a scalar factor, a, to give a closer fit, as shown in eq. 5.4.
m = an exp(−anτ) (5.4)
Figure 5.3 shows the measured vs expected counts for each current (count rate), for images
processed with each charge sharing correction algorithm. The results show that the correction algo-
rithms have a significant effect on the output counts. Both CSA and CSD show a paralysable-type
response to high count rate. The uncorrected images show an intermediate response between the
paralyzable and non-paralysable regimes. As explained in section 5.2, many real systems exhibit this
intermediate behaviour due to the added contributions of different components within the system.
CSD gives a much lower measured count than CSD and drops to zero measured counts per pixel
above a true count rate of 4000 s−1. Although CSA follows the same trend, the measured counts
decrease at a slower rate. The maximum measured count rates, given by the fit data, were 1021 and
482 true counts for CSA and CSD respectively. In order to fully understand the shape of the graphs
in fig. 5.3, some simple simulations of single frames were made.
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Figure 5.3: Expected vs measured counts for images acquired with the HEXITEC detector with (a) no charge
sharing corrections, (b) CSA corrections and (c) CSD corrections. Error bars were calculated based on the
difference in counts for ±1 cm of the source-detector distance and on the uncertainty in the current.
5.4.1 Full Frame Simulations and Spectrum Analysis
To visualise how each correction algorithm would work in the most extreme cases, where all pixels
in a given frame are occupied, single-frame images were simulated and processed with the charge-
sharing corrections. An 80 x 80 array was created in MATLAB, where every pixel had registered a
count. The value of each pixel, which represents the pulse height of a given event, was modelled on a
Gaussian distribution about a chosen mean energy, generating varying pulse-heights across the array.
This was important to ensure that different 3x3 pixel groups had maximum pulse-heights in different
positions (as the CSA algorithm assigns the final energy summation to the pixel with the greatest
original share). The actual values are arbitrary here as only the number of counts is of interest.
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Figure 5.4: A comparison of the correction algorithms at full frame capacity in terms of number of counts
only for no corrections, CSA and CSD.
Figure 5.4 shows the original, uncorrected array of counts, where all pixels have registered a
count. The mean of the Gaussian distribution was 1000 and the standard deviation was 50 in this
case. The resulting counts with CSA or CSD applied are also shown for the same starting array.
The corrections were achieved using 8-connectivity nearest neighbour analysis on each pixel. The
colour bars show pulse-height, and show that for CSA the counts in the corrected frame have a value
approximately nine times higher than the original mean (as all 3x3 pixel grids have effectively been
summed). Some edge and corner pixels are lower as they have less neighbours to sum.
The case for CSD is relatively simple because, in a saturated frame, there would be multiple
counts in every 3x3 pixel grid. Because all neighbouring counts are deleted for a given frame, a fully
saturated frame would yield zero counts. Therefore, in this extreme case, the situation is similar to
a paralyzable system where the detector spends its entire time paralysed and insensitive to further
counts.
For CSA, the relationship is more complex. The CSA image in fig 5.4 shows that only around
11% of counts remain after the correction. The exact number depends on which pixel in each 3x3
pixel grid contributed the highest signal initially. If we were interested purely in the number of counts
in the spectrum, then one would expect the relationship between measured and detected counts to
plateau to around 11% of the uncorrected data set (corresponding to 1/9 pixels, or one per 3x3 pixel
grid, as is the case in fig. 5.4). However, because the CSA algorithm sums the values all of the
neighbouring charges, when the detector is saturated with independent counts there may be cases
where 9 full energy charge clouds are summed, resulting in large photon energies that are off the
scale for the 50kVp spectrum used. This means that after correction, the corrected counts cannot be
assigned to an energy bin and are effectively lost from the system.
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Figure 5.5: A comparison of the CSA algorithms at full frame capacity after pixels have been assigned an
energy bin. At very high count rate, the summation of multiple full events results in energies off the scale
which are lost from the spectrum.
Figure 5.5 shows the detected counts after CSA correction and after counts have been assigned to
an energy bin. As in fig 5.4, normally-distributed images were created. For HEXITEC, the spectrum
comprised of 400 energy bins, each covering 10 ADU, giving a maximum of 4000 ADU for counts
to be into an energy bin; counts above this are effectively lost. Gaussian means of 50, 450 and 600
were used (with standard deviations of 2.5, 22.5 and 30 respectively) to give approximate maximum
pulse-heights of 450, 4050 and 5400 respectively. These gave final corrected counts of 776, 325 and
30 counts across all pixels respectively. This explains why the CSA graph in fig 5.3 does not plateau.
In any case, the resulting energies would be meaningless.
Figure 5.6: A comparison of the energy spectra obtained for different charge sharing corrections for different
currents (count rates). Graphs show spectra after individual pixel calibration. The inset graph in (c) compares
only CSA and CSD to show the pile-up of counts above 50 keV.
Figure 5.6 shows the output spectra for the images obtained at 2, 10 and 30 µA after individual
pixel calibration had been performed, as per section 3.4.2. As the current increases, the proportion
of counts for CSA in the higher energy bins increases, as a result of multiple full energy peaks being
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summed together. At 10 µA, approximately a third of the total counts are in bins corresponding to
energies above 50 keV. As can be seen from the inset graph of (f), at 30 µA, there are more counts
above 50 keV than below it, and the proportion of CSA counts compared to the uncorrected counts
is significantly reduced to less than 10%.
5.4.2 With Phantom
The images acquired in section 5.4 are based on much higher count rates than would typically be
used in an acquisition. In order to achieve significantly lower count rates, a second set of images was
taken with the test object in the beam. As shown in fig. 4.2 in section 4.3, this is composed of a 5 cm
x 5 cm plastic container filled with Perspex spheres and cooking oil. In this instance, the perspex slab
was not attached to the phantom. Although the presence of the phantom would introduce some extra
scatter into the images, it was necessary in order to see the effects of imaging the test phantom, which
is present for all other acquisitions. The results without the phantom clearly showed a paralyzable
behaviour for both CSA and CSD charge sharing corrections, and an intermediate between the two
for no applied corrections. The results with the phantom are shown in fig 5.7. Images were acquired
for 180 seconds at 50 kVp at a source-detector distance of 70 ±1 cm. Currents of 2, 3, 5, 10, 15, 20,
30, 50 and 70 µA were used, equating to count rates of ∼20-670 counts/s/pixel. As before, the beam
was filtered with 3.5 mm Al.
Figure 5.7 shows a linear relationship between measured and true counts for no corrections, a
non-paralyzable effect for CSA and a paralyzable effect for CSD. As before, fits were made to the
data for CSA and CSD based on the paralyzable model, with true rate multiplied by a scalar factor
as in equation (5.4). Both CSD and CSA are also dependent on the number of counts detected in the
uncorrected spectrum, the dead time of which is dominated by the frame rate. The dead times were
measured to be 1.41±0.03x10−3 s and 3.82±0.05x10−3 s for CSA and CSD respectively. As there is
added scatter in this set-up, and the test phantom does not have a uniform structure, it is important
to check that the dead time equations applied with and without the phantom are consistent.
A comparison of the extrapolated fits generated with and without the phantom is shown in fig.
5.8. The fitting parameters (with errors generated from the 95% confidence intervals of the fit) and
the calculated EMR per pixel are compared for CSA and CSD, with and without the phantom in
table 5.1. For CSD, the fits are very close, with almost indistinguishable maximum values.
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Figure 5.7: Expected vs measured counts for phantom images acquired on the HEXITEC detector with (a)
no charge sharing corrections, (b) CSA corrections and (c) CSD corrections. Error bars were calculated based
on the difference in counts for ±1 cm of the source-detector distance and the uncertainty in the current.
The phantom data does give a sightly lower value of maximum for the peak, but the fit has been
extrapolated far from the measured value. For CSA, the two fits overlap at very low counts and
deviate after the maximum of the phantom data. However, there is an almost constant difference
between the two curves up to approximately 4000 counts/px/sec, as fig. 5.8 shows. These results
confirm that the fits are close at the lower count rates. The data for the fits with the phantom were
based on much lower count rates than those without. Therefore, differences are likely to have arisen
from the extrapolation from low counts.
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Figure 5.8: A comparison of the fits generated with and without the phantom in the beam, extrapolated to
high count rate. Fits were generated in MATLAB in the form of a paralysable dead time curve. Peak values
for CSA were 923 and 1021 counts/s with and without the phantom respectively. Peak values for CSD were
482 and 472 with and without the phantom respectively.
Phantom? Correction Model a τ EMR (s−1px−1)
Yes CSA Paralysable 0.77±0.02 1.41±0.03x10−3 714 ±15
Yes CSD Paralysable 0.53±0.01 3.82±0.05x10−3 263±2
No CSA Paralysable 0.75±0.04 1.31±0.04x10−3 769±23
No CSD Paralysable 0.59±0.02 3.61±0.07x10−3 277±5
Table 5.1: Table to show the effective dead times for the different charge sharing correction algorithms with
and without the phantom in the beam. EMR values are per pixel and cover the whole spectrum. Errors were
calculated using the 95% confidence intervals of the fitting parameters.
Figure 5.9 shows the output spectra for currents from 2-100 µA. A similar relationship to that
of fig 5.6 is seen but with a much slower progression (as less counts are reaching the detector at a
given current). That is to say, at 10 µA, there is still only a very small proportion of counts above
50 keV. At 70 µ A, this proportion has become significant. If approximated non-paralysable fits are
created by omitting some of the higher current results, it may be possible to correct the spectra of
images by inverting the dead time equations.
5.5 Testing for Different Energy Bands
Although these results provide useful information in terms of the loss of counts through the detection
and correction system, it is important to also investigate how the counts in the specific energy bands
of interest are affected. This is especially important for CSA data, where over-correction leads
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to incorrect energy being associated with an event. Figure 5.10 shows the curve of both current
against measured counts and of expected vs measured counts for the specific energy bins used for
iodine imaging for both CSA and CSD, where expected counts were calculated by integrating the
appropriate energies of the generated W spectrum.
Figure 5.9: A comparison of the energy spectra obtained for different charge sharing corrections for different
currents (count rates). Graphs (a)-(e) show the spectra after individual pixel energy calibration.
The spectra in fig. 5.9 suggest that the relationship between the true and measured count rate
is dependent upon on the energy. Therefore, in order to correct the spectra of images taken at
higher currents, dead time fits need to be made specifically to the bands of energy that will be used.
In the case of iodine K-edge imaging, the bands used, based on the most recent calibration were
bins 95:102 (30.1:32.2 keV) for the low energy and bins 108:115 (34.0:36.0 keV) for the high energy.
To determine how sensitive the bin range was, a second set was compared in the inset graphs in
fig. 5.10, using bins 90:100 (28.6:31.6 keV) and 120:130 (37.5:40.5 keV). These are shown as inset
graphs. A response consistent with the first set of bins was seen. In both cases it can be seen that a
non-paralysable type response is seen if the 70 µA data is not included. Fits were made to the data
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Figure 5.10: Expected vs measured counts for high and low energy bands for CSA and CSD. Top: results
compared to true counts. Bottom: results compared to the 2µA spectrum. The inset graphs compare a second
set of energy bins for comparison.
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in the non-paralysable region only (up to 30 µA), approximated to a non-paralysable dead time,
where true rate was multiplied by a scalar factor, a to give a better fit, as shown in eq 5.1. The fits,
the resulting parameters of which are given in table 5.2, determined an EMR for CSA of 24±3 and
26±3 counts per energy band per pixel for the high and low energy bands respectively. For CSD,
the results were 16±2 counts/s for both the high and low bands. The parameters of τ (the effective
dead time) and a (a multiplying factor to improve the fit) will be used in sec 5.8.1 to generate the
corrected CA-phantom images.
Correction Band (bins) Band (keV) a τ (s) EMR (s−1)
CSA 95:102 30.1:32.2 1.075±0.09 0.0422±0.005 24±3
CSA 108:115 34.0:36.0 1.067±0.08 0.0389±0.005 26±3
CSD 95:102 30.1:32.2 1.067±0.08 0.06255±0.008 16±2
CSD 108:115 34.0:36.0 1.062±0.08 0.06335±0.008 16±2
Table 5.2: Table to show the effective dead time, τ and EMR of different energy bands as well as the fractional
multiplier, a, used for the fit, for CSA and CSD charge sharing corrections. All results shown are for a whole
band per pixel and errors were calculated using the 95% confidence intervals determined by the fit.
5.6 Dead time Simulation applied to DE
In order to investigate the effects of DE reconstruction when using count rates above the EMR, a
simulation code written to create simulated images of a hypothetical test object composed of iodine
and water for different incident count rates and detector EMRs. The test object is shown in fig. 5.11.
A graphical user interface (GUI) was incorporated to allow faster analysis and for ease of control
in the selection of imaging parameters. This is shown with annotation in fig 5.12. Although the
count rate restrictions for HEXITEC are not strictly comparable to conventional dead time effects,
a comparison of the incident and measured counts at rates above the EMR showed behaviour of the
form of a non-paralyzable dead time curve for low count rates. Therefore, a conventional source was
modelled, subject to a non-paralyzable dead time regime and was used to test how reconstruction
was affected at count rates above the EMR. Detector behaviour was simplified such that only effects
caused by the dead time were considered. Based on an initial count rate, emerging counts were
calculated after passing through different sections of the test object. The count rate reaching the
detector is given by equation 5.5.
I = I0 exp(−µIxI − µWxW ) (5.5)
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Figure 5.11: Left: Diagram of the simulated test object. Arrows show the direction of X-rays and red arrows
show the sections through which detected counts will be measured. Right: Example of the simulated image
array generated.
where I0 and I are the incident and final intensities respectively, the subscripts I and W refer to
the iodine and water components respectively, x is the thickness of that material and µ is the linear
attenuation coefficient. All attenuation coefficients used in this work were obtained from XMuDat
(Nowotny, 1998).
To account for dead time effects, the true emerging count rates were converted into measured
rates using the non-paralyzable dead time equation, as given by eq. 5.1. τ was taken to be the
inverse of the EMR. The resulting values were used to generate an image matrix, as shown in fig.
5.11. To give a more realistic image appearance, the counts were converted into Poisson-distributed
numbers, where the mean number of emerging photons for each region was used as the mean of the
distribution. The Poisson probability distribution is given by equation 5.6.
P (x) =
(x¯)xe−x¯
x!
(5.6)
where x is the number of successes (positive integer) and e is the mathematical constant. The Poisson
distribution is based only on the mean of the dataset; the standard deviation is given by the square
root of the mean. A summary of the simulation procedure is as follows:
1. Set an incident count rate, dead time, acquisition time and test object parameters.
2. For each region of the test object, calculate the attenuated count rate, Nout, from the attenu-
ation equation, using the attenuation coefficients for the low energy.
3. Use Nout to populate a matrix, as in 5.11.
4. Convert the matrix values into Poisson numbers for a more realistic image.
108
CHAPTER 5. DEAD TIME INVESTIGATIONS
Figure 5.12: The automated graphical user interface created for the dead time simulation, allowing fast
analysis and data saving.
5. Calculate the measured rate, M.
6. Repeat steps 2-5, summing the M-values, for a suitable number of seconds (acquisition time)
for sufficient statistics.
7. Repeat steps 2-6 for the high energy.
8. Use the DE algorithms to obtain the reconstructed thicknesses of iodine and water.
The simulation process (steps 1-6) was carried out for both a high and a low energy (above and
below the K-edge of iodine, which is 33.2 keV, respectively). Taking this into account, energies of
35 keV and 31 keV were chosen as the high and low energies respectively. Using the attenuation
coefficients of water and iodine at these energies, the two images were combined to create an iodine
equivalent and a water equivalent image. Equations 2.10, discussed in section 2.3, were used to
generate the reconstructed images on a pixel-by-pixel basis. The simulation was used to generate
the reconstructed thicknesses of different sections and components of the test object using different
initial count rates and different applied dead times.
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5.6.1 Simulation Results
Figure 5.13: Results of the dead time simulation. (a) and (b) show the reconstructed thicknesses for iodine
and water respectively for a range of incident count rates. (c) shows the relationship between EMR and
reconstructed thickness for different count rates.
Using an expected EMR of 103 s−1 (comparable to that of HEXITEC with charge sharing corrections
applied), the simulation was run with different initial count rates, ranging from 1 to 105 counts per
pixel per second. These are shown in Fig. 5.13, where (a) gives the iodine results and (b) gives the
water results. The count rates displayed are per pixel. The reconstructed thickness for the water
starts to decrease significantly from the true thickness value at count rates above 100 s−1. However,
it is the iodine thickness that is of greatest importance for this application. Using a true thickness
of 0.03 cm, the reconstructed I thickness was found to be 97%, 74% and 24% of the true value for
initial count rates of 100, 1000 and 10000 photons/pixel/s respectively. This thickness was chosen
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as it was comparable to the equivalent iodine thickness of the undiluted Omnipaque300 used when
imaging the real test object (figure 4.2, shown in chapter 4). True thicknesses of 2 cm and 2.5 cm
were used for water (see fig. 5.11), termed water and water 2 respectively.
Figure 5.13 (c) shows the reconstructed iodine thickness for a series of different count rates against
the EMR. It shows that lower count rates lead to reconstructed thicknesses that are closer to the
true thickness for a given EMR. The lower the EMR, the further the reconstruction becomes from
the true value. Sufficient statistics (counts) were ensured by adapting the acquisition time for each
count rate.
These results highlight the importance of imaging at rates below the EMR in order to correctly
reconstruct the CA components of an image. The results at very low rates show the correctness of
the algorithms as the thickness of each component was perfectly reconstructed. The green vertical
lines in (a) and (b) show the EMR values, which show that even imaging at the EMR value still
leads to a loss in reconstruction because it is still likely that counts will arrive in quick succession at
least some of the time.
5.7 Validation with Phantom
In order to test the results of the simulation, HEXITEC was used to image the custom-made phantom,
which is designed to be approximately breast tissue equivalent. The test object, as shown in Fig.
4.2 in chapter 4, is composed of a 5 cm x 5 cm plastic container filled with cooking oil and Perspex
spheres. A Perspex block with drilled tubes of 3 mm, 2 mm and 1 mm in diameter was attached to the
side facing the detector using Parafilm®. For this work, iodinated contrast agent (Omnipaque300),
with an iodine concentration of 300 mg/ml, was injected into the tubes prior to acquisition.
Images were acquired with the X-ray source, desribed in section 3.3, at a voltage of 50 kVp using
a range of currents. The beam was filtered with 3.5 mm Aluminium to ensure that the maximum
intensity of the spectrum occurred in the region of the iodine K-edge. A simulated spectrum is shown
in figure 4.4 in chapter 4. Because incident count rate increases linearly with current, acquisition
times were adjusted for each current to give the same incident statistics in each case. Images were
acquired at currents between 2-60 µA for times ranging between 30 and 1 minutes, giving incident
count rates between approximately 140 and 2300 s−1 per pixel, as calculated from a generated Al-
filtered W-spectrum at 50 kVp (Cranley et al.). The source-detector distance was (70±1) cm and
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the source-object distance was (65±0.5) cm.
The detector was calibrated and energy-gain corrected as per section 3.4.2 and the resulting
output consisted of an energy spectrum per pixel. High and low energy images were created by
integrating the appropriate energy bins to produce 2 keV wide bands. Bands of 34-36 keV and 30-
32 keV were used to create the high and low images respectively. The high and low images were
combined and converted into iodine-equivalent and water-equivalent images on a pixel-by-pixel basis
as per equations 2.5 and 2.11, given in chapter 2. In this case, I low and Ihigh refer to the pixel values
of a given pixel and µhigh or µlow are the average linear attenuation coefficients across the band,
where the average energies were 35 keV and 31 keV for the high and low bands respectively.
5.7.1 Results
The average profiles across the iodine-equivalent images, which were calculated from the average
across 41 image rows (rows 20:60, avoiding regions of noisy pixels) are shown in fig. 5.14. Tube
outlines can be clearly seen. A significant decrease in the surface concentration of iodine with
increasing incident count rate can be seen. The results suggest that, for a 70 cm source-detector
distance, reconstructed concentration is affected at currents of 5 µA and above, which equates to
an incident count rate per pixel of approximately 41 s−1. When no corrections were applied, no
measurable change in reconstructed concentration was seen for the currents tested. This is the
expected result because the count rate was significantly below the EMR of the frame rate (up
to 10 kHz). However, the uncorrected reconstructed c do concentrations exaggerate the iodine
concentration. This could be due to distortions to the spectrum, caused by the charge shared events
(seen in figures 5.6 and 5.9), as well as errors in tube thickness and exact iodine concentration. The
maximum profile value of each tube was divided by the tube diameter to obtain the reconstructed
iodine concentration (mg/ml). These are shown for each charge sharing correction in fig. 5.14 for
2 µA, 30 µA and 60 µA. At 2µA (equivalent to ∼ 16.2 counts/pixel/s), the reconstructed iodine
concentration for the 3 mm tube was 304±6 mg/ml, 300±6 mg/ml and 311±6 mg/ml for CSA, CSD
and no corrections respectively. At 60 µA (∼ 487 counts/pixel/s) results were 146±7 mg/ml, 150±7
mg/ml and 312±8 mg/ml respectively. Error bars were calculated from the standard error in the
mean of the columns used to create the average profile.
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Figure 5.14: Left: Reconstructed iodine profiles for each tube as a function of current for each correction
algorithm. Right: Bar charts to show the reconstructed iodine concentration obtained from currents of 2, 20
and 60 µA for each correction algorithm. Error bars were based on the standard deviation in the image rows
averaged to create the profile.
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Figure 5.15: Spectra obtained in ROIs behind the 3 mm Omnipaque-filled tube and in a background ROI for
CSA, CSD and no corrections. The iodine K-edge (33.2 keV) is shown as a dashed line in each case.
5.7.2 Comparison of Spectra
An important step to correcting the data was to look at the output spectrum for different incident
count rates. The output spectra for each charge sharing algorithm in regions of interest both behind
the 3mm CA-filled tube and in a background ROI are shown in fig 5.15. The iodine K-edge (33.2
keV) is marked by a vertical line in each spectrum. In each case, the spectrum for all currents are
superimposed onto the same graph to show how they are affected by count rate. The ROIs used for
both the background and the CA regions are shown in figure 5.16, where the background ROIs are
shown in grey and the iodine tube ROI in white. It can be seen in fig. 5.15 that the relationship
between counts per pixel and current varies across the spectrum. The relationship across the K-edge
is important as this is the energy that the DE bands are centred on. The profiles for both CSA and
CSD show a decrease in the height of the K-edge with increasing current. Without the corrections,
this drop is much smaller, and there is no noticeable change between 10 and 60 µA. As can be seen in
fig. 5.6, there is a build-up of counts in the energy range beyond 50 kV for the CSA data, particularly
in the background region where counts arrive at the detector at a higher rate. This is caused by
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Figure 5.16: Image to show the ROIs used to generate the average spectra for the background (grey) and
behind the 3 mm tube (white).
multiple full-energy pulses being incorrectly identified as charged-shared events and being summed
together to give one high-energy measured event.
5.8 Correcting the Data
Inversion of the dead time fitting equations applied to the experimental data was investigated as
a means of correcting spectra taken above the EMR post-acquisition. This is only practical in the
non-paralyzable regime due to the exponential form of the paralyzable model. Although the results
in both sections 5.4 and 5.4.2 show that a paralyzable effect is seen both with and without the
phantom present when CS corrections are applied, if the count rate incident on the detector is low,
this can be approximated as non-paralyzable for CSA and CSD (as in section 5.5) and as linear for
no corrections.
5.8.1 Corrected Profiles
The graphs in fig 5.17 show the results of correcting the 20µA spectra in two different ways. The
left graph corrects based on the relationship between 20µA and the true counts. The reconstructed
iodine surface concentration is shown in purple, with a solid and dashed line for the original and
corrected data respectively. The original result for 2µA is shown with a red dashed line. The graph
shows that, whilst the height of the bars has increased post-correction, the correction has been too
much, resulting in a corrected iodine surface concentration of 400 mg/ml.
In an attempt to remove the over-correction, rather than correcting the data to the true counts,
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Figure 5.17: Phantom profiles giving reconstructed I surface concentration after correction to the true counts
(left) and to the 2 µA counts (right).
the data were instead compared to those of the lowest current (2 µA). This was deemed a reasonable
assumption because, in this case, the true iodine concentration was known and because the 2 µA
images gave the correct reconstructed iodine concentration for the 3 mm Omnipaque-filled tube.
Corrections were only applied up to 30 µA as currents above this were not used in the fit. The
results are shown in the right-hand graph of fig. 5.17. In this case the corrections are much closer
to the 2µA result. Figure 5.18 and 5.19 show the corrected profiles for all currents, compared to the
2µA uncorrected, CSA and CSD profiles. These results are shown quantitatively for each tube in
terms of the reconstructed iodine concentration in the adjacent bar charts.
Figure 5.20 shows the reconstructed iodine concentration for the 3 mm tube for CSA (left)
and CSD (right) superimposed onto the original results. Overall, the results show that, while the
uncorrected results display a negative correlation between current (count rate) and reconstructed
concentration, the corrected results do not vary significantly with current; all error bars overlap. The
corrections are therefore successful in terms of removing the differences in reconstructed concentration
seen between different currents. As a percentage of the original 2 µA result, all corrected results
were within 7±1% for CSA and 6±1% for CSD, equating to 8.3% and 6% of the nominal iodine
concentration respectively. Results were based on the assumption that the response of both CSA and
CSD corrections could be approximated to a non-paralyzable dead time regime and that measured
and true counts were the same for 2 µA.
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Figure 5.18: Left: Corrected CSA profiles compared to the original 2 µA profile. Nominal results for each
tube are shown by horizontal black lines. Right: Bar charts showing the reconstructed iodine concentration
for each current and each tube after corrections, compared to the original 2 µA result.
Figure 5.19: Left: Corrected CSD profiles vs original 2 µA profile. Nominal results for each tube are shown
by horizontal black lines. Right: Bars showing the reconstructed iodine concentration for each current and
each tube after corrections, compared to the original 2 µA result.
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Figure 5.20: Bar charts to show reconstructed iodine concentration of the 3 mm tube before and after the
dead time corrections have been applied for CSA (left) and CSD (right).
5.9 Conclusions
The aim of this work was to quantitatively analyse the effects of imaging at different count rates and
with different implemented charge sharing corrections on reconstructed iodine images obtained from
the dual energy algorithms. Corrections for charge sharing are necessary to prevent degradation of
the output spectrum but impose an effective maximum count rate above which charge shared events
cannot be distinguished from two independent counts arriving at neighbouring pixels.
HEXITEC was used to verify this by acquiring images at different currents both with and with-
out the test object in place, to allow different initial count rates. Results were used to visualise the
form of the expected vs measured counts curve. They showed that, at high count rates (without the
phantom present), images processed with both CSA and CSD corrections displayed a paralyzable
relationship. However, at low count rates of up to 50 kVp (approximately 470 counts/pixel/second
across the spectrum) at a (70±1) cm source-detector distance with the phantom in the beam, both
could be approximated to a non-paralyzable response. When no corrections were applied, an inter-
mediate relationship between paralyzable and non-paralyzable response was seen, which could be
approximated to a linear relationship at the lower count rates.
As a proof of principle to determine whether reconstructed iodine thickness could be affected
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by these dead time effects, a simulation was created to model an ideal detector with added non-
paralyzable dead time. Images were created and were reconstructed using the DE equations (eq.
2.10). Results showed that reconstructed thickness became further from (lower than) the true value
with increasing count rate.
The ultimate goal of this work was to determine and implement correction algorithms to acquired
data at higher count rates, thus allowing faster acquisitions at a higher current whilst simultaneously
correcting for charge sharing effects. After application of the correction algorithms, it was found
that, when imaging the CA-filled test phantom, the iodine concentration in the 3 mm tube could
be corrected to within 8.3% of the nominal for CSA and within 6.0% for CSD. These results are
comparable to the concentrations obtained with no corrections but with the ability to analyse the
spectrum without charge sharing events. The corrections were based on those counts expected with
a 2µA current.
The results provide a proof of principle that, once a solid algorithm is found for the detector
response, it is possible in principle to correct back to equivalent counts with lower incident count
rates whilst retaining higher statistics and, therefore, shorter acquisition times. The results showed
that count rate could be increased by 15 times and be accurately corrected for. This would allow
acquisitions of 1-2 minutes. This is still far from clinical requirements but is a significant improvement
and shows that in principle image correction is achievable. Possible improvements could potentially
be made to the current algorithms by acquiring images at a wider variety of initial count rates,
particularly at the lower end of scale in order to refine the fitting parameters further.
119
Part II
Radiobiology
120
Chapter 6
Background and Theory: Radiobiology
and the use of AuNPs
6.1 Radiobiology: the Use of Gold Nanoparticles
Gold has been associated with medicine and well-being for many centuries (Higby, 1982). In the
modern day, the biocompatibility of bulk gold is well-established through several medical applications,
such as in the treatment of rheumatoid arthritis (Empire Rheumatism Council et al., 1961; Sutcliffe
et al., 1973) and is known to be chemically inert. At the nanoscale, gold has been shown to display
radiosensitizing effects (Hainfeld et al., 2004; Zhang et al., 2008; Butterworth et al., 2010, 2012;
Hainfeld et al., 2014). Its size also allows nano-gold to preferably accumulate in tumours as a result
of leaky vasculature, resulting from gaps in the endothelium wall. The nano-gold’s surface chemistry
can be easily tailored, or functionalized, by the attachment of molecules such as proteins. This,
and its high atomic number (Z=79), allowing greater photoelectric absorption, make it a potential
imaging agent. It could overcome some of the limitations of more traditional iodinated contrast
agents, such as short imaging times (caused by fast renal clearance).
Gold nanoparticles have fairly recently emerged in many medical applications including drug
delivery, imaging, tissue engineering and cancer treatment (Kim et al., 2009; Clark et al., 2013; Rana
et al., 2012). Nanoparticles are typically between 1-100 nm in size in at least one dimension. They
are many times smaller than human cells, making it possible for them to cross cell membranes (<50
nm) or even through blood vessel walls (<20 nm) (Yih and Wei, 2005). At this scale, size affects
the resulting properties, something that is not seen on the macro scale. The high surface area to
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volume ratio of these particles compared to the bulk material can result in increased absorption
and can alter the interactions both between the particles themselves and with other proteins and
molecules. These properties lead to further applications, particularly in medicine. AuNPs with
specific proteins attached can become more easily assimilated by cancer cells. They can also be
used in targeting, where they act as drug delivery vehicles. In this case the advantage is that the
nanoparticles will preferentially accumulate into the tumour volume (either naturally or because
they have been functionalised). Therefore a combination of the two can give targeted application
of cancer treating drugs. However, as a consequence of their size, the properties of nano-sized gold
are yet to be fully understood. This is of great importance for potential clinical applications and
demands the development of methodologies and assays to test toxicology and efficacy of specific NP
products (Subiel et al., 2016). Further investigation is therefore required to test the effectiveness and
suitability of AuNps as contrast agents, in particular the radiobiological impacts of their use and the
underlying biological mechanisms.
6.1.1 Goals of Radiotherapy and Radiosensitizers
The goal of radiotherapy is to kill cancer cells whilst sparing as much healthy tissue as possible. The
latter can be achieved to a degree by using shaped beams such as in Intensity Modulated Radiation
Therapy (IMRT). This uses 3D imaging such as CT or MRI to determine tumour shape and location.
The radiation beams are then shaped around the tumour to allow maximum tumour dose and
minimum surrounding tissue dose. Other techniques include boron neutron capture therapy, charged
particle beams and stereotactic radiosurgery (Barth et al., 1992; Moss, 2014). However, the similarity
in radiation dose absorption between the tumour cells and surrounding healthy tissue still causes a
significant dose to the surrounding tissues, limiting the effectiveness of these methods. In order to
improve radiotherapy outcomes, treatments are needed that can specifically target the cancerous
cells or increase their radiosensitivity compared with healthy tissue. Radiosensitizers increase the
sensitivity of cancerous cells to radiation, allowing increased cell killing (for a given dose) or a lesser
impact on healthy tissue (as the increased radiosensitization allows the same amount of cell killing
with a lower dose). Oxygen acts as a radiosensitizer. However, tumours grow much faster than
healthy tissue due to rapid cell division and as a result often have depleted oxygen levels (hypoxia).
This is because angiogenesis cannot occur fast enough to provide sufficient oxygen for the entire mass
(Liao and Johnson, 2007). This results in a lower sensitivity to radiation in dense tumours than in
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healthy tissue, leading to higher radioresistance in the hypoxic region of the tumour. The addition
of a high-Z material, such as gold, to a tumour would greatly increase its photoelectric absorption
compared to soft tissue at kV energies, therefore increasing the absorbed dose.
An early simulation study (Mesa et al., 1999) highlighted the need for better localisation of dose
into the tumour to minimise doses in surrounding tissue. A Monte Carlo algorithm (MCNP4A),
based on patient-specific data was used to simulate the dose distribution in brain tumours obtained
via X-ray phototherapy. The modelled tumours were loaded with iodinated contrast agent, with
uniformly distributed concentrations ranging from 0-20 mg/ml. They were then irradiated with kV
X-rays using a modified CT scanner (CTRx) at several non-coplanar 360◦ arcs separated by 20◦. It
was found that the presence of iodine increased both the dose to the tumour and the localisation. The
higher the iodine concentration, the better the localisation became. Drawbacks included radiation
dose to the skull and a non-uniform dose distribution if the tumour was shaped asymmetrically, due
to the low energy of the X-rays. The authors also noted that it may be difficult to physically obtain
concentrations of Iodine above 5 mg/ml in practice via IV injection and therefore other delivery
methods may be needed.
6.1.2 Gold as a Radiosensitizer
Gold has a high atomic number (Z=79) compared to soft tissue (Z ∼ 7). Therefore, a tumour
containing just a small amount of gold by mass will have increased radiosensitivity as photoelectric
absorption will be much more likely to occur there than in the surrounding soft tissue. One review
(Butterworth et al., 2012) suggested that approximately a 10-150 fold increase for kV energies is
expected, whereby the introduction 1% gold by mass to the tumour is predicted to double the energy
deposition by a kV X-ray source .
One of the earliest papers to describe the radiation enhancement effects of gold nanoparticles in
vivo was that of Hainfeld (Hainfeld et al., 2004). Mice were injected with cancerous cells which were
allowed to develop into tumours in the leg. Some mice were injected with 1.9 nm AuNPs before being
irradiated with 250 kVp x-rays in the tumour area. Others received irradiation only. It was found that
mice receiving both gold and X-rays had much more successful treatment. The long-term remission
percentages were 20% for irradiation only and 50% and 86% for injection of gold nanoparticles at
1.35 and 2.7 g Au/kg respectively. They found that the gold nanoparticles accumulated more in
the tumour and cleared almost twice as fast from the healthy tissue as from the tumour. Another
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study, which used the same sized AuNPs as Hainfeld (Butterworth et al., 2010) investigated the
potential use of gold nanoparticles for cancer therapy. Different human cancer cell lines (including
prostate lines DU-145 & PC-3 and breast lines MDA-231-B & MCF-7) were irradiated with AuNPs
of concentration 100 µg/ml Au. The cells were found to have a surviving fraction of 0.323±0.02,
compared to 0.52±0.2 for cells irradiated without AuNPs. The former had been incubated with
the nanoparticles for 1 hr prior to irradiation. The study also showed significant differences in the
dose response curves for cells with and without gold. 1.9 nm gold nanoparticles were shown to be
cytotoxic and overall results showed that AuNPs induce apoptosis and damage to DNA. The authors
concluded that detailed characterization and optimisation of cellular response of AuNPs needs to
be fully investigated. Following the Hainfeld paper, there have been many others, in vitro (Zhang
et al., 2008; Chithrani et al., 2010; Jain et al., 2011; Geng et al., 2011; Liu et al., 2010; Chen et al.,
2015). However, the major drawback to these studies is the large range in AuNP properties, most
notably their size (1.9-74 nm), concentration ( nM-mM) and surface coatings. Therefore, although
all of the studies showed AuNPs to be radiosensitisers, it is difficult to compare them quantitatively.
A few in vivo studies have also been published (Chang et al., 2008; Clark et al., 2013; Hainfeld et al.,
2013) to support these results. It was also noted (Butterworth et al., 2012) that the results of some
studies vary considerably from predictions based on dosimetric calculations and therefore suggest
(as do many others) that there is a strong biologically-driven mechanism affecting radiosensitization
as well as the physical mechanisms associated with the dose. It is also important to note that the
majority of these studies have been performed at energies above 200 keV and that little has been
done in the diagnostic range. These mechanisms therefore need to be investigated further and are
discussed in section 6.1.3.
6.1.3 Mechanisms of AuNP Radiosensitization
Physical Mechanisms of AuNP Radiosensitisation
Several recent reviews have outlined the mechanisms via which AuNPs can cause radiosentitization
(Butterworth et al., 2012; Rosa et al., 2017). The main physical mechanisms of interactions between
nanoparticles and radiation at keV energies are the photoelectric and Compton effects (Rosa et al.,
2017; McMahon, 2018), both of which are described in Chapter 2. The addition of High-Z materials
to tumours can cause both an increase of the physical dose absorbed by the tumour cells and the
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quality of the damage imparted (Rosa et al., 2017). This difference, quantified with the radiation
enhancement factor, i.e. ratio of survival fractions with/without AuNPs at 2 Gy, arises from the
increase in photoelectric absorption compared to soft tissue in the keV range. Previous work has
indeed shown the radiosensitising properties of iodine and gold at these energies (M. Herold, 2000;
Regulla et al., 2002). However, MeV energies are typically used for radiation therapy due to the
penetration depth limitations of keV X-rays. The expected dose enhancement is negligible at MeV
energies and, in fact, no significant increase in dose would be expected by the presence of high-
Z materials at the tumour site. However, many studies (as outlined in section 6.1.2) have shown
apparent radiosensitisation effects at MeV energies and for AuNP concentrations below 0.1% of
the tumour mass where no physical dose increase is predicted, suggesting that there is a strong
biologically-driven component. Before AuNPs can be used clinically, these biological mechanisms
must be fully understood.
Biological Mechanisms
Cell damage can arise through oxidative stress, which describes an imbalance in a biological system
between reactive free radicals and the readiness of that system to counteract their presence with
antioxidants. This can lead to apoptosis and necrosis (Kannan and Jain, 2000; Pan et al., 2009).
Oxidative stress usually occurs as a result of a sudden increase in the production of reactive oxygen
species (ROS), although it can be caused when antioxidants bind to other molecules, preventing them
from functioning correctly. In the presence of AuNPs, it is thought to occur when the surface of
the nanoparticle (or coating/contaminant molecules) donates electrons to oxygen molecules, thereby
creating superoxide (•O2 – ) as per equation (6.1).
O2 + e
− −−→ •O2− (6.1)
The superoxide can react further via dismutation to form hydrogen peroxide (H2O2) which in turn
can react to form hydroxyl free radicals (•OH). Both •OH and H2O2 cause cell damage, including
to mitochondrial membranes and DNA. Although •OH is more reactive, H2O2 is more damaging to
DNA as it is more likely to reach cell nuclei before reacting. Double strand breaks (DSBs) in DNA
are a major cause of cell death and mutation. Radiation causes DSBs by itself but there have been
some reasonably conflicting studies investigating the added effect of DSBs when AuNPs are present.
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However, the wide range of experimental conditions, including cell lines and AuNP size mean that
little inter-comparison of the studies can be made. Another, indirect way in which radiation can
damage cells is by the so-called radiation-induced bystander effect. This occurs when otherwise
healthy cells receive signals from irradiated cells in their vicinity, usually via ROS or direct contact
between cells, that cause them to exhibit radiation damage effects. The effect was first discovered
with α-particles (Nagasawa and Little, 1992; Najafi et al., 2014) but has also been seen with X-rays
(Tomita et al., 2012; Yang et al., 2015; Schettino et al., 2003).
DNA Repair Mechanisms
A key component of the radiobiological effects is the ability of cells to repair the radiation damage
(Kavanagh et al., 2013). Although cells have efficient mechanisms for repairing the DNA lesions
(which are considered the main radiation insults), this efficiency strongly depends on the clustering
of the ionising caused to the DNA molecules. The presence of high-Z nanoparticles can also alter the
spatial distribution of ionisations (McMahon et al., 2016) due to the production of Auger electrons
emitted from the ionised nanoparticles. Therefore, although the presence of NPs would not cause an
increase in the dose absorbed by the cells, the damage caused may be differentially processed by the
cells.
Cell Cycle Effects
The cell cycle is the series of processes a cell goes through between its formation and the point where
it divides. Broadly speaking, the cell cycle consists of five main phases: G0 (rest/gap between division
cycles), G1 (where the cell increases in size and prepares for cell division), S (DNA replication), G2
(further cell growth) and M (growth stops). Nuclear division, mitosis, occurs and is followed by cell
division (cytokinesis). Checkpoints also exist during the major phases to regulate the cell cycle and
to allow the repair of defects.
Disruption to the normal operation of the cell cycle, including induced apoptosis (cell death)
caused by the activation of cell cycle checkpoints, can be caused by exposure to radiation (Pawlik
and Keyomarsi, 2004; Rosa et al., 2017), which could be further affected by the presence of AuNPs and
other nanomaterials, as reported in the literature (Roa et al., 2009; Geng et al., 2011; Turner et al.,
2005). In particular these studies reported an increase in G2/M cell populations after irradiation
with glucose capped AuNPs. The radiosensitivity of cells has also been found to depend upon the
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Figure 6.1: Energy against mass attenuation coefficients for gold, iodine and breast tissue. Graph generated
using XMudat (Nowotny, 1998).
stage of the cell cycle, where the S-phase is the most and the M-phase the least radiosensitive (Pawlik
and Keyomarsi, 2004). The presence of NPs can therefore synchronize cells in a particular phase of
the cell cycle, consequently altering their radiobiological response.
6.1.4 Gold Nanoparticles as Imaging Agents
As explained in Chapter 2, contrast agents (CA) act by increasing the attenuation of tissues into
which they are taken up. Their typically high atomic number results in much greater photoelectric
absorption than in soft tissue in the low kV range, causing regions where CA is present to be
highlighted in an image. Conventional agents such as iodine are typically injected intravenously and
are taken up the most in areas of high vascularisation, such as tumours. However, iodine suffers from
rapid renal removal and therefore imaging time is restricted to just a few minutes after injection. As
some imaging procedures such as mammography or CT require multiple views, this can be a problem.
As iodine is a non-specific agent, it will be taken into all of the surrounding blood vessels and therefore
a higher dose is needed for enough to concentrate in a lesion. AuNPs, however, have the potential
to be preferentially taken up into particular kinds of cells (using targeting and functionalization)
and are removed from the body at a slower rate than iodine (Nanoprobes, 2011a). They also have
a higher atomic number and hence higher attenuation than iodine, meaning a smaller amount is
required to obtain an image of sufficient quality. The mass attenuation coefficients over a range of
energies for both gold and iodine are shown in figure 6.1.
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Many of the studies investigating the use of gold nanoparticles have focused on radiosensitization
properties; a few have investigated their potential as imaging agents, mostly in CT (Domey et al.,
2015; Cole et al., 2015; Mahan and Doiron, 2018). One study (Clark et al., 2013) used AuNPs (∼15
nm, 200 mg/ml) as well as Liposomal Iodine (Lip-I) nanoparticles (130 nm, 110 mg/ml) as imaging
agents in micro-CT imaging of rodents. Dual energy decomposition, as described in section 2.3, was
implemented, using high and low energies of 80 and 40 kVp respectively. Soft tissue sarcoma was
generated in a compound mutant mouse. The mouse was injected with 0.1 ml/25 g of AuNPs and,
four days later, with 0.4 ml/25 g Lip-I. In total six scans were taken of the same mouse, amounting
to a combined dose of 0.78 Gy. They were able to decompose both contrast agents separately, which
the authors say can be used as a tool in the assessment of the vascular changes in tumours (non-
invasively). Another (Hainfeld et al., 2006) also compared iodinated and AuNps (1.9 nm) as imaging
agents. They concluded that the properties of the AuNPs allowed higher contrast and longer imaging
times than conventional contrast agents and appeared to be non-toxic.
One study (Jackson et al., 2010) compared gold nanoparticles (spherical, 1.9 nm) to conventional
iodinated agents. They found the gold to have greater attenuation and a consistently higher CNR,
particularly for energies below 50 kVp, which includes mammography. Another (Tu et al., 2013) tested
AuNps as contrast agents in CT planning images to aid delineation of organs prior to treatment.
They concluded that AuNPs could be used as CA in the future providing that studies into the toxicity
are thoroughly investigated. As the biological effects of using AuNPs as contrast agents are not yet
fully understood, further investigation is required before they can be used clinically.
6.2 Measurement of Radiobiological Effects
When used in radiotherapy, the aim is for the gold nanoparticles to cause as much cell killing as
possible (in the tumour). However, if gold is to be used as an imaging contrast agent, where we wish
to visualise cells without affecting them, it is important to determine whether there are any adverse
biological effects. This can be investigated by performing established biological tests on cells that
have been exposed to radiation after injection of gold nanoparticles. So far, the majority of studies
discussed have either been in-vitro or have looked at small rodents. A much more thorough under-
standing of the mechanisms of AuNp interactions needs to be carried out before they could be used
clinically. This is particularly important as reported enhancement of radiation effects do not match
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the predictions from macroscopic dose enhancement calculations based on mass attenuation alone.
A recent review has highlighted the need for standard methods of quantifying and characterising the
radiobiological impact of nanoparticles for both therapy and diagnostics (Subiel et al., 2016) to allow
a more comprehensive evaluation and to enable comparison between studies. Many of the studies
already discussed have used the techniques that will now be described in greater detail.
6.2.1 Measurement of Cell Effects: Methods
Although there are many interpretations and definitions of cell death, it can be thought of as the
loss of reproductive integrity of that cell. That is to say, the cell is no longer able to continually
divide although it may undergo several further divisions. Clonogenic assays (Franken et al., 2006)
are the gold standard for cell response to radiation and are also used to assess exposure to chemical
compounds or potentially cytotoxic agents (Rafehi et al., 2011) as well as to determine effects of
irradiation with AuNPs (Butterworth et al., 2010; Jain et al., 2011). The former used the clonogenic
assay to investigate the effects of exposure to 10-100 µg/ml AuNPs for different cell lines. The latter
used the assay to determine the cytotoxicity caused by 24 hr exposure to 1.9 nm AuNPs followed by
kV X-ray irradiation. Other studies have also used the clonogenic assay to determine the long-term
cytotoxicity of AuNPs (Coulter et al., 2012). Common alternative techniques for toxicity include dye
reduction assays such as the MTT assay and live/dead staining such as the Trypan Blue exclusion
assay.
In the MTT assay, the metabolic activity of cells is determined by measuring the reduction
of MTT solution (a yellow tetrazolium salt) by specific enzymes into purple formazan dye. The
formazan is dissolved and measured at a particular wavelength (typically 500-600 nm) using a spec-
trophotometer; the degree of absorption is proportional to the enzymatic activity, rather than to the
number of living cells (Menyhart et al., 2016). The assay is generally used to measure chemosen-
sitivity/toxicity of drugs (Buch et al., 2012; Kratzke and Kramer, 1996). Several limitations have
been highlighted (Nikzad and Hashemi, 2014), including spectral shifts of the formazan depending
on the pH and the quality of the DMSO used, which do not necessarily correspond to changes in cell
viability. Over-confluency within the well plates can also affect the formazan formation (Menyhart
et al., 2016). MTT and clonogenic assays have also been directly compared in the literature (Buch
et al., 2012). Clonogenic assays have sometimes been favoured as they are directly related to cell
survival (Lacoste-Collin et al., 2015).
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The Trypan Blue exclusion assay (Strober, 1997), makes use of the principle that Trypan Blue dye
can penetrate dead cells but not live cells, which have their membranes intact. Dead cells therefore
appear blue; the cells can be counted under a microscope. As the precise number of live and dead
cells can be counted, this assay provides a more quantitative result than the MTT assay but, unlike
the clonogenic assay, does not take into account that cells may still be metabolically active and
undergo several cell divisions but are unable to continue dividing to form a colony. Therefore, the
clonogenic assay was chosen for this work due to its simplicity and eases of use with slide flasks. Its
independence of the method by which cells are killed also makes it a good choice, especially as the
full mechanisms of AuNP interactions with cells are not yet fully understood (Kabakov et al., 2011).
If time had allowed, the other methods would have also been compared in order to get a fuller
picture of the effects of AuNPs and the mechanisms of cell death (for example in order to see more
immediate effects or trends over time) and any differences between cell lines (including both cancer
and healthy cell lines).
6.2.2 Clonogenic Assays
A clonogenic cell is one that is able to divide indefinitely to form a colony. First proposed by Puck
and Marcus (Puck and Marcus, 1955), the clonogenic assay is a simple but effective method to test
a cell’s ability to continually proliferate following exposure to ionising radiation and/or any other
potentially cytotoxic agents. These assays are, for example, useful in cancer research to determine
whether a particular drug could reduce tumour cell survival. The aim of the assay is to obtain a
relationship between treatment dose and cell-survival.
A clonogenic assay begins with a flask of cells grown in culture. They are grown to approximately
80% confluency i.e. until approximately 80% of the flask surface is covered, for adherent cells. Figure
6.2 shows an example of different confluence levels. The cells must then be removed from the container
surface to form a single cell suspension. This is achieved using trypsin, a protease enzyme that is
able to cleave the proteins attaching the cells to their growing surface. A known number of cells are
then plated into flasks or well-plates, where the initial number of plated cells is determined by the
dose of treatment to be given. It is important that a range of treatment doses are given, including a
control flask that receives no treatment.
Following plating, the flasks are incubated for several hours to allow the cells to attach to the
container surface. The flasks are then irradiated in turn, each flask receiving a different dose. Other
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Figure 6.2: Cell photographs to show different levels of confluency for adherent cells. Cells grown attached to
the bottom surface of their container. Figure from (Transfectopedia®, 2018)
treatments may be given before irradiation. After irradiation, the cells are incubated for 1-2 weeks,
depending on the doubling time of the cell line, to allow the cells to divide and form colonies.
After this time, the colonies can then be fixed and stained. This is achieved using a solution of
Crystal Violet dye (to provide the staining so that the colonies can be easily seen), diluted in 1:1
acetone and methanol (to provide the fixing so that the cells stop dividing and remain adhered to
the growing vessel surface). The final experimental step is to count the number of colonies in each
flask. Although a cell may become non-clonogenic (reproductively dead) after irradiation, it may
still be able to carry out other cell functions and undergo several cell divisions. However, the cell has
lost its reproductive integrity so has not survived the irradiation. To account for this only clusters
containing at least 50 cells (≥ 6 cell divisions) are counted as colonies, as defined by the Puck and
Marcus Criteria (Puck and Marcus, 1955).
Following the assay, the plating efficiency (PE) and survival fraction are calculated from equations
(6.2) and (6.3) respectively. The survival fraction is simply the ratio of the PEs of the treated and
non-treated flasks, where control refers to the flask or well that was not exposed to radiation.
Therefore, the survival fraction of the control flask(s) is always 1.
PE =
number of colonies
number of plated cells
(6.2)
SurvivalFraction =
PEirradiated
PEcontrol
(6.3)
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Figure 6.3: Typical cell-survival curve for mammalian cells (Puck and Marcus, 1956).
6.2.3 Cell Survival Curves and Associated Models
The effect of radiation dose, or indeed any other cell treatment, can be visualised using a cell survival
curve, where the survival fraction of cells after irradiation is plotted against the absorbed dose for
those cells. The surviving fraction is usually displayed on a logarithmic scale. Figure 6.3 shows
an example of a cell-survival curve (Puck and Marcus, 1956). There is typically a curved region
with a shallow slope for low doses, termed the shoulder. Smaller width shoulders indicate higher
radiosensitivity, as the survival fraction begins to fall off exponentially at a lower dose.
Several theoretical models to explain the shape of the survival curve have been proposed. Models
include the single-target and multi-target models (Fowler, 1964). The single-target/single-hit model
is based on target theory. It assumes that each cell has a single target (susceptible region) that, if
hit, will cause cell death. It does not take into account a cell’s ability to repair sub-lethal damage
and therefore cannot describe the shoulder-region. It gives a straight line on the semi-log plot. In
the multi-target model, it is assumed that at least two targets must be hit to cause cell death.
Between hits, the cell may repair itself and reverse the effect of the hit. Therefore, in order for cell
death to occur, the cell must be subject to enough hits in a short amount of time so that the repair
mechanisms cannot function quickly or effectively enough to reverse the damage. In other words,
cell death is the result of an accumulation of sub-lethal damage which eventually becomes lethal.
The most used and accepted model of cell-survival is the Linear Quadratic model (Dale, 1985;
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Brenner, 2008). In the Linear Quadratic Model, it is assumed that a cell-survival curve has two
distinct, independent regions: a linear single-hit region and a quadratic two-hit region. It uses two
parameters, α and β, to describe the curve. In the single-hit region, damage from a single photon
causes lethal damage; there is no potential of repair. The survival fraction is proportional to dose
and is given by equation (6.4).
SFlin = exp(−αD) (6.4)
where SF is the survival fraction, D is the delivered dose and α is a constant. The low dose section
of the curve is a modelled as a two-hit region, proportional to the square of the dose. Here, damage
from different photons accumulates to cause lethal damage. For example, two double strand breaks
(DSB) could occur. It is possible that the first could be repaired before the second occurs. However,
if both occur in quick succession, they may be repaired incorrectly i.e. they may be re-joined in the
wrong position. This causes a chromosome aberration which can lead to cell death. The surviving
fraction is given by equation (6.5), where β is also a constant. Combining these two regions, the final
Linear Quadratic equation, describing the whole survival curve, is given by equation (6.6).
SFquad = exp(−βD2) (6.5)
SFtotal = exp(−αD − βD2) (6.6)
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Main Investigations: Radiobiology
7.1 Methodology: Biological Effects
The imaging part of this work evaluated the success of using gold nanoparticles and clinical iodinated
contrast agents in CEDM in terms of both image quality and background removal. The aim of the
radiobiology component of this work is to investigate the effect on cells when exposed to these contrast
agents. These effects will be quantified by means of cell survival curves obtained from clonogenic
assays, a standard method in cell survival which is relatively simple to perform. As iodine-based
contrast agents are already used clinically, the results using these (as well as results without contrast
agents) will act as a basis against which to compare the AuNPs. Cell work and cell irradiation were
carried out at NPL.
All irradiation experiments will be performed in triplicate in order to minimise uncertainty. Cells
will be prepared and grown in culture. Before irradiation, a known number of cells will be plated into
flasks. Any CA will be added at least 16 hours before irradiation, to allow the maximum absorption
of AuNPs into the cells. Following irradiation, cells will be incubated for approximately 10-14 days to
allow enough cell divisions for colonies to form. The cells will be fixed and stained using crystal violet
solution. This makes the colonies visible enough to be counted manually. In principle, each colony
arises from a single cell. Dividing the number of colonies by the original number of cells gives the
survival fraction. Cell survival curves will be plotted, where the survival fraction is plotted against
the dose. Before any irradiation experiments take place, the plating efficiency must be calculated for
iodine, AuNPs and no contrast agent. This shows the survival fraction without exposure to radiation
and therefore acts as a normalisation factor. Ranges of concentrations for both iodinated CA and
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AuNPs will be investigated in order to determine how CA dose affects cell response to radiation. For
irradiation, slide flasks will be used. In order to determine the effects of the growing surface, the PE
for both 6-well plates and slide flasks will be compared. This will allow an estimate of the α and β
parameters of the linear-quadratic form of the survival curve which, in turn, will allow estimates of
the number of cells that should be plated for radiation experiments. 50-100 colonies per slide flask
would be optimal after irradiation and therefore the number of cells to be plated will vary with both
CA type, concentration and radiation dose, based on existing α and β and on the results of plating
efficiency tests.
Training in cell culture will be required. This will include learning and practising sterile technique,
maintaining, splitting, freezing and defrosting cells. For cell culture practice and training, V79 cells
(cells derived from Chinese Hamsters) will be used as they are cheap, easy to handle and reproduce
quickly. This will allow for suitable experiments to be designed, initially with Omnipaque and later
with the gold nanoparticles. For experimental work, the MCF-7 breast cancer cell line will be used
as it is more relevant to mammography.
As the Surrey X-ray systems will be used for the imaging part of the project, the beam must be
characterised so that the results from the two parts of the project are comparable. To achieve this,
the Half Value Layer (HVL) of the beam will be measured. Dose for the HVL will be calculated
using a Farmer-type ionisation chamber. The concentration of contrast agent to be used will be
determined by consulting the relevant literature and will be based on the amount reaching cells after
injection for imaging. Exposures covering the dose range 1-5 Gy, as well as those in the low mGy
range will be performed to ensure that both the region giving the full shape of the survival curve and
clinically relevant doses are considered. Cell survival curves for no added contrast agent, AuNPs and
iodinated CA will be compared in order to decide whether the imaging benefits from using AuNPs
outweigh any potential cell effects.
7.2 Beam Quality Characterisation: HVL and Dosimetry
The HVL (half value layer) is a measure of beam quality which describes the thickness of a particular
filter required to reduce the intensity of a beam by half (Bushberg et al., 2002). Lower energy X-rays
are preferentially absorbed over higher energies. Therefore, for a polychromatic beam, the addition
of filtering material acts to shift the average energy of the beam towards higher energies. The
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HVL is therefore an important parameter as it characterises the hardness of the X-ray beam. It is
typically measured in terms of millimetres of Aluminium. The HVL is most meaningful for narrow
beam geometries or those which account for scatter. Broader beams have an increasingly significant
proportion of scattered photons reaching the detector. This causes the attenuation of the material
to be underestimated which, in turn, causes the HVL to be overestimated.
As outlined in chapter 3, a tungsten (W) X-ray source was used for the imaging work (Hamamatsu
L6731-01 SPL). It was filtered with a total of 945 mg/cm2 Al, equating to a thickness of 3.5 mm.
This represents 100% transmission. The beam was further filtered by 5 x 5 cm Al sheets of different
thicknesses, which were placed in the beam and irradiated at 50kVp/80kVp and 100 µA. In each case
the dose was measured using a Farmer ionisation chamber (model 2530/1C). For each Al thickness,
the total, integrated dose over one minute was recorded three times, at a distance of (60±0.5) cm
from the source. This was converted into the average dose rate in µGy/s.
The results for the unfiltered beam (except for the usual 3.5 mm Al present) gave average dose
rates of (1.44±0.01) µGy/s and (3.14±0.01) µGy/s for a 50 kVp and an 80 kVp beam respectively,
when using a current of 100 µA and a source to ion chamber distance of 40 ± 0.5 cm. Based on
these results, the dose at the entrance surface of the phantom was calculated to be approximately
50 µGy for a single acquisition of 30 minutes at 2 µA at a source-object distance of 65 ± 1 cm at 50
kVp (applying the inverse-square law and scaling to the appropriate current). For the same imaging
time, the equivalent dose for the 80 kVp beam was found to be approximately 110 µGy.
The percentage transmission (i.e. the percentage of dose penetrating the Al) was plotted against
the extra Al filtration thickness, which is shown in figures 7.1 and 7.2 for the 50 and 80 kVp beams
respectively. The HVL was found to be (2.1±0.1) mm Al for the 50 kVp beam and (3.3±0.1) mm
Al for the 80 kVp beam. The second HVL is the filtration required to reduce the radiation intensity
by a further 50% i.e. to 25% of the initial intensity. The second HVL for 50 kVp was found to be
(4.9±0.2) mm Al. The data was fitted using an exponential fit in MATLAB. For the 50 kVp beam, a
prior measurement was taken approximately one year earlier and was found to give the same results
(within error bars) for both the first and second HVL values. Error bars were calculated using both
the standard error in the mean of the three measurements taken and taking into account uncertainties
in the Al thicknesses.
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Figure 7.1: Graph to show transmission against added Al filtration for 50 kVp to generate the HVL curve.
Errors were calculated using the standard error in the mean.
Figure 7.2: Graph to show transmission against added Al filtration for 80 kVp to generate the HVL curve.
Errors were calculated using the standard error in the mean.
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7.3 Cell Culture and Sterile Technique
7.3.1 Sterile Technique
In order to prevent contamination to the cell cultures, good sterile technique is required. This means
ensuring that anything that comes into contact with the culture is sterile. A cell culture hood is
used as a work area for cell culture work only. Inside the hood, the culture is protected from in-air
contaminants such as dust. This is achieved by means of a continuous HEPA-filtered air flow in one
direction. Before and after working in the hood, the work surface was sprayed with 70% ethanol and
wiped clean. Anything entering the hood was sprayed with 70% ethanol beforehand and resprayed
each time they were removed and re-entered. A lab coat was worn at all times during the lab, as
well as nitrile gloves, which were changed upon leaving and re-entering the lab. Sterile, disposable
plasticware and glassware was also used to prevent cross-contamination.
7.3.2 Cell Culture
Cell culture describes the growing cells in an external but controlled, typically optimal, environment,
allowing cells to be investigated independently of their associated organism. In this work, the cells
were grown from an established cell line. These are cells which are derived from a specific type of
cell (known as the primary culture) and are able to continually divide provided that they are kept
under certain conditions. These conditions are provided by incubation, choice of media and the use
of aseptic technique. The cell culture medium is the liquid in which the cells are grown. It contains
all the necessary nutrients and chemicals to allow the cells to grow and divide optimally. The specific
components of the medium is dependant upon the cell line used. All handling of cells (except fixing
and staining colonies) must be carried out under sterile conditions to prevent any external factors,
such as contaminant particles, contributing to the results. Cells are left to grow in an incubator,
which provides the cells with a desirable atmosphere of 5% CO2 at 37◦C.
Cells cannot remain in culture for long periods of time. As the cells continue to grow and divide,
space becomes more and more limited, hindering (and eventually inhibiting) further proliferation.
The nutrients provided by the growth medium will also be exhausted. Therefore, in order to maintain
continued cell division, sub-culturing is necessary. This is the process by which cells are divided and
subsequently transferred into a new container with fresh medium.
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Figure 7.3: Graph to show the general phases during cell division in culture. Passage should take place during
the exponential growth phase, ideally in the shaded grey region.
Figure 7.3 shows a typical growth curve of cells in culture. Although the exact shape and timescale
of the curve will be dependent upon the cell type used, the general phases are the same. The first
phase after sub-culturing is the lag phase. Cell growth is slow during this phase as the cells recover
from the recent sub-culturing procedure and adapt to their environment. This is followed by the
exponential phase, a period of exponential increase in cell density. For adherent cells, this phase
ends at confluency i.e. when the container surface is fully covered. It is during this phase that
sub-culturing should occur. Following the exponential phase is the stationary phase where, due to
lack of both space and nutrients, cell division slows and potentially stops. This is eventually followed
by cell death if cells are left in culture beyond this phase.
7.3.3 Cell Culture in this Work
All cell work was performed in a laminar flow hood, using sterile technique (as explained in section
7.3.1). For all experiments, the MCF-7 cell line was used. This is a human epithelial breast cancer cell
line, established in 1973 (Comşa et al., 2015). The cells had been derived from breast adenocarcinoma
cells, which were taken from a 69-year-old Caucasian female in 1970. In appearance, the cells are
relatively large (around 20-25 µm), and are adherent. This means that they grow in a monolayer
attached to the surface of the vessel they are cultured in. MCF-7 cells have been used extensively
in cancer research. Initial cells were thawed from stock which had been cryopreserved at -80◦C and
stored in liquid nitrogen. A 1 ml vial was rapidly thawed in a 37◦C waterbath.
During culture, the MCF-7 cells were maintained in Gibco Mimimum Essential Medium (MEM,
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Fisher Scientific, Loughborough, UK). Each 500ml of MEM was supplemented with 50 ml Foetal
Bovine Serum (FBS, Fisher Scientific, Loughborough, UK), 5ml of Penicillin streptomycin (HyClone
Laboratories, Utah), and 5 ml of non-essential amino acids, NEAA (Fisher Scientific, Loughborough,
UK). The cells were regularly subcultured, allowing them to be maintained for long periods of time.
This was achieved, under sterile conditions, by removal of the media, followed by washing with 5ml of
PBS (phosphate buffer solution, Fisher Scientific, Loughborough, UK), for a T75 flask. The flask was
then incubated with 3-5 ml of 0.05% Trypsin-EDTA (Gibco, Fisher Scientific, Loughborough, UK)
for approximately three minutes, until the cells were in solution. Tryspin is a proteolytic enzyme
that breaks down the proteins that allow adherent cells to attach both to a surface and to each
other, thereby causing them to form a single-cell solution. Cell detachment was checked under a
microscope. Once cells had detached, approximately 10 ml (3x the volume of trypsin) of complete
media was added to the flask to inhibit the trypsin to prevent cell damage. The solution was then
removed from the culture flask and into a universal tube. The solution was pipetted up and down
repeatedly in order to disaggregate cells that may have still been attached to one another. Cell
concentration was counted manually using a haemocytometer as described in section 7.3.4. Both
T-75 and T-175 flasks were used to maintain the cells, which gave a growth surface area of 75 cm2
and 175 cm2 respectively.
7.3.4 Counting Cells
During cell biology experiments, it is often necessary to count cells, such as when an exact (or
approximate) number of cells are to be plated or in order to find the correct splitting volume during
sub-culturing. In this work, cells were counted manually using a haemocytometer. This consisted of
a thick microscope slide, within which two loading chambers were located. A cover slip was placed
on top, which is designed to stick to the device (rather than float), trapping the desired amount of
liquid (0.1 µl) between the slip and the chamber when a sample is loaded. Newton’s rings will be
seen when the cover glass is adequately stuck down; this can be achieved by moistening the chamber
edges lightly with ethanol. The chambers have a fine grid of known dimensions etched into them
to allow precise measurement under the microscope. The grid is shown in figure 7.4. Usually the
cells in 1-4 of the labelled 4x4 grids will be counted under a microscope and averaged. Multiplying
this number by 104 gives cells per ml. From this number an appropriate volume to plate can be
calculated. Sometimes a dilution is necessary to avoid working with very small volumes.
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Figure 7.4: Diagram of a typical haemocytometer grid. the labels 1-4 show the four 4x4 grids used to count
cells. A specific volume of cell solution (0.1 µl) is trapped between the grid and cover glass.
7.3.5 Fixing and Staining with Crystal Violet
After a set incubation period, the resulting colonies must be fixed (to keep cells in place and inhibit
further growth) and stained (to allow for easy counting by eye). The cells were also checked after a
week and after 10 days to assess colony growth under the microscope and to ensure that the colonies
didn’t become too large and start overlapping. The media was discarded and the flasks were washed
with 1-2ml PBS. The PBS was removed using a 5ml pipette, ensuring as much was removed as
possible, to prevent dilution of the stain. Cells were fixed and stained using crystal violet diluted
into a 1:1 acetone to methanol solution. The solution was gently pipetted into the flasks so that the
surface was covered and left for 25 minutes. During washing with PBS and addition of the stain, the
flasks were kept whole. After 25 minutes, the stain was removed using a 5ml pipette. To wash, the
flasks were gently submerged into a beaker of water several times, slowly tipping out the contents
each time. The flasks were then laid cell-face up for several minutes to dry. Once dry, the flasks were
carefully broken (meaning that the slide is peeled away from the flask) using the provided breaking
tool. The colonies were then counted.
7.3.6 Growth Surface: Slide Flasks
Petri dishes or well-plates are often used as growing surfaces for these types of experiment. For
this work, it was decided that polystyrene slide flasks (Fisher Scientific, Loughborough, UK) would
instead be used, an example of which is shown in 7.5. They consist of a 9cm2 (15x50 mm) polystyrene
slide, attached to a flask structure using a leak-free ultrasonic weld. The slide flasks can be sealed
water-tight. This is advantageous during irradiation experiments where the flasks must be filled
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Figure 7.5: Polystyrene slide flask as used in this work. The top flask can be removed to leave a microscope
slide with the resulting cell colonies. Image taken from the Fisher Scientific web catalogue from which the
flasks were purchased.
completely with media and transported, as it avoids the need for sealants such as laboratory films
and improves the sterility of the experiments. The flasks also need to be kept in an upright position
for up to 40 minutes during irradiation. After incubation, the slide can be snapped away from the
adjoining flask using a provided tool, providing a flat surface which is easy to analyse. The geometric
shape of the growing surface allows easier automated analysis.
7.4 Clonogenic Assays & The Plating Efficiency
As described in section 7.1, the biological effects of using different contrast agents were assessed
in this work via clonogenic (or cell-survival) assays, which test the ability of cells to continually
proliferate after exposure to radiation and, in this case, to contrast agent. The assay is performed by
plating a known number of cells, exposing them to radiation with the CA present and counting the
number of colonies present after a suitable incubation period. The ratio of the number of colonies to
the original number of plated cells gives the survival fraction, which is plotted against dose to create
a cell-survival curve. Cell survival cures were generated and compared for each contrast agent used
(none, iodine, AuNPs). In this case, iodine is the CA against which AuNPs are compared, as it is a
clinically used contrast agent.
7.4.1 The Plating Efficiency
The plating efficiency describes the number of colonies that are expected to form under optimal
conditions (i.e. without exposure to radiation or any substances) as a percentage of the number of
cells initially plated. The cells must be plated at low density relative to the growth surface area. Its
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value depends heavily on the cell line used. It is important to have an idea of the PE value in the
absence of both radiation and contrast agents as a control. The plating efficiency test is performed
by plating different numbers of cells (usually in triplicate) into appropriate vessels and growing them
in culture for 10-14 days to allow them to grow and divide to form colonies. The colonies are counted
and this number is converted into a percentage of the number of cells initially plated. 50 colonies
per flask is typically ideal for small vessels, but 20-150 colonies can usually be easily counted in a 9
cm2 slide flask (Rafehi et al., 2011).
While the plating efficiency describes the proportions of cells expected to form colonies, the α
and β parameters from the linear quadratic model (section 6.2.3) describe the shape of the survival
curve and, therefore, these are all used together to determine the number of cells that should be
plated for each dose in the irradiation experiments in order to produce a sensible number of colonies.
As well as the effects of radiation, the effects of exposure to different contrast agents (15 nm
AuNPs and iodinated CA) are also investigated in this work. Similar PE experiments were performed
for cells with no irradiation but with exposure to CA. The experimental process is the same except
that different CA concentrations, each with the same number of initial plated cells (based on PE
results) will be investigated instead. This is important as it will show any effects on cells caused by
CA which can then be compared to cell effects with CA plus irradiation in order to distinguish the
two.
7.5 Irradiation Set-up and Procedure
7.5.1 Procedure
For the irradiation experiments, 80% confluent cells were passaged, counted and plated into slide
flasks in specific numbers. The cells were left for a minimum of 5 hours to attach to the flask surface.
Once the cells had attached, any required contrast agents were added to the cell media in appropriate
concentrations. If no contrast agent was required, the flasks were left to incubate overnight until
irradiation. The contrast agents were left for 15-36 hours (depending on the experiment). After
this time, the flasks were completely filled with cell media, with the contrast agent still in the
flask. This was to ensure a uniform dose across the whole surface during irradiation, as the beam
was horizontal. The uniformity of the beam was checked using calibrated radiochromic film, which
changes colour depending on absorbed dose without the need of additional processing (Lewis et al.,
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Figure 7.6: X-ray set-up for irradiation. Flasks were secured vertically with radio-transparent tape. The cell
growth surface was positioned to face the source. The arrows show the direction of the X-rays
2012; Niroomand-Rad et al., 1998). Post irradiation, the films were scanned using an optical scanner
and the optical density (which is proportional to the dose absorbed) measured using ImageJ. This
was checked before each irradiation experiment to determine the uniform region of the X-ray beam
and the slide flasks were placed appropriately within this area.
Dose in air was measured using a calibrated ionization chamber and converted to dose to water
as per the IAEA Code of Practice (Andreo et al., 2000). This was measured on the back surface
of the slide flask (the side facing the X-ray beam). Between this surface and the cells was 1 mm of
polystyrene; this thickness was taken into account during the final dose calculations using the linear
attenuation coefficients of polystyrene from 0-70 keV (as a 70 kVp beam was used). Backscatter
conditions (required for the use of the IAEA Code of Practice) were achieved by attaching the back
surface of the flask to a 10 cm thick block of solid water, as shown in fig. 7.6.
The slide flasks were transported from the incubator to the X-ray lab in a polystyrene lab box, to
keep the temperature of the cells. The X-ray source was a W-target source, operated at 70 kVp, with
an HVL of 2mm Al, matched to that of the Surrey source. The distance from the beam window to
the front surface of the water phantom was 75 cm. The centre of the beam was marked out on paper
and taped to the water-equivalent phantom. The set-up and flask orientation is shown in figure 7.6,
with the cell-containing surface facing the X-ray source. The flasks were secured with thin adhesive
tape, which does not significantly absorb X-rays, and aligned to the centre of the beam. The flasks
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were irradiated one at a time, making sure that all other flasks were in the control room when the
beam was on. After irradiation, the flasks were taken back to the cell lab. The media was removed
under sterile conditions. Flasks were then washed with PBS to remove any residual contrast agent
and were filled with 2-3 mm of fresh media. The flasks were then incubated for two weeks before
being fixed, stained and counted.
7.6 Doses Used in This Work
Two ranges of X-ray doses were used in this work: low mGy range and the 0-5 Gy range. Typical
doses for mammography (in terms of mean glandular dose, as explained in section 2.2.1) are of the
order of a few mGy (Hendrick, 2010; Olgar et al., 2012). For this reason 5 mGy was chosen as the
dose for the main experiments as it was the lowest achievable dose with the available set-up without
acquisitions being so short as to cause significant uncertainty in the received dose i.e. at least a few
seconds.
There is a particular interest in the potential use of AuNPs as both diagnostic (imaging) agents
and therapeutic (radiation treatment) agents simultaneously, in what is known as theranostic tech-
niques (Rosa et al., 2017; Gao et al., 2005). In such a technique, the AuNPs would first be used
as imaging agents in order to locate a tumour and give a more refined dose deposition. MV irra-
diation delivered to the nanoparticle accumulation sites, determined by the diagnostic component,
would provide the therapeutic component. Previous work has demonstrated that iodine, gadolinium
and AuNPs have shown the ability of both imaging and radiosensitisation of tumours (Robar et al.,
2002; Luchette et al., 2014). AuNPs are of particular interest in this field as their surface chemistry
allows them to be easily functionalised (Guo et al., 2017; Dreaden et al., 2012) by the attachment of
chemicals, such as proteins or drugs, to allow specific targeting.
Therefore, in this work, as well as investigating the effects of AuNP and iodine exposure at
diagnostic doses, the effects at higher doses (0-5 Gy), similar to those seen in therapeutic procedures
were also investigated. This also allowed a full survival curve to be obtained which is the gold
standard for radiobiological investigations and therefore it would provide insight on the wider effect
of AuNP on cells exposed to ionizing radiation.
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7.7 Analysis by Percentage Surface Cover
7.7.1 Colony Counting
In order to achieve both sufficient statistics and a small enough number of colonies to be individually
counted by eye, it is generally desirable to aim for 50-100 colonies per slide flask. Larger numbers can
be counted but overlapping and clumping of colonies are more likely, leading to greater uncertainty
in results. However, the number of cells to plate to achieve the desired number of colonies is often
difficult to predict, especially when different doses and/or concentrations of CA, for example, are
required. Estimates can be made based on PE results (with no irradiation or CA) and on estimated
α and β parameters of the MCF-7 survival curve. The number of cells actually plated is also a source
of uncertainty because a specific volume, rather than an exact number of cells, is plated.
As there was a difficulty in both choosing an appropriate number of cells to seed and in delivering
that exact number of cells to each flask, some flasks in the initial investigations did not lead to an
easily countable number of colonies. An example can be seen in the left column of figure 7.7. One
way to attempt to overcome this would be to keep repeating and adapting experiments. However,
taking into account the limited availability of the X-ray source, it was decided that a more suitable
and versatile analysis would be to calculate the percentage of the flask surface covered with cell
colonies. This is justifiable as MCF-7 cells form a mono-layer, providing that the whole surface is
not covered.
7.7.2 Analysis Procedure
A semi-automatic routine was written in MATLAB, using binary thresholding, in order to calculate
the percentage cover based on photographs of the slide flasks. This provided a more versatile analysis
for flasks with overlapping or large numbers of colonies. The analysis procedure was as follows:
1. High quality photograph of stained slide are loaded into program.
2. ROI of growing surface is outlined by the user.
3. ROI is converted into a normalised greyscale image (with pixel values 0-1)
4. ROI is converted into binary image based on a threshold. Three different thresholds are com-
pared each time the code is run.
5. The binary image is displayed to allow the user to check how it compares to the original image.
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Figure 7.7: Examples of original slide flask photographs (left, shown in greyscale) compared to their resulting
binary images (right), where black pixels indicate the presence of cells stained with crystal violet. Images (a),
(c), (e), (g) and (i) show the greyscale images for 0, 0, 1, 3 and 5 Gy exposures respectively. Images (b), (d),
(f), (h) and (j) show the resulting binary images for doses of 0,0,1,3 and 5 Gy exposures respectively.
6. The percentage of the ROI covered with cell colonies for each threshold is calculated.
7. The result is normalised to account for different numbers of seeded cells.
For each flask, two different photographs were analysed, each of which are run through the code
with multiple thresholds and multiple ROI outlines in order to quantify the uncertainty in the results.
Figure 7.7 shows examples of stained slides as greyscale images (left) and their corresponding binary
images (right) after they had been run through the software. These particular examples were for
high dose (up to 5 Gy) irradiation without CA. The binary images show good agreement with the
original photographs.
147
CHAPTER 7. MAIN INVESTIGATIONS: RADIOBIOLOGY
7.8 Main Experimental Work
7.8.1 PE with No Added Contrast Agents
The plating efficiency in the absence of radiation and contrast agents was determined for MCF-7
cells. As slide flasks were used for irradiation experiments in this work, they were also used to
determine PE. The PE when using petri dishes was also compared to determine the effect of different
growing vessels. MCF-7 cells at 80% confluency were passaged as per section 7.3.3 to produce a
single-cell solution. Cell concentration was determined using a haemocytometer as per section 7.3.4.
The number of cells in all four 4x4 grids was averaged. This process was repeated three times as
statistics were low. The average number of cells per grid was 4.5, corresponding to 4.5±0.5x104
cells/ml.
To avoid the need to work with very small volumes, a 1 in 30 dilution was prepared by adding 1
ml cell solution to 29 ml media, giving a diluted concentration of 1500 cells/ml. Using larger volumes
reduced the uncertainty in the volume measurement. Before cells were plated, each flask/dish was
filled with approximately 3 ml media to allow a more even distribution of cells and to reduce clumping.
Literature values of the plating efficiency for MCF-7 were used as a starting point in deciding the
number of cells to plate. Two petri dishes and one slide flask were plated with each of 100, 200, 500,
1000 and 2000 cells by adding 67, 133, 333, 667 and 1333 µl of cell solution respectively. Once the
cells were plated, they were incubated at 37◦C, 5% CO2 for 14 days to allow the cells to undergo
enough division cycles to grow into visible colonies. After the incubation period, the flasks/dishes
were fixed and stained as described in section 7.3.5.
The stained colonies are shown on the top row of figure 7.8. As can be seen, some colonies appear
much larger than others. These are usually caused by multiple cells being plated very close together,
causing a joint colony. These cases are marked as a single colony. In some cases, over-lapping or figure
of 8 colonies may be visible. These count as separate colonies as they can be visually distinguished.
Very small ’colonies’ are not counted. These examples are shown in figure 7.8.
When counting by eye, a threshold system for size must be used, which should be consistent
throughout an experiment (keeping in mind the Puck and Marcus criteria (Puck and Marcus, 1955),
which states that only colonies including 50 or more cells should be counted). Colonies were counted
by eye, and marked with a pen to prevent double counting. Figure 7.9 shows the results for both
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Figure 7.8: Left: The resulting colonies in petri dishes (top) and slide flasks (bottom) following a plating
efficiency experiment. Right: Diagram to show some rules followed in this work when counting colonies.
Figure 7.9: Graph to show the surviving fraction of cells grown in both petri dishes and slide flasks following a
plating efficiency experiment. Results are normalised to the number of cells plated and errors were calculated
using the standard error in the mean.
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slide flasks and petri dishes. For slide flasks the PE ranged from 8.5 to 20.4% with an average of
14.2±0.5 %. Based on the results, platings of 1000 or 2000 led to the most appropriate number of
colonies. At these plating densities, PE is closer to 10%. The petri dishes gave much lower plating
efficiencies with little variation. The average PE was 5.8±0.5%. For dishes plated with 1000 and
2000 cells, the number of colonies seems significantly lower than those plated at lower densities. This
is likely due to underscoring as well as merging of colonies. Evidence of this, particularly at 2000
cells/dish can be seen in figure 7.8.
7.9 Clonogenic Assays with Contrast Agents
7.9.1 Plating Efficiency Test with CA
Cell Plating
Cells were harvested from an 80% confluent T175 flask (passage number 23) and counted as per
section 7.3.4. Flasks were plated with 1000 cells per flask. The cell concentration was determined to
be 20±1x104 cells/ml, based on an average of 20 cells per 4x4 grid of the haemocytometer, over eight
grids. A 1 in 10 dilution was made by adding 1 ml cell solution to 9 ml complete growth medium.
2-3 ml media, followed by 50µl of the diluted cell solution was added to each flask. The flasks were
incubated for approximately 4.5 hours until the cells were attached (checked by inspection under a
microscope). The contrast agents were then added.
Addition of Contrast Agents
The contrast agents used in this work, Omnipaque300 and Aurovist® 15 nm AuNPs, are described in
section 4.5. Each concentration was set up in triplicate (3 flasks). After cell attachment, all media was
removed from the flasks using a 5 ml pipette. For the iodinated contrast agents, concentrations of 200,
500, 750, 1000, 2000 and 3000 µg/ml I were chosen, based on typical iodine surface concentrations
in tumours (Jong et al., 2003). The iodinated contrast agent, Omnipaque®, was supplied at a
concentration of 300 mg/ml. This was diluted to 30 mg/ml by adding 1 ml Omnipaque to 9 ml cell
media. 18 of the flasks were filled with 3 ml fresh medium. The appropriate amount of iodinated
contrast agent was then added (20, 50, 75, 100, 200 and 300 µl), which gave exact concentrations of
(0.20, 0.49, 0.73, 1.0, 1.9 and 2.7 mg/ml) of iodine respectively.
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For the AuNPs, concentrations of 50, 100, 200 and 500 µg/ml Au were chosen, based on those
used in previous in vitro studies (Jain et al., 2011; Coulter et al., 2012). The former used 1.9 nm
AuNPs to test toxicity of three different cell lines at both kV and MV energies. Measurements
were performed as a function of NP concentration to ensure comparison with available literature
data. Toxicity was determined by clonogenic assay with and without exposure to 500 µg/ml 1.9 nm
AuNPs for 24 hrs. They also investigated AuNP concentration vs cell survival for MDA-MB-231
cells irradiated with with 4 Gy of 160 kVp X-rays after 24 hr exposure to AuNPs of concentrations
up to 1 mg/ml; cell survival decreased with increasing AuNP concentration up to 500 µg/ml after
which the curve plateaued.
The AuNPs in this work were supplied in vials of 40 mg in 0.2 ml, giving a concentration of
200 mg/ml Au. Due to the small volume available, it was not practical to make large dilutions
and therefore, very fine scale pipettes were used. The required volumes for the 500, 200, 100 and
50 µgml−1 were 2.5, 1, 0.5 and 0.25 µl respectively. The smallest practical volume that can be
dispensed with the available pipettes is 1 µl. For 500 and 200 µg/ml, AuNPs were added directly to
flasks containing 1 ml media. For the lower concentrations, the medium and AuNPs were mixed in
a universal tube first and then divided between the flasks. For the 100 µg/ml Au flasks, 1.5 µl of
AuNPs were added to 3ml of media and 1 ml was added to each flask. For the 50 µg/ml Au flasks,
1 µl of AuNPs were added to 4ml of media and 1 ml was added to each flask.
The reason for adding only 1 ml of media to the flasks was to conserve the stock of AuNPs,
which are expensive. This is the smallest volume that will adequately cover the slide flask surface.
As it is the concentration of the nanoparticles that is important, rather than the overall amount,
the less media used, the less nanoparticles are required. As the Omnipaque is readily available in
large quantities, larger media volumes can be used. Control flasks were also prepared, in triplicate,
to which 3 ml cell medium only was added. The flasks were placed in the incubator and left for 40
hours (this is the CA exposure time). After this time, all media was removed from the flasks and
replaced by 2-3 ml of fresh cell media. The flasks were then returned to the incubator and left for
two weeks to divide and form colonies, then fixed and stained.
Results
The results, in terms of percentage area covered (generated as per section 7.7) are shown in fig
7.10. Error bars for average flasks were based on the standard deviation of the three flasks for each
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Contrast Agent Conc. (µg/ml) p-value
Iodine 200 0.2392
500 0.2012
750 0.0916
1000 0.2957
2000 0.2709
3000 0.2970
AuNPs (a) 50 0.1465
100 0.7948
AuNPs (b) 50 0.3959
100 0.6559
200 0.7321
500 0.0732
Table 7.1: Table to show the resulting p-values obtained from a two-tailed unpaired t-test comparing colony
growth of flasks containing a particular concentration of contrast agent to the control flasks.
concentration. For individual flasks, estimated uncertainty was based on differences when using
different images and thresholds in the software. Images of the slide flasks after staining are shown
in figures 7.11 and 7.12.
Results for the average and individual AuNP flasks are shown in graphs (b) and (e) respectively.
Although unclear, they do not show a clear decrease in percentage cover with increasing Au concen-
tration. In fact, all concentrations except 500 µg/ml have overlapping error bars with the control.
Graph (e) shows that there are 3-4 flasks with a much higher % cover than the others, two of which
were for the same concentration. However, the results do suggest that the highest concentration of
gold (500 µg/ml) may have some effect as the error bar did not overlap with the control and the
individual flasks for both the control and 500 µg/ml were very uniform. Due to the large differences
in individual flasks, a second experiment with 0, 50 and 100 µg/ml was performed (shown in graphs
(a) and (d)). This time the flasks were much more uniform and suggest that uncertainties in plat-
ing, measurement and individual cells, rather than the presence of AuNPs, contributes most to the
differences seen. However, the results do suggest that 500 µg/ml may have some effect. It can be
seen in fig. 7.10 that (b) and (e) have a much lower percentage cover than do (a) and (d). This is
largely due to the incubation time. As there were some overlapping and large colonies in the initial
experiment (see fig. 7.11), flasks were removed earlier from the incubator for ease of analysis. This
would not be detrimental to the results as all results were normalised to their control.
Some statistical tests were performed on the data to determine whether there were any statisti-
cally significant differences between concentrations or between individual flasks. A one-way ANOVA
(analysis of variance) was conducted using the MATLAB-intrinsic anova1 function in order to com-
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Figure 7.11: Final slide flasks after fixing and staining for the plating for flasks exposed to different concen-
trations of AuNPs or Omnipaque with no radiation exposure. The control flasks, which were not exposed to
any contrast agent, are shown along the top row. The far right row shows the AuNP flasksn for 50 and 100
µg/ml Au.
Figure 7.12: Final slide flasks after fixing and staining for cells exposed to AuNPs in concentrations between
50 µg/ml and 500 µg/ml. Flasks were not exposed to radiation.
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Figure 7.13: Normalised percentage cover vs CA concentration (no irradiation) for AuNPs (a) and Omnipaque
(b), normalised to the control flasks.
pare the effect of gold and iodine concentration on the percentage cover of cells. In both cases, no
statistical significance was found (p=0.05), with results of F(4,10)=1.09, p=0.414 and F(6,14)=1.05,
p=0.4352 for AuNPs and iodine respectively. Each concentration was also compared to the control
using a 2-tailed unpaired student’s T-test, the resulting p-values of which are shown in table 1.1.
None of the results show a statistically significant difference at the 95% confidence level. However,
the p value for the 500 µg/ml, p=0.0732 is close to significance and five times smaller than any other
AuNP p-value.
Graphs (a) and (b) in figure 7.13 summarise these results, normalised to the control, for AuNPs
and iodine respectively. A Pearson test for correlation gave a result of R2=-0.0056, p=0.9905 for
iodine and R2=-0.5493, P=0.3376 for AuNPs. In conclusion, iodine does not show a significant
relationship between I concentration and percentage cover for concentrations of 0- 3 mg/ml, which
covers clinically expected cell concentrations. AuNPs show similar results, although they were in
general less uniform across flasks of the same concentration. Results appeared to show a decrease for
the 500 µg/ml AuNP flasks, however this was not found to be statistically significant by statistical
analysis. These results will be supported by those of a low dose irradiation experiment using the
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same CA concentrations.
7.10 Irradiation at Low Dose
Cell Plating
MCF-7 cells (p.19) were harvested from an 80% confluent flask and counted. Cell concentration was
determined to be 10 ± 1x104 cells ml−1, based on an average of three counts. 20 ml of a 1 in 10
dilution was made by adding 2 ml cell solution to 18 ml media. 2-3 ml of complete growth medium
was added to each slide flask, followed by 100 µl diluted cell solution (1000 cells). As the same CA
concentrations were used and a very low radiation dose delivered, the number of plated cells was
kept the same as in the contrast agent PE. After plating, the flasks were incubated (37◦C, 5% CO2)
for 4-5 hours, until the cells had attached.
Addition of Contrast Agents
Once cells had attached, the contrast agent was added, using the same procedure given in section
7.9.1. This time, for Omnipaque, approximate iodine concentrations of (0.2, 0.5, 1.0, 2.0 and 3.0
mg/ml) were chosen. These were made by adding 20, 50, 100, 200 and 300 µl of 30 mg/ml Omnipaque,
which gave exact iodine concentrations of (0.20, 0.49, 1.0, 1.9 and 2.7 mg/ml) respectively, to flasks
containing 3 ml media. The Omnipaque had been diluted in PBS from 300 mg/ml iodine as in
section 7.9.1. For AuNPs, the same concentrations as in section 7.9.1: 50, 100, 200 and 500 µgml/ml
were used, containing 0.25, 0.5, 1.0 and 2.5 µl AuNPs in 1ml media respectively. Control flasks were
also prepared, in triplicate, to which only cell medium was added.
Irradiation
Flasks were incubated overnight (approx. 16 hours) to allow the AuNPs to be absorbed. Flasks were
then topped up with media until the flask was full. The lids were tightened to prevent leaking and
contamination. In order to replicate a clinical imaging situation, the contrast agent solution was left
in the flask during irradiation. The set-up and procedure for irradiation was the same as described
in section 7.5.1 and the set-up is given in figure 7.6. The beam parameters were changed in order to
achieve lower doses. Beam parameters of 71 kVp and 1 mA were used (70.57 kVp when read from the
Keithley picoameter), with an average dose rate of 0.172 mGy/s. The beam HVL was 2.1 mm Al,
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Figure 7.14: The final slide flasks after staining and drying. The flask outlined in a red dashed line was exposed
to a larger dose due to a timer malfunction. The flask outlined in solid green has a distinctly different colony
growth pattern compared to all other flasks, displaying very few, poorly formed colonies.
matched to that used for the imaging work at Surrey. All flasks were irradiated for 29±1 seconds,
equating to a total dose of 5 mGy. This was a compromise between delivering a clinically relevant
dose and achieving sufficiently long exposure time and was based on the literature. The error in time
here largely comes from the need to manually time and shut off the X-rays, which would become
more significant for shorter exposures (although was estimated to be less than 1 s). Literature values
suggested that patient dose could be as high as 3.6 mGy per breast view for CEDM, depending on
both breast thickness and composition, based on clinical images acquired using a GE SenoBright
detector (Luczyńska et al., 2014). Another study found the mean average glandular dose to be 2.8
mGy, based on the clinical results from 47 patients (Jeukens et al., 2014). After irradiation, cell
flasks were taken immediately back to the cell lab. All media was removed from the flasks. The
flasks were then washed with PBS, filled with 2-3 ml fresh media and incubated for two weeks.
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Figure 7.15: Average results per concentration for both AuNPs and Omnipaque. (a) and (d) give percentage
cover for Au and I respectively. (b) and (e) show number of colonies counted for gold and iodine respectively.
(c) and (f) show average colony size (as a fraction of total surface coverage) for gold and iodine respectively.
Error bars were calculated using the standard error between the flasks. All flasks received a dose of 5 mGy.
Results
The resulting colonies, after 13 days of incubation, are shown in figure 7.14. Although it is difficult
to draw firm conclusions from the images alone, it can be seen than the control slides have the most
coverage and largest colonies. It can also be seen that cells exposed to iodinated CA also have slightly
higher surface coverage and larger colony sizes than those exposed to AuNPs. The highest AuNP
concentration gave noticeably less coverage and smaller colonies than the other concentrations and, in
particular, the control. Based on this qualitative assessment alone, the results indicate that exposure
to AuNPs reduces surface coverage by some extent and leads to smaller colonies after the incubation
time. For iodine, the percentage cover appears less for some concentrations when compared to the
control flasks but does not show a clear relationship between concentration and colony growth. This
was quantified using statistical analysis.
The graphs in fig. 7.15 show the average results for percentage cover, number of colonies and
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Figure 7.16: Results from individual slide flasks as a function of CA concentration. (a) and (c) show percentage
cover for AuNPs and Omnipaque respectively. (b) and (d) show number of colonies for AuNPs and Omnipaque
respectively.
average colony size. Percentage cover was obtained using binary thresholding as described in section
7.7. As the colonies in this experiment were generally well-distributed and easily countable, the
number of colonies was also counted, by eye. This manual approach was necessary as some flasks
had small areas of overlapping colonies. These sections were carefully inspected in order to estimate
the number of colonies as accurately as possible and uncertainty was adjusted on a flask-by-flask
basis. Figure 7.16 gives the same results but for each individual flask.
For AuNPs the flasks were reasonably consistent, considering that the radiation introduces an
extra step into the experiment, and an extra time that the flasks must be opened and disturbed. (b)
and (d) show the distribution of number of colonies for individual flasks. Interestingly, the flasks
with the highest percentage cover were not always the flasks with the largest number of colonies.
In figure 7.15 for AuNPs there is a general negative correlation between coverage and concentration
with percentages of 20.1, 10.7, 15.0, 12.3 and 8.3 % for AuNp concentrations of 0, 50, 100, 200 and
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500µg/ml. 50 µg/ml is the notable exception, but when looking at the individual flask results in
fig. 7.16 it can be seen that one flask had significantly less coverage than the other two. The results
show that the number of colonies is not affected in the same way as surface coverage.
Graphs (c) and (f) of figure 7.15 show average colony size as a fraction of the total surface coverage,
obtained by dividing the covered area by the number of cells counted. For AuNPs, a decrease in
cell size with increasing AuNP concentration is seen, but with large uncertainties. One possible
explanation for this is an AuNP-induced slowing down of the cell cycle. There doesn’t appear to be
a significant effect for the iodine results (shown in (b), (c) and (d) of fig. 7.15), where five of the six
error bars overlap. One iodine flask for 3 mg/ml had significantly less coverage than the other two
(12.4% compared to 34.1% and 27.3%). This highlights the importance of performing all studies in
triplicate, as there can be considerable inter-flask variation. This is partly due to differences in the
initial number of cells plated (as they are plated by volume based on cell concentration). Exact CA
concentration and dose delivered will also have small variations.
Different concentrations were used for the two contrast agents due to different literature recom-
mendations/observations and to better relate the measurement to clinical scenarios. Two concen-
trations (200 µg/ml and 500 µg/ml) were common to both contrast agents and have been used for
direct comparison. Both a larger percentage cover and a greater number of cells were seen for iodine
than for AuNPs at these concentrations, particularly at 200 µg/ml. For 200 µg/ml, percentage cover
was 20±2 and 12±1 for iodine and AuNPs respectively and for 500 µg/ml it was 12±2 and 8.3±0.2
for iodine and AuNPs respectively. For 200 µg/ml, the mean number of colonies was 240±20 and
190±10 for iodine and AuNPs respectively and for 500µg/ml, it was 180±20 and 170pm10 for iodine
and AuNPs respectively.
An ANOVA test was performed to determine whether there was a statistically significant relation-
ship between concentration and percentage cover. AuNPs yielded a result of F(4,10)=3.25,p=0.0596.
This result does not prove statistical significance but is borderline (p<0.05 is significant) and is sig-
nificant at the 90% level. There were also two outlying results, at least one of which acted to increase
the p-value. The slide in question is shown outlined in green in fig. 7.14; colonies were absent in
large areas of the flasks and most did not look fully formed, as if the fixing and staining had not
worked correctly. A second flask, shown with a dashed red line, could not be included as it had been
exposed to more than 5 mGy radiation. This makes the ANOVA results less reliable. A student’s
t-test between the control and the 500 µg/ml AuNPs generated a p-value of 0.096. There is a definite
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Figure 7.17: Results for average percentage cover and average number of colonies for AuNPs (a) and Omni-
paque (b) against contrast agent concentration, normalised to the control flasks.
visual difference between the size, number and appearance of colonies at higher concentrations of
AuNPs. The ANOVA test for iodine generated a result of F(5,12)=1.71, p=0.2073, indicating no
statistical significance. This result was more reliable than for AuNPs as all flasks could be used.
In order to visualise the relationships between concentration and cell survival more clearly, results
for average percentage cover and average number of colonies are shown, normalised to the control
flasks, in fig 7.17. When seen plotted on the same graph, the percentage cover falls away more quickly
with increasing AuNP concentration than does number of colonies, with only one overlapping error
bar. For iodine percentage cover and number of colonies follow a more similar pattern, with all but
one error bars from the two overlapping, suggesting no significant difference.
7.11 Irradiation at Higher Doses
The radiation experiment given in section 7.10 was repeated with a range of doses and with only a
single concentration of each contrast agent.
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7.11.1 Plating
MCF-7 Cells at p19 were harvested and counted as per section 7.3.4. The counting process was
repeated three times, giving an average of 30±1 cells per grid, equating to 3x105 cells/ml. The
decided doses to be administered were 0, 0.5, 1, 2, 3 and 5 Gy. The number of cells to be plated for
each of these doses (in triplicate) were 1000, 1000, 1000, 2000, 3000 and 10000 respectively. These
numbers were decided based on the previous experiments and estimated α and β parameters for
the higher doses. A 1 in 30 dilution was made by adding 1 ml of cell solution to 29 ml media.
Therefore to plate 1000, 2000, 3000 and 10,000 cells, 100, 200, 300 and 1000 µl were added to each
flask respectively (after 2-3 ml media had been added).
7.11.2 Addition of Contrast Agents
As the doses used for this experiment were high and therefore required long exposure times, it was
only practical to use one concentration of each contrast agent. For iodine, 2 mg/ml was chosen.
As iodine did not show an obvious effect on cell survival, the highest concentration could be used.
However, 3 mg/ml was not used because there was a lot of variation between the flasks in the previous
experiments and therefore 2 mg/ml I was chosen instead. For AuNPs, a concentration of 200 µg/ml
Au was chosen as this was the first concentration that seemed to give an effect. In both previous
experiments, the 500 µg/ml concentration caused very noticeable effects and therefore 200 µg/ml
was chosen as a compromise between seeing an effect and still allowing enough cells to survive the
high doses of radiation.
7.11.3 Irradiation
The flasks were incubated overnight, for approximately 18 hours. The flasks were then completely
filled with media for irradiation. As the exposure times were long for these doses (up to 40 minutes
per flask), the flasks were filled in batches throughout the day, to avoid unnecessary disruption to the
cells. After irradiation, the media was completely discarded (also in batches after several exposures
were completed), washed with PBS and filled with 2-3 ml of fresh media. The same set-up and
procedure was followed as in section 7.5.1. Beam parameters of 71 kVp and 15.1 mA were used, with
an HVL of 2.1 mm Al, giving an average dose rate of 2.339 mG/s. Therefore, in order to achieve
doses of 0, 0.5, 1, 2, 3 and 5 Gy, flasks were exposed for 0, 214, 427, 855, 1282 and 2137 s respectively.
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Figure 7.18: The final slide flasks after staining and drying for the full dose experiment. Iodine and controls
are shown on the right. AuNP and controls are shown on the left. Each flask is labelled with the CA and
the dose. Flasks labelled CON received neither radiation nor exposure to contrast agents. The slide marked
with a red cross was not used in analysis as it moved during irradiation.
The source-flask distance was 75 cm (32 cm from source to X-ray shutter and 43 cm from shutter
to flask). The distance from the flask surface to the cells was 1.3 mm. Three flasks were irradiated
for each dose and for each contrast agent. Flasks receiving 0 Gy were still treated in the same way
as the other flasks; they were completely filled with media and taken to the X-ray lab. This was to
eliminate any differences in colony size arising from cell distress. The control flasks however, that
were neither exposed to CA nor X-rays, were left in the incubator as a true control.
7.11.4 Results
The final stained slide flasks for both AuNP and iodine exposure are shown in figure 7.18. As
different numbers of cells were plated for different doses, the results had to be normalised before
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Figure 7.19: The final slide flasks after staining and drying for the full dose experiment with no exposure to
contrast agents.
relationships could be seen. However, the slides do show a trend towards smaller colony size with
increasing radiation exposure. The control flasks, which were the same for both CAs, clearly show
the largest coverage and the biggest colonies. However, they did not have to be disturbed for the
addition of contrast agent or filled with media for irradiation. Figure 7.19 shows the results with no
contrast agent exposure, which were irradiated on a different date.
Figure 7.20 shows the results in graphical form. Graphs (a), (b) and (c) show the percentage
cell coverage for individual flasks for iodine, gold and no CA respectively. This is to give an idea of
the uniformity of results between the triplicate flasks. In most cases, at least two of the flasks were
reasonably consistent, given the large number of variables involved. The error bars were calculated
based on percentage cover analysis using different images and different thresholds. Graphs (d), (e)
and (f) show the corresponding normalised average results per dose for iodine, gold and no CA
respectively. The normalisation factor was calculated from the initial number of cells plated. In all
three cases, a clear relationship can be seen. Even taking into account some overlapping of error
bars, a negative correlation between dose and cell survival is seen as would be expected.
A 2-way ANOVA was performed to assess effects of both dose and contrast agent (AuNP or
Omnipaque). The results showed that there was a statistically significant difference between the
doses (p=0), but that there was no statistically significant difference between AuNPs and Omnipaque
(p=0.3359) at either the 95% or the 90% level. The test also showed a lack of interaction between
dose and CA (p=0.9102) at the doses tested.
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7.11.5 Survival Curves: Gold vs Iodine
For better visualisation, the results were converted to cell survival graphs both for individual CAs
and for all CAs together. These are shown in figure 7.21. In graph (d) the error bars have been
omitted for display purposes. Based on these graphs, there doesn’t appear to be a quantifiable or
significant difference between the different contrast agents. In particular, the results for AuNPs and
for no CA are very similar, with error bars overlapping at every dose. Iodine-exposed flasks fared
better at higher doses but had relatively large uncertainties due to differences between individual
flasks.
Figure 7.21: Results of cell survival for each contrast agent individually, before any fits have been made. Error
bars were calculated using the standard error in the mean. (d) shows all the results together, with error bars
omitted for better visualisation.
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Contrast
Agent α (Gy
−1) 95% Conf.Limits (α)
68% Conf.
Limits (α) β (Gy
−2) 95% Conf.limits (β)
68% Conf.
limits (β)
Iodine 0.4016 (0.1375,0.6656)
(0.2937,
0.5095) 0.00165
(-0.0911,
0.0944)
(-0.0363,
0.0396)
AuNPs 0.1947 (-0.0690,0.4584)
(0.0870,
0.3024) 0.0667
(-0.04536,
0.1788)
(0.0209,
0.1125)
No CA 0.4587 (0.2078,0.7096)
(0.3822,
0.5352) 2.05x10
−8 (-0.0805,
0.0805)
(-0.0245,
0.0245)
Table 7.2: Table to show the α and β parameters as generated by the LQ model fitting algorithm. In each case
a lower limit of zero was imposed to both parameters. Errors are given by both the 95% and 68% confidence
intervals generated by the fit.
Fitting the Data to the LQ Model
The final cell survival curves, fitted with a linear quadratic fit, are shown in figure 7.22 on both a
linear plot (a) and a semi-log plot (b). These were generated in MATLAB, by fitting to equation
(6.6), where both α and β were forced to be positive values. These plots allow the overall aim of
this part of the project, which was to generate and compare cell survival graphs for all three CA
combinations over a range of doses, to be realised. For no Contrast agent exposure, the α and β
parameters were 0.4593 Gy−1 and 1.5x10−8 Gy−2 respectively. For iodine, the α and β parameters
were 0.402 Gy−1 and 0.0016 Gy−2 respectively. Finally, for AuNPs, the α and β parameters were
0.1948 Gy−1 and 0.0667 Gy−2 respectively. The errors for all parameters, in terms of the 95%
confidence intervals generated by the fit, are given in table 7.2.
Results in the literature (for MCF-7 survival curves with exposure to radiation only and fitted
with the linear quadratic equation) show varied results: One study (Lacoste-Collin et al., 2015)
reported the α and β values for MCF-7 to be 0.2 Gy−1 and 0.095 Gy−2 respectively, with a 50%
surviving fraction at approximately 2 Gy (where 8 different doses were used, up to 10 Gy). The
alpha value was within the 95% confidence intervals for the results presented in this work for AuNPs,
iodine and no CA. The beta value was within the 95% confidence interval for AuNPs. Another study
(Wang et al., 2012), found the α and β values for MCF-7 to be (0.552±0.05) Gy−1 and (0.002±0.014)
Gy−2 respectively. They used doses of 0, 1, 2, 3 and 4 Gy. Both alpha and beta were within the
95% confidence limits for our iodine and no CA results, as was the beta result for AuNPs. A third
study (Ghita et al., 2015), who used doses of 0-8 Gy, found the α and β values to be 0.29±0.1 and
0.06±0.03 respectively. These were particularly comparable to the results we obtained with AuNPs
in this work.
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Figure 7.22: Graph to show the fitted LQ curves for Omnipaque, AuNPs and irradiation only, (a) with a
linear y-axis and (b) with a logarithmic y-axis.
Although the numbers seem quite different for AuNPs than for the other two curves, when looking
at the individual data points and the error bars in fig. 7.22, the differences are largely due to forcing
a particular fit to the data. In fact, at the lower doses of 2 Gy and below, AuNPs had a higher
survival fraction than both iodine and no CA.
According to the literature, a decrease in cell survival can manifest as an increase in the LQ
parameters. One study (Chithrani et al., 2010) compared the cell survival of Hela cells with and
without the addition of 50 nm AuNPs using doses of 0-8 Gy. They compared 105 kVp, 220 kVp,
6 MVp and a Cs-137 source. In all cases, a significant decrease in cell survival was seen (with
greater decreases with increasing energy), shown by an increase in the α parameter of the LQ model.
The 105 kVp, which is the closest to diagnostic energies, α increased from 0.237±0.05 Gy−1 to
0.528±0.007n Gy−1. In our work, the alpha value decreased for AuNPs compared to no CA while
the beta parameter increased. AuNPs show a wide âĂŸshoulderâĂŹ region at low doses, which is
not present for iodine or no CA. This low-dose region is dominated by the linear α term and its
decreased value indicates a lower radiosensitivity with the addition of AuNPs (McMahon, 2018).
The β parameter was found to be higher for AuNPs, giving an increased curvature and therefore
higher sensitivity at higher doses.
Based on the 95 % confidence intervals, the differences seen between α and β were not deemed
to be significant. However, 95 % is a strong confidence to use for biological data, particularly when
only a small range of doses have been investigated. Therefore, the 68% confidence limits were also
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calculated and are shown in table 7.2. Results show a significant difference at this confidence level
between the α parameters of AuNPs and no CA (Au and iodine had a 8.7x10−3 Gy−1) but no
significant differences between the β parameters.
7.12 Conclusions
The aim of this work was to quantify and compare the radiobiological effects of AuNPs and iodinated
contrast agents in terms of cell survival. This was achieved by performing cell survival assays under
different conditions, based on initial plating efficiency results. As discussed in section 7.10.5, the
clonogenic assay was chosen (over others such as the MTT and Trypan Blue exclusion assays) due to
its ability to distinguish between clonogenic cells and those which are dead but may undergo several
cell divisions. Resulting colonies were measured by calculating the percentage of the surface covered
by the cells, using a binary thresholding technique. Where practical, cells were also counted by
eye, as is typical. Cell clumping was present in some experiments, which made counting individual
colonies difficult and prone to large uncertainties. It was also difficult to predict the optimum number
of cells to seed to give a sufficient (but countable) number of colonies. Seeding too many cells led to
large numbers of colonies that overlapped due to lack of space. Given the timescale of this project,
it was decided that measuring the percentage cover would allow a quick and repeatable analysis and
allowed overlapping colonies to be analysed rather than having to repeat the experiments. However,
this method does have its own difficulties, for example, high levels of clumping can lead to a non-
linear relationship between number of colonies and covered surface area. The choice of threshold can
also affect results. However, for the scope of this work, it was determined to be the most appropriate
method. Methods of reducing cell clumping in future include pipetting and reducing the amount of
trypsin used during cell passage. This will be discussed in greater detail in chapter 8.
Cells were first exposed to contrast agents at different concentrations without radiation. Omni-
paque was investigated at concentrations between 200-3000 µg/ml iodine, based on literature values
of clinical cellular concentrations (Coulter et al., 2012; Rosa et al., 2017). No relationship between
concentration and cell survival was observed at either the 90% or the 95% confidence level, backed
by ANOVA analysis. The same was seen for AuNPs, which were investigated at concentrations be-
tween 50-500 µg/ml Au, but there did appear to be some reduction in the number of colonies for the
highest concentration (500 µg/ml Au). This was found to be significant at the 90% level based on a
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Student’s T-test compared to the control. The same concentrations of contrast agents were used for
an irradiation experiment in which all flasks were given a clinically-relevant dose of 5 mGy. From the
resulting slide flask images, it could be seen that AuNPs produced smaller colonies than iodine, with
a decrease in both number and size of colonies with increasing concentration. No relationship was
seen with iodine. ANOVA testing on AuNPs generated a p-value of only 0.0596, which is significant
at the 90% level. The p-value for iodine was p=0.2073. For this experiment, number of colonies was
also counted, by eye, as a comparison to the surface coverage. It was found that the size of colonies
was more affected than the number of colonies for AuNPs, which could suggest slower cell growth
and longer doubling times when cells are exposed to AuNPs. As described in section 6.1.3, changes
to the cell cycle are one of the possible mechanisms of AuNP radiosensitisation (Rosa et al., 2017)
and this has been explored in the literature (Li et al., 2018; Roa et al., 2009). The latter observed
acceleration of the G0/G1 phase and arrest in the G2/M phase for Cs-137-irradiated DU-145 cells
when exposed to 10.8 nm glucose-AuNPs. The former compared cell cycle response to bare AuNPs
compared to those coated with bovine serum albumin (BSA), using flow cytometry. They found that
both affected the cell cycle, but with different pathways. A more thorough comparison has been
made by Rosa and their colleagues (Rosa et al., 2017).
Finally, cells were irradiated at a range of doses up to 5 Gy, at concentrations of 200 µg/ml
and 2000 µg for gold and iodine respectively, based on expected cellular concentrations given in the
literature (Jong et al., 2003; Coulter et al., 2012; Rosa et al., 2017). As expected, results showed a
clear negative correlation between cell survival and dose. Normalised results were used to generate
cell survival curves with a Linear Quadratic fit. Based on 95% confidence intervals, no significant
differences in either the α or β parameters were seen. 68% confidence intervals were also generated
due to the small range of doses and of repeats, which showed a significant difference in the α values
between AuNPs and no CA. In particular the α was lower for AuNPs compared to iodine or no
CA, while the β parameter was higher. The decreased α value indicates a lower radiosensitivity at
low doses with the addition of AuNPs (McMahon, 2018; Chithrani et al., 2010) whilst the higher β
parameter gives an increased curvature and therefore higher radiosensitivity at higher doses. Similar
observations have been seen in the literature (Chithrani et al., 2010) when comparing survival of Hela
cells with and without the addition of 50 nm AuNPs using doses of 0-8 Gy. At 105 kVp, which was
the closest energy tested to the diagnostic range, α increased from 0.237±0.05 Gy−1 to 0.528±0.007
Gy−1.
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One of the limitations of the clonogenic assays used in this work is that they do not give any
information on the mechanism of the cell death. This is important to achieve a full understanding
of the biological mechanisms of cell effects caused by exposure to AuNPs and/or iodine. In order
to expand upon this work, the same methods could be adopted as in the literature (Li et al., 2018),
using flow cytometry (see section 6.2.1) to determine the mechanisms of radiosensitisation (if any)
with both iodine and AuNPs. This would allow DNA to be analysed which can allow discrimination
between cell cycle phases. Other techniques such as MTT assays and Trypan Blue exclusion assays
(as outlined in section 6.2.1) would also have aided a more specific analysis. If more time had
been available, it would also have been advantageous to compare cell lines, in particular a healthy
breast cell line such as MCF-10, in order to determine whether there were any differences between
cancerous and healthy cells. More refined experiments, with more repeats and with more carefully
chosen numbers of plated cells would also be desired in order to be able to count cell colonies in the
conventional manner rather than relying on percentage cover. This would remove any differences in
the cell survival curves related to the limitations of the technique.
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Conclusions and Further Work
The purpose of this work was to investigate both the use of spectroscopic detectors and to compare
different contrast agents in contrast-enhanced mammography in an attempt to overcome some of
the current limitations such as short imaging times and patient movement. Alternatives are needed
because conventional mammography is less effective for some patients, particularly those with dense
breasts. The investigation was conducted in two distinct parts: imaging (to test both the detector
performance and the success of each contrast agent in terms of reconstructed CA concentration and
CNR) and radiobiology (to investigate the biological effects on cells of exposure to each contrast
agent and/or to radiation).
Spectroscopic Imaging
Images were acquired on the HEXITEC detector, which gives a full energy spectrum per pixel,
using both a clinical iodinated contrast agent (Omnipaque, GE Healthcare, UK) and 15 nm AuNPs
(Nanoprobes, NY, USA). A custom-made test object was used, which consisted of a plastic box filled
with perspex spheres and oil, with a superimposed PMMA block with drilled cavities of 1, 2 and 3
mm diameter into which the contrast agent was injected. The detector was calibrated using known
peaks from a variable X-ray source. Spectrum analysis showed this to be accurate as the expected
K-edge of iodine (33.2 keV) coincided with a sudden drop in counts on the spectrum. Application of
the calibration on an individual pixel basis gave rise to a higher and sharper K-edge.
For iodine, the high and low images were obtained by integrating 2 keV energy bands above
and below the K-edge of iodine respectively in order to fully exploit the change in attenuation
across it. For the undiluted CA (300 mg/ml I) an accurate reconstructed iodine concentration of
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(304±6) mg/ml I was observed when using CSA corrections. Good agreement was also seen with
the expected data for other dilutions, taking into account the uncertainties in the dilution process.
CNR measurements taken from the iodine-equivalent images showed a good, linear correlation with
the nominal surface concentration. Large uncertainties were seen when using diluted concentrations.
Improvements could be made by using calibrated fine-volume pipettes as well as using serial dilution.
This would also allow more thorough mixing. The dilution factor could also be adjusted in different
concentration regions in order to zone-in on concentration regions of interest e.g. near the limit of
visibility.
AuNP Images were acquired at both 50 kVp and 80 kVp and different combinations of energy
bands were investigated to determine the optimum energy separation to allow a large enough differ-
ence between the attenuation of gold and water. The optimum bands (23:25 keV and 43:45 keV, at
80 kVp) generated reconstructed gold concentrations which were in agreement with the nominal for
each concentration tested. The gold-equivalent images were much noisier than those generated with
iodine and the CNR measurements were less consistent due to the large standard deviation in the
background regions.
Due to the issues with dilution, the contrast agent concentrations used in this work are higher
than those that would be typically seen clinically, which can be as low as 1-2 mg/cm2 (Jong et al.,
2003) at the tumour site for iodinated CA. Equivalently, this may be between 60 µg/ml and 10 mg/ml
Au for AuNPs (Coulter et al., 2012; Rosa et al., 2017; Chithrani and Chan, 2007). The literature
has shown that CNR is directly proportional to the CA concentration and to the square root of
the dose (Baldelli et al., 2006). Based on this, it was calculated that in order to visualise a surface
concentration of 2 mg/cm2, a dose of 1.25 mGy would be required, which is within the acceptable
limits for mammography (Boyd et al., 2011b). This was not the case with AuNPs (due to the low
CNR values caused by image noise) which were calculated to require a dose of approximately an order
of magnitude higher than the acceptable limits. Therefore, iodinated contrast agent outperformed
AuNPs in this case. However, for AuNPs, energy bands would have ideally also been integrated
above and below the gold K-edge (80.7 keV) (Alivov et al., 2013). With the highest voltage available
the source had a maximum operating voltage of 80 kVp and therefore compromises had to be made.
Some detector limitations were seen, in particular pixels with lower gain which gave less counts in
the higher energy ranges after individual pixel calibration. In order to overcome this, a thresholding
system was used to omit significantly different pixels from the reconstructed profiles. This had more
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of an effect when imaging AuNPs due to the higher energies used. This is likely to depend on
degradation of the CdTe during the course of the project.
The effects of imaging at different count rates when using different charge sharing corrections
was also investigated (Chapter 5). As the spectrum analysis throughout the imaging work has
shown, charge sharing corrections are important in order to avoid degradation to the spectrum in
terms of both number of counts and recorded energies. However, as the charge sharing corrections
rely on locating and removing (CSD) or summing (CSA) counts, there is an effective maximum
rate above which the correction algorithms cannot be implemented correctly (approximately 10%
detector occupancy). Images acquired at a range of count rates showed that a paralysable dead
time behaviour is seen for both CSA and CSD corrections. However, at low count rates this could
be approximated to a non-paralysable behaviour, allowing a correction algorithm to be generated.
When charge sharing corrections were not applied, an intermediate behaviour between paralysable
and non-paralysable was observed, which could be approximated to linear at low count rates. After
implementing the correction algorithms, it was found that the iodine concentration in the 3 mm
tube could be corrected to within 8.3% and 6.0% of the nominal for CSA and CSD respectively.
In both cases the decrease in reconstructed thickness with increasing current was largely removed,
allowing for shorter acquisition times (2 mins rather than 30 mins) and a higher dose rate whilst still
correcting for charge-sharing.
Radiobiology
The radiobiological effects on cells of exposure to both CA and different doses of radiation was
investigated via clonogenic assays, chosen (over alternative assays such as MTT or Trypan Blue
exclusion) due to their ability to distinguish between clonogenic cells and those which are dead but
may undergo several cell divisions. This was achieved by growing a specific number of cells in culture,
with an appropriate volume of CA, followed by exposure to irradiation and incubation for 10-14 days
to allow colonies to form. Colonies were then counted by eye and/or determined by percentage cover
via semi-automatic binary thresholding. As explained in section 7.7, this method was chosen because
cell clumping was present in some experiments, which made counting individual colonies difficult and
prone to large uncertainties. It was also difficult to predict the optimum number of cells to seed to
give a sufficient (but countable) number of colonies. Therefore percentage cover analysis allowed a
more versatile analysis within the limited experimental time frame. However, this method did have
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limitations, in particular the possibility that high levels of clumping could result in a non-linear
relationship between number of colonies and covered surface area.
There are several causes of cell clumping outlined in the literature (Sigma-Aldrich, 2018) including
over-digestion of proteolytic enzyme (which can occur from over-use of trypsin during cell passage),
stress caused by the physical handling and movement of the cells (this can include multiple cycles of
freezing and thawing), cell rupture (caused by the processes involved in the preparation of a single-
cell suspension such as pipetting and centrifugation) and overgrowth (leaving cells growing beyond
confluency can cause a large build-up of cell debris).Based on this, improvements to the technique
could be made by a more careful cell passage technique, by reducing the amount of Trypsin used and
the time for which it is left to act. A more careful and longer de-clumping procedure by pipetting
up and down could also further reduce the clumping. To reduce the overlap and to prevent colony
over-growth, the size of cell colonies could be more closely monitored so that fixing and staining are
performed at the optimum time. When cells are added directly to slide flasks of other growth vessels,
the solution should be gently swished immediately after seeding i.e. before the cells can begin to
attach. This method was adopted in this work but a more refined or longer method may be required.
The plating efficiency experiment gave an average PE of 14.2±0.5 % for plating densities of up
to 500 cells per slide flask; for plating densities of 1000+ cells, the results was closer to 10%. These
results were used to determine the initial number of cells plated for irradiation experiments.
The effects of CA concentration were investigated by plating slide flasks with 1000 cells (based
on the plating efficiency results as this should lead to approximately 100 colonies before taking CA
exposure into account). Different volumes of CA were added to the cell media to achieve different con-
centrations. Concentrations of 50-500 µg/ml and 200-3000 µg/ml were made for AuNPs and iodine
respectively in order to cover clinical concentrations at the cellular level. Results for iodine showed
no correlation between concentration and cell survival. For AuNPs, there was large uncertainty in
some concentrations due to inter-flask variation.
A second AuNP experiment with concentrations of 0, 50 and 100 µg/ml gave much more consistent
results and suggested that differences at these concentrations in the previous experiment were of a
statistical nature. No significance was found at the 95 % level (p=0.05) when using one-way ANOVA
analysis, with results of F(4,10)=1.09, p=0.414 and F(6,14)=1.05, p=0.4352 for AuNPs and iodine
respectively. However, the AuNP results for the highest concentration of 500 µg/ml did appear to
show significantly lower cell survival. A two-tailed unpaired T-test was also performed and although
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none of the results were significant at the 95 % level, the 500 µg/ml AuNPs were significant at the
90% level with a p-value of 0.0732. These results were also backed up by observation of the final
colony images.
To support these results, flasks with the same CA concentrations were prepared and exposed
to a low clinically-relevant dose of 5 mGy, using the same range of concentrations. The slide flask
images showed much smaller colonies for AuNPs at higher concentrations compared to both the
control and to the iodine results. Both percentage cover and number of cells (which were counted
by eye) showed a general negative correlation with concentration for AuNPs. Iodine did not show a
clear relationship. One-way ANOVA generated p-values of 0.0596 and 0.2073 for AuNPs and iodine
respectively. Although neither are significant at the 95% level, AuNP is significant at the 90% level
and is four times smaller than the result for iodine. This warrants further investigation with larger
datasets. Interestingly, there was a noticeable difference between percentage cover and number of
colonies seen for AuNPs; colony size was affected more than colony number.
In conclusion for the multiple-concentration studies, neither iodine nor AuNPs showed a statisti-
cally significant toxicity apart from the highest concentration of Au (500 µg/ml) which significantly
reduced the number of colonies formed compared to the control. However, when cells were exposed to
low dose radiation (5 mGy) as well as the CA a statistically significant decrease in cell survival with
increasing Au concentration was found at the 90% level. Iodine on the other hand showed no effect
for the doses tested. These results, however, are hampered by some variation between individual
flasks as well as the cell clumping which has already been described. CA exposure/incubation time
was also different for the two experiments (40 hours without radiation vs 16 hours with 5 mGy).
Different incubation times after the addition of AuNPs were used across the experiments (40
hours for the plating efficiency test with CA), however all irradiation experiments had incubation
times of 16-18 hours. This difference was a matter of convenience, depending on the availability
of the cell culture and irradiation facilities and the need for minimum incubation times to allow
cells to attach after plating. According to the literature, there is generally a saturation point (<
24 hrs), after which AuNP uptake does not change (Coulter et al., 2012). Ideally cells would have
been plated in the morning, the AuNPs added the same afternoon (after cell attachment) followed
by irradiation the following morning. In agreement with the published data, the presented results
showed no indication that the longer incubation times had induced any toxic effects compared to
those with shorter incubation time.
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Finally cells exposed to one particular CA concentration (200 µg/ml and 2000 µg/ml for AuNPs
and iodine respectively) were exposed to a range of radiation doses between 0-5 Gy. Different numbers
of initial cells were plated depending on the dose. Results were analysed using percentage coverage,
normalised to the number of cells plated. Results showed a clear correlation between dose and cell
survival for both AuNPs and iodine, as well as for no CA, as expected. A 2-way ANOVA analysis
showed a statistically significant difference between doses (p=0) but no significant difference between
AuNPs and Iodine (p=0.3359). No interaction between radiation dose and CA type was found. The
results were used to generate survival curves for each contrast agents. As they were normalised they
could be directly compared. In terms of the individual points on the survival curve, both AuNPs
and iodine had a higher survival fraction than no CA at all points except 3 Gy. Compared to iodine,
AuNPs showed higher survival at 0, 1 and 2 Gy and a lower survival at 3 and 5 Gy. The survival
curves were fitted with the linear-quadratic model. Although the curve for AuNPs was of a different
shape, no significant difference was seen in either the α or β parameters. The overall results suggest
that there may be some reduction in cell survival when using AuNPs when cells are exposed to
high enough concentrations, which was seen both with and without exposure to radiation. Upon
comparison to literature results, which have been discussed in chapter 7, some similar trends in α
and β parameters were seen with the addiation of AuNPs.
As discussed in section 7.11.5, the literature for MCF-7 survival curves with exposure to radia-
tion only and fitted with the linear quadratic equation show varied results. Three different studies
(Lacoste-Collin et al., 2015; Wang et al., 2012; Ghita et al., 2015) found α parameters of 0.2 Gy−1,
(0.552±0.05) Gy−1 and (0.29±0.1) Gy−1 respectively. For this study, α was found to be 0.4593 Gy−1
(95% confidence intervals can be found in table 7.2). The three studies found the beta parameters to
be 0.095 Gy−2, (0.002±0.014) Gy−2 and 0.06±0.03 respectively. These are particularly comparable
to the results we obtained with AuNPs in this work. Other studies, which have been discussed in
chapter 7, also found a decrease in the alpha values in particular when cells were exposed to AuNPs
as well as to radiation (Chithrani et al., 2010).
Further Work
The current work was aimed at performing a feasibility study of quantitative imaging using a pixel-
lated spectroscopic detector. Future work should be aimed at bringing these applications closer to
the technical and clinical environment.
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The first step to evaluate the capacity of the system for the quantification of AuNPs would be to
acquire images using energy bands across the K-edge of gold in order to give a more direct comparison
with iodine. In order to perform an acquisition in clinically viable times, higher X-ray flux will be
needed and therefore further work should also include refining the dead time model of the detector
in order to correct for any underestimations of the reconstructed concentration that this may cause.
The dead time corrections already described in chapter 5 allowed an acquisition time reduction from
30 minutes to 2 minutes. However, further improvement is required to bring this in line with clinical
imaging times of under three seconds (Perry et al., 2006). As an example clinical benchmark, the
GE senobright dual energy system (Carton et al., 2012), described in section 2.3.2 claims that the
entire imaging procedure, including high end low energy images for two views of each breast with
compression and decompression in between takes 5 minutes.
Comparison with other spectroscopic detectors or larger detectors, such as Medipix (Ballabriga
et al., 2011), is also important. Aside from the count rate limitations, another major limitation of
the HEXITEC detector is its small imaging area which, at 2 cm x 2 cm is not ideal for clinical
mammography. However, recent advances to the detector have included both a 4 cm x 4 cm and a
10 cm x 10 cm version (Wilson et al., 2013, 2015).
Another important step to bring the technique closer to the clinical environment is to improve the
spatial resolution of the system. Measurements determined the 0.5 MTF level to be 3.7 ± 1 lp/mm,
which is not sufficient for the clinical requirements of 5-10 lp/mm needed to resolve features on the
order of 50-100 µm such as microcalcifications (Philips, 2011). A potential means to achieve the
required spatial resolution would be to use sub-pixel resolution algorithms to identify the centroid of
the charge distribution produced by an event. This is because the pixel size of HEXITEC, at 0.25
mm, is much larger than that of typical mammography detectors but reducing pixel size would lead
to more charge sharing events.
In addition to quantification of CA, a further potential clinical application of hyperspectral imag-
ing is quantification of breast density, i.e. the volumetric fraction of glandular tissue in the breast,
as several studies have suggested a link between breast density and the likelihood of breast cancer
(Turashvili et al., 2009b; Boyd et al., 2011b; Wanders et al., 2017). Previous studies (Ducote and
Molloi, 2010; Laidevant et al., 2010) have demonstrated the capability of DE for this application
and the use of a spectroscopic detector would have the previously highlighted advantages in terms
of dose reduction and energy optimisation. As well as in the medical field, other applications of
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dual energy imaging with spectroscopic detectors could also be investigated, such as improving the
imaging technology used in the food inspection industry, where products are routinely examined by
X-ray for contaminants.
Based on the radiobiology work, cell survival experiments could be further investigated with larger
datasets and, in particular, the effect of different concentrations of AuNPs at no or low radiation
dose. These experiments indicated a greater concentration dependence with AuNPs than with iodine
and therefore both a larger range of concentrations and more flasks per concentration should be
investigated. Although cell survival assays give an overall assessment of cell survival, they do not
provide information as to the mechanisms by which cell death occurs. This is important to establish
as these mechanisms are not fully understood. Therefore, because differences in colony size were also
seen, further and more advanced biological tests could be performed to investigate in more detail
the characteristics of the resulting colonies. Further techniques such as flow cytometry, in which a
cell solution is fed one cell at a time through a laser and quantitative information can be determined
by the scattering of the light. This has been used in the literature for cell cycle analysis (Jain
et al., 2011; Coulter et al., 2012). Trypan Blue Exclusion assays or MTT assays could also help
provide a more in-depth analysis into the exact mechanisms by which AuNPs interact with cells.
Improved and refined methods of growing and counting colonies could alkso be adopted to allow a
more typical counting method without the need for percentage cover calculation. This would allow
results to be more comparable to literature values. Part of this work could include more thorough
plating efficiency tests to determine optimum number of cells to seed as well as refining the plating
techniques to remove clumping and allow for a more even distribution of cells.
A recurring theme in the literature is the difficulty in directly comparing AuNP studies due to
the vast range of AuNP sizes, surface coatings and concentrations as well as the cell lines, radiation
levels and beam quality used (Butterworth et al., 2012; Rosa et al., 2017). For example, smaller
AuNPs are thought more likely to cause toxicity and bind onto cell surfaces more easily than larger
nanoparticles (Jong et al., 2003). In-vivo studies on rate have shown that AuNP distribution is also
dependent on nanoparticle size, with smaller AuNPs (10 nm diameter) accumulating in more organs
than larger AuNPs (50-250 nm). AuNPs of other shapes and sizes therefore need to be investigated
and compared to determine whether there is a relationship between particle size and cell survival,
as many AuNP studies have used different combinations which have generated conflicting results. A
study into how functionalisation could be used to improve contrast-enhanced imaging with AuNPs
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would also be beneficial (Thanh and Green, 2010).
The cell line chosen for this work was MCF-7. The experiments in this work were not aimed
at comparing cell lines but rather to compare the effect of each contrast agent for the same cells.
However, if time had permitted, the results with the MCF-7 cells would have been compared to a
healthy human breast cell line such as MCF-10A or MCF-12A (Sweeney et al., 2018) as healthy
cells would be relevant for diagnostic irradiation. As further work this would allow a comparison of
AuNPs and iodinated CA for both healthy and cancerous cells, which would be particularly useful
for theranostic applications.
The effects and differences between typical manual colony counting methods and of other tech-
niques, such as percentage cell cover, could also be compared as results suggested differences in the
relationships between size and number of colonies with both dose and AuNP concentration.
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